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ABSTRACT

Cerebrovascular Dysfunction and Degeneration in
Alzheimer’s Disease Pathophysiology
Dominic D. Quintana

Alzheimer’s disease (AD) is a terminal illness and the most common form of dementia,
which disproportionately affects the aged population. The pathophysiology of AD is
characterized by neurodegeneration that slowly progresses, affecting regions of the brain that
are involved in learning, memory, language, and executive function. In patients with the
disease, early symptoms include non-disruptive forgetfulness that evolves into the inability to
form new memories and ultimately the loss of autonomy at late stages. Histopathological
hallmarks in the brain from patients with AD is the presence of amyloid-β (Aβ)-plaques and
neurofibrillary tangles (NFT) deposited in the parenchyma. Since the discovery of these
hallmarks, the majority of AD research has disproportionately focused on Aβ -plaques and
NFT. Although the etiology of AD remains unknown, considerable advances have been made
describing the cellular, molecular, and genetic contributions to the disease. Aging is the
important risk factor for the development of AD, many other factors that increase the risk of
developing AD later in life are vascular in nature. The function of the cardiovascular system is
known to decline during healthy aging, and the same is true for the cerebrovasculature.
Empirical evidence has demonstrated a decline cerebrovascular function in AD that exceeds
the decline that occurs in healthy aging. Cerebrovascular dysfunction is the major contributor
to the development of hypoperfusion and hypometabolism in patients diagnosed with AD.
Cerebral amyloid angiopathy (CAA) is a neuropathological condition defined by the abnormal
accumulation of Aβ on the walls of the cerebrovasculature. CAA occurs in as many as 90% of
patients with AD and is implicated in the weakening of the walls of cerebral blood vessels.
The occurrence of microhemorrhages, aneurysms, and microinfarctions are pathological
manifestations associated with weakened walls of cerebral blood vessels in the brains of
patients with confirmed AD. Noteworthy, cerebrovascular dysfunction, hypoperfusion, and
hypometabolism occur before the onset of Aβ-plaque and NFT deposition in the brain of
patients and animal models with AD. These findings provide a compelling basis that suggest a
prominent role of dysfunctional cerebrovasculature in the etiology and for the progression of
AD.
Although the overwhelming evidence that implicates cerebrovascular dysfunction in
AD, a thorough account of the changes that occur to the cerebrovasculature nor the
mechanisms that drive these changes during the development and progression of AD has not
been previously reported. The overarching goal(s) of this work are to; (1) provide a thorough

description of the changes that occur to the cerebrovasculature during age and the progression
of AD; (2) describe the mechanisms involved in cerebrovascular damage in AD; and (3)
characterize the degeneration that results from cerebrovascular hypoperfusion. These
overarching goals were achieved by completing five separate studies. Described in study 1, we
investigated the effects of hypoxia on astrocytic mitochondria by assessing mitochondrial
fission-fusion dynamics, reactive oxygen species production, synthesis of ATP, and
mitophagy. Overall, we found a drastic mitochondrial network change that is triggered by
metabolic crisis during hypoxia; these changes are followed by mitochondrial degradation and
retraction of astrocytic extensions during reoxygenation. In study 2, we provide a novel model
for the gradual development of cerebrovascular hypoperfusion in mice. Cerebrovascular
hypoperfusion developed over 34-days by inserting an ameroid constrictor ring and microcoil
bilaterally around the external carotid arteries. We investigated the neurodegenerative effects
of hypoperfusion in mice by assessing both gray and white matter pathology. Histopathological
analyses of the brain revealed neuronal and axonal degeneration as well as necrotic lesions.
The most severely affected regions were located in the hippocampus and corpus callosum.
Described in study 3, we performed a series of experiments to investigate the effects of Aβ on
cerebrovascular endothelial cells. In this study, we focused on characterizing the changes to
mitochondrial oxidative phosphorylation, superoxide production, mitochondrial calcium, ATP
synthesis, and endothelial cell death. These results describe a mechanism for mitochondrial
degeneration caused by the production of mitochondrial superoxide, which was driven by
increased mitochondrial Ca2+ uptake. We found that persistent superoxide production injures
mitochondria and disrupts electron transport in cerebrovascular endothelial cells. In study 4,
we developed a method to evaluate the cerebrovasculature of the whole-brain and constructed
analyses to assess the angioarchitecture. We used vascular corrosion casting method to
replicate the cerebrovasculature in adult mice and used MicroCT to acquire volumetric
imaging data of the cerebrovascular network at a resolution required to investigate the
microvasculature. Our analyses of the cerebrovasculature evaluated the morphology, topology,
and organization of the angioarchitecture. With these developments, we investigated the effects
of age and progression of disease on the cerebrovasculature in wild type mice and the triple
transgenic mouse model of AD. Study 5 provides data describing degenerative changes to the
microvascular network that progress with age in the triple transgenic mouse model of AD.
These changes to the microvasculature occurred early, before the onset of Aβ-plaque
deposition and NFT development.
Overall, this body of work provides evidence of an early cerebrovascular disruption in
the etiology of AD that progresses with age. Aβ mediates early cerebrovascular damage
through direct interaction with vascular endothelial cells. Microvascular degeneration can lead
to hypoperfusion which damages both gray and white matter. Hypoperfusion-associated
hypoxia may mediate parenchymal damage by disrupting mitochondrial fission-fusion
dynamics and enhancing mitophagy. These data provide a basis for the development of novel
therapeutic strategies that target the changes to the cerebrovasculature for the treatment of AD.
These observations may substantiate a prophylactic strategy for the treatment of AD by
preventing the initial factors that lead to compromised cerebrovasculature.
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Chapter 1
Introduction and Literature Review
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Introduction and Literature Review
Ageing is a terminal condition, characterized by a slow progressive loss of an
organism’s viable state. The complex network of factors that determine an individual’s unique
pattern of aging is dependent of the genetic, environmental, and circumstantial elements that
occurs throughout life. Aging is unavoidable. However, the pathway that we take during aging
can be refined with technological and biomedical advancement, so that our course through life
is a pleasant one.

Background
The cerebrovascular system is a complex array of interconnected pathways that
participate in a stringently regulated transport of fluid throughout an elaborate network of
vessels. These systems provide crucial functions that maintain metabolic and homeostatic
states of the cerebral tissue. Under physiological conditions, the hemodynamic demand of the
brain fluctuates in accordance to the specific condition and activity of the cerebral tissue.
Frequent changes in neuronal activity during normal function determine specific hemodynamic
parameters to be met at the submicron level. Therefore, to match these functional requirements,
the cerebrovasculature must maintain a highly dynamic and sensitive state to remain
sufficiently responsive to the fluctuating demand of the central nervous tissue. Due to this
highly sensitive nature, the cerebrovascular system is exceptionally responsive to pathological
conditions. It is likely that even the smallest dysregulation of physiological cerebrovascular
signaling or function will manifest into vascular dysfunction implicating the dynamic
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properties of the system and would compromise its regulatory potential and likely result in a
failure to meet hemodynamic demand of the cerebral tissue.
Vascular pathology is a known risk factor for the development of Alzheimer’s disease
(AD) and other dementias. However, the precise role of dysfunctional vasculature in AD
progression remains unknown. The aim of this research is to identify the mechanism by which
the accumulation of amyloid-β (Aβ) on or within the cerebrovasculature exerts structural and
functional changes associated with vascular damage and degeneration, and to determine how
these changes influence the progression of AD.
A role for the dysfunction of the cerebrovasculature in the development and
progression of AD is likely to occur. A number of reports made in human AD show regional
hypoperfusion, hypometabolism, and blood-brain barrier hyperpermeability; the hallmark
pathology of dysfunctional vasculature (de la Torre 2004; Brundel et al. 2012b; Brundel et al.
2012a). To date, a large prevalence of patients with AD are at risk for developing severe
vascular conditions including, hemorrhagic stroke, spontaneous cerebral emboli, cerebral
microinfarctions, and microhemorrhages (Chi et al. 2013; Brundel et al. 2012a; Purandare and
Burns 2009; Tolppanen et al. 2013). The increased prevalence of developing these severe
vascular conditions is substantial evidence indicating a degrading cerebrovascular integrity in
patients with AD. Recently, a body of evidence has emerged documenting cerebrovascular
dysfunction preceding cognitive decline in AD patients (de la Torre 2010; Jellinger 2010;
Kalaria 2010). Although, vascular issues are co-morbid in 90% of all AD cases, a significant
deficit exists in the field that adequately describes the role for the cerebrovascular system in
the neurodegeneration in AD.

4

The entirety of this research has been conducted to assess the following hypothesis;
the accumulation of Aβ on the cerebral microvasculature compromises capillary function
resulting in cerebrovascular hypoperfusion and vascular degeneration.
The hypothesis will be assessed by means of completing the following research aims:
(1) to identify the specific structural and functional changes that occur to the cerebral
vasculature during the progression of AD; (2) to characterize the time-course of cerebral
amyloid angiopathy (CAA) development in 3xTg AD mice and to evaluate its pathogenicity
on cerebral microcirculation; and (3) to assess the hemodynamic state that follows the changes
to the cerebrovasculature in aging 3xTg AD mice.

Anatomy of the Cerebrovascular System
Arterial System
Arterial blood supply can enter the cranium through two pairs of cerebral arteries, the
carotid arteries and the vertebral arteries (Figure 1.1). The vertebral arteries supply blood to
the upper part of the spinal cord, brain stem, cerebellum and posterior part of the brain. The
vertebral arteries lie on the surface of the brain stem and join at the medulla oblongata, forming
the basilar artery. Projecting laterally from the vertebral arteries over the surface of the brain
stem, are the posterior inferior cerebellar arteries. Further along the vertebral arteries, the
anterior spinal arteries project toward the midline, fusing into a single anterior spinal artery
over the medulla oblongata. The basilar artery that is formed by the joining of the two vertebral
arteries ascends superiorly over the basilar sulcus ventral to the pons, where it then terminates
by branching into the two posterior cerebral arteries at the Ponto mesencephalic junction close
5

to the pituitary stalk. The basilar artery projects a number of branches laterally, including the
anterior inferior cerebellar arteries, labyrinthine arteries, pontine arteries, and superior
cerebellar arteries. The posterior cerebral arteries supply blood to the posterior aspect of the
brain, are formed from the branching of the basilar artery. The posterior cerebral arteries
project a number of branches into the cortex, including the anterior temporal branching that is
distributed between the uncus and the anterior part of the fusiform gyrus. The posterior
temporal branching of the posterior cerebral arteries extends into the fusiform and the inferior
temporal gyri. The lateral occipital branching of the posterior cerebral artery further branch
into the anterior, middle, and posterior inferior temporal arteries. The medial occipital branch
extends into the calcarine, cuneus, gyrus lingualis, and the posterior aspect of the occipital
lobe. A stroke involving the posterior cerebral arteries, can cause the development of
prosopagnosia, defects in the oculomotor nerve, defects of the facial nerve, Horner’s syndrome
and visual field defects. The posterior cerebral arteries communicate blood flow to the middle
cerebral arteries via posterior communicating arteries. The middle cerebral arteries project
laterally to the sulcus then branching to the lateral cerebral cortex, temporal lodes, and insular
cortices. Following a stroke that involved the middle cerebral arteries, paralysis, sensory loss,
Broca’s aphasia, Wernicke’s aphasia, and contralateral neglect syndrome can result.
Converging on the middle cerebral arteries, the carotid arteries constitute the second route of
arterial blood entering the cranium. Branching from the middle cerebral arteries, the anterior
cerebral arteries extend frontally then loop back around between the two hemispheres at the
midline fissure above the corpus callosum and continue to extend posteriorly. The anterior
cerebral arteries supply blood to the frontal lobes and to the superior medial parietal lobes.
Anterior cerebral artery syndrome can result following a stroke that involved the anterior
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cerebral arteries. Anterior cerebral artery syndrome is characterized by the loss of sensory
perception and weakness to the foot and lower leg contralateral to the lesion. The anterior
cerebral arteries are joined by a conduit noted as the anterior communicating artery. Together,
the posterior cerebral arteries, posterior communicating arteries, internal carotid arteries,
anterior cerebral arteries, and the anterior communicating artery composes an arterial system
known as the circle of Willis. The circle of Willis is a ring-like structure formed by
anastomoses that serves a function of redundancy allowing collateral circulation of cerebral
blood flow. This redundancy is advantageous in the event of an occlusion of any artery that
composes the circle, allowing the delivery of blood from the remaining anastomotic segments.

Pial Network
Consisting of large veins and arteries, the pial network forms a large number of loops
within the venous and arterial networks. These loops serve vital functions in the maintenance
of continuous blood flow by providing redundant pathways of blood delivery to cortical areas
that protect cerebral tissue against ischemic perturbations in blood flow (Blinder et al. 2010).
In a mathematical simulation of stroke, the occlusion of any pial vessel is compensated for by
the shunting of blood flow from other areas to the occluded region (Schaffer et al. 2006). In
contrast to these vascular loops providing redundancy of blood flow, arteriovenous
anastomoses are another form of vascular loop that seem to contribute to instead of protecting
against pathology (Duvernoy et al. 1981). The development of arteriovenous anastomoses is
problematic in that these new networks provide pathways that allow blood flow to bypass
capillary networks and flow directly into the venous system.

7

Figure 1.1. Diagram of the major cerebral arteries. Ventral perspective of the major cerebral
arteries including the vertebral arteries, internal carotid arteries. Magnified ventral
perspective depicting the major cerebral arteries that form the circle of Willis. Sagittal
perspective of the anterior cerebral arteries, middle cerebral arteries, and posterior cerebral
arteries on the surface of the brain. Sagittal perspective at the midline of the brain depicting
the anterior cerebral artery and posterior cerebral artery within the internal structures of a
hemisphere of the brain.
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Venous System
The organization of the venous system is inverse of the arterial system in that many
venioles systematically join into larger veins and these veins feed blood to the sinus. The
cerebral venous system often classifies into five divisions, the external and internal veins, the
meningeal veins, dural sinuses, and the posterior fossa veins (Kiliç and Akakin 2008). The
cerebral veins are often divided into internal and external veins that correlates to the area of
the brain that they drain. The external venous system consists of the cortical veins and the
sagittal sinus that drains the superficial surface of the cerebral hemispheres (Figure 1.2, top).
The internal venous system consists of the straight sinus, sigmoid sinus, and the transverse
sinus including the deeper cortical veins (Figure 1.2, bottom). Of the external division,
consisting of the superior, inferior, and middle cerebral veins, which drain into the basal vein
(Kiliç and Akakin 2008).

Vessel Wall Biology
Glycocalyx
The glycocalyx is the innermost lumenal layer of the vascular wall extending from the
lumen to the internal elastic lamina. The glycocalyx is a carbohydrate-rich matrix that lines the
surface of endothelial cells and is thought to maintain this position via interactions of
proteoglycans and glycoproteins, which form a structural backbone that facilitate the
incorporation of other molecules from blood plasma and endothelial derived. The glycocalyx

9

Figure 1.2. Diagram of the major cerebral veins and sinus. Sagittal perspective of the
surface of the brain and at the midline of the major cerebral sinus and veins including,
superior sagittal sinus, confluence of sinus, straight sinus, sigmoid sinus, transverse sinus,
superior anastomotic vein of Trolard, inferior anastomotic vein of Labbe, superficial
midline cerebral vein, internal jugular vein, great vein of Galen, basal vein of Rosenthal,
and internal cerebral vein.
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is generally considered associated with the endothelium and is often identified as the
endothelial glycocalyx. Additionally, the composition of the glycocalyx differs between its
endothelial exposed surface and the surface exposed to the vascular lumen. The lumenal
surface of the glycocalyx exists in a dynamic state with the soluble components in the blood
plasma and flow mediated shearing. Blood plasma derived soluble components are
incorporated into a network of proteoglycans, glycoproteins, and glycosaminoglycans to form
the glycocalyx as a positive function to blood flow. However, as blood flow increases the
shearing off rate of the glycocalyx increases proportionally.

Function of the Glycocalyx
The endothelial glycocalyx is an influential factor of vascular permeability (Vink and
Duling 2000; Henry and Duling 1999). The glycocalyx contributes to endothelial barrier
formation via steric and electrostatic hindrance (Ueda et al. 2004). Many of the
glycosaminoglycan chains are heavily sulfated resulting in the glycocalyx having a net
negative charge (Ueda et al. 2004). Experimental neutralization of the glycocalyx charge
increases the uptake of albumin in cultured endothelial cells (Ueda et al. 2004) and increased
permeability of fluorescent dextrans (van Haaren et al. 2005). The glycocalyx also functions
in repulsing red blood cells from the endothelium (Vink and Duling 1996). The repulsion of
red blood cells from the lumenal wall of the endothelium composes a red blood cell (RBC)
exclusion zone (Vink and Duling 1996). The interaction between red blood cells and the
glycocalyx influence local blood viscosity and blood flow resistance (Pries and Secomb 2003;
Lipowsky 2005).
Exposure of the glycocalyx to high shear stress has been reported to result in an increase
in the amount of hyaluronan in the glycocalyx by approximately two-fold (Gouverneur et al.
11

2006) suggesting a mechanism for sensing shear stress by endothelial cells. Shear stress has
also been shown to reduce the thickness of the glycocalyx in the mouse carotid artery whereas
regions that maintain laminar flow had a relatively thick glycocalyx layer (van den Berg et al.
2006). Shear stress is thought to be signaled through the glycocalyx core proteins that are then
transduced into specific cell signaling processes such as nitric oxide production and
reorganization of the cytoskeleton (Tarbell and Pahakis 2006).

Proteoglycans
Proteoglycans are considered the most important molecular component of the
glycocalyx, serving as the major structural component of the matrix, and are termed the “backbone” molecule. A number of variations of proteoglycans exist that differ relative to the
specific core protein the molecule contains. The particular core protein that is incorporated into
a proteoglycan determines the size and number of glycosaminoglycans that can be attached to
the complex and determine whether the complex is attached to the endothelial surface. The
core proteins syndecans and glypicans result in a firm attachment to the cell membrane via
membrane-spanning domain of a glycosylphosphatidylinositol domain in syndecans or
glypicans, respectively (Carey 1997; Fransson et al. 2004). The proteoglycan core proteins
mimecan, perlecan, versican, decorin, and biglycan are secreted after their assembly and
glycosaminoglycan chain modification, resulting in soluble proteoglycans that diffuse into the
blood stream or reside in the glycocalyx (Iozzo 1994; Kinsella et al. 2004). Syndecan-1
proteoglycan is often addressed as a heparin sulfate proteoglycan, while containing similar
numbers of heparin sulfate and chondroitin sulfate chains (Mulivor and Lipowsky 2004).
Syndecans are stringently regulated by endothelial cell activation and by chemokine signaling
(Tkachenko et al. 2005).
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There are five different types of glycosaminoglycan chains, keratan sulfate, heparin
sulfate, chondroitin sulfate, dermatan sulfate, and hyaluronan (Funderburgh 2000; Laurent and
Fraser 1992). Heparin sulfate, dermatan sulfate, and chondroitin sulfate containing
proteoglycans are synthesized in the endoplasmic reticulum and Golgi apparatus of endothelial
cells. The glycosaminoglycan chains are composed to linear polymers of disaccharides with
variable lengths that are modified by sulfation or deacetylation to a variable extent. The
composition of the disaccharides includes uronic acid and hexosamine. The specific
classification of glycosaminoglycan depends on the incorporation of uronic acid or hexosamine
and the specific pattern of sulfation (Esko and Selleck 2002).
In the vasculature, heparin sulfates proteoglycans represent as much as 50-90% of the
total amount of proteoglycans present in the glycocalyx (Pries et al. 2000; Ihrcke et al. 1993).
Chondroitin sulfate is the second most abundant glycosaminoglycan found in the endothelial
glycocalyx (Rapraeger et al. 1985). Hyaluronan is a polymeric molecule that does not link to
any core proteins but can be found attached to its assembly molecule, hyaluronan synthase that
is located on the cytosolic region of the cell membrane (Weigel et al. 1997).

The Glycocalyx in Pathology
The endothelial glycocalyx provides a number of indispensable roles to blood vessels
that are protective, including the regulation on vascular permeability, limiting red blood cell
interaction with vessel walls, sensing of shear stress, and signal transduction.
Ischemia/reperfusion injury has been shown to reduce the thickness of the glycocalyx in rat
mesenteric venioles (Mulivor and Lipowsky 2004) likely caused by the shedding of
glycosaminoglycan chains from the glycocalyx.
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Endothelium
Endothelial cells are the principal cells of vessels and form a layer called the
endothelium, which is the innermost cell compartment of all hierarchy of vessels (Figure 1.3).
The endothelium forms a size-selective semipermeable barrier between the interstitium and the
blood plasma. Endothelial barrier formation regulates the passage of plasma proteins, solutes,
and fluid across the endothelium via transcytosis and paracellular permeability. The
approximate cell thickness varies from 0.1 μm in the capillaries and veins to 1 μm in the aorta.
Endothelial cells are oriented to the direction of blood flow and overlap immediately adjacent
cells of the endothelium. The membranes of adjacent cells are separated by an intercellular
space of 15 to 20 nm is size. The lumenal surface of the endothelium is covered by a
glycoprotein coat termed the glycocalyx. The endothelial cells are supported by the basal
lamina, an acellular extracellular matrix layer present to all vessels. The basal lamina is located
at the basolateral surface of the endothelium, where is provides attachment and supports
endothelial processes such as migration and proliferation. In vitro studies have demonstrated
that endothelial cells cultured on different basal lamina components produces different rates of
gap junctions, cell proliferation, membrane proteins, and actin messenger RNA (Kocher and
Madri 1989; Grant et al. 1991).

Endothelial Cell Transport and Barrier Formation
Endothelial cell transport is a crucial process that maintains the viability of cerebral
tissue. Endothelial cell transport mechanisms allow the influx of nutrients and signaling
molecules from periphery into the brain via both passive and active mechanisms. The passive
movement of solutes from the blood to the extralumenal space occurs via the paracellular
pathway – the space between endothelial cells. In contrast, the active movement of molecules
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from blood to the extralumenal space occurs via transcytotic pathway that involves ATPdependent cellular machinery. Paracellular transport and transcellular transport are typically
considered to be non-interacting independent pathways that can modulate endothelial barrier
function. However, recent progress in the field is beginning to reveal that these pathways
cooperate in some physiological processes such as the maintenance of tissue fluid homeostasis.

Paracellular Transport
Paracellular transport is innately coupled to the permeability of the endothelium and in
most cases is an effective transport pathway for solutes smaller than 3 nm in radius (Komarova
and Malik 2010). Therefore, large macromolecules must follow the transcellular transport
pathways for entrance to the extralumenal compartment. In paracellular transport, the
permeability of the endothelium to solutes is governed by the presence of cell-cell junction
proteins that function by holding adjacent endothelial cells together on the endothelium. There
are two classes of cell-cell junction proteins present on the endothelial cell membrane that
restrict permeability, tight junction proteins and adherens junction proteins (Irudayanathan et
al. 2017). While tight junctions and adherens junctions primarily function to promote adhesion
of opposing cells in the monolayer and to mediate selective permeability, gap junctions
assemble to form channels between immediately adjacent endothelial cells that allow the
passage of water, ions, and solutes, and participate in paracellular signaling between
endothelial cells. Together, these interendothelial junction proteins form a highly size-selective
barrier that can be regulated by modulating the density of these proteins.

Transcellular Transport
Transcellular transport is an energy-dependent process that can occur via a receptordependent or receptor-independent pathway. The transport of molecules across endothelial
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cells requires an extensive network of cellular machinery that serve in functions such as
endocytosis, endocytic trafficking, cargo localization, and exocytosis. The initial step of
transcytosis occurs at cholesterol rich invaginations termed caveolae, where a complex chain
of molecular events trigger the endocytosis of cargo molecule(s) by caveolar fission from the
lumenal surface of the membrane (Minshall et al. 2002; Predescu et al. 2001; Tuma and
Hubbard 2003). Endocytosis of the cargo molecule(s) result in the formation of an endocytic
vesicle that must enter the correct vesicular trafficking pathway for proper delivery to the
ablumenal surface of the cell. After endocytosis, the cargo-containing vesicle enters the
secretory pathway and localizes to the appropriate docking site on the inner surface of the
ablumenal membrane. Once docked, the cargo can be released by exocytosis via vesicular
membrane fusion with the plasma membrane (Minshall et al. 2002). Transcytosis of molecules
can be regulated at nearly all stages of the transcellular transport pathway by protein complexes
and processes that function in receptor-mediated recruitment of cargo to caveolae domains for
endocytosis and/ or vesicle sorting and recycling. As such, the selectivity of molecules that are
transported transcellularly by these cellular mechanisms allows the endothelial barrier to
maintain a stringently regulated permeability to very specific molecules.

Basal Lamina
The basal lamina borders the ablumenal surface of endothelial cells and forms an
essentially continuous boundary between the endothelium and underlying structures of the
intima (Figure 1.3). The basal lamina is a major source of support and attachment of the
endothelial layer but also influences vascular permeability and the initiation of blood clotting
(Kramer et al. 1984). The basal lamina consists of the lamina rara (inner zone) and the lamina
densa (dense fibrillar zone) (Makhoul and Dattilo 1998). The lamina rara is composed
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primarily of the glycoprotein laminin, whereas the lamina densa is composed of collagen type
IV. The basal lamina provides a lithe substrate for cell attachment, allowing the endothelium
to accommodate mechanical displacement caused by cardiac pulsations and with the torsion of
vessels (Ts’ao and Glagov 1970).
The basal lamina is a major source of structural fortification of the vascular wall,
primarily attributed by the type IV collagen-rich composition of the lamina densa. The
covalently stabilized, polygonal framework of the type IV collagen chains afford the
mechanical resilience of the dense fibrillary layer (Wang and Shuaib 2007; Schnittler et al.
1993). Collagen is a proline-rich protein of helical structure and is essential for the attachment
of endothelial cells to the subcellular matrix (Madri and Pratt 1986; Ingber and Folkman 1989).
Endothelial cells are attached to the collagen component of the lamina densa via self-assembled
laminin of the lamina rara (Wang and Shuaib 2007; Schnittler et al. 1993). Fibronectin
redistributes mechanical force between the extracellular matrix and the integrin receptors on
the surface of vascular smooth muscle cells (vSMC) (Laurent et al. 2005). Microvascular
endothelial cells preferentially attach and migrate to fibronectin, opposed to laminin and
collagen (Makhoul and Dattilo 1998). Entactin binds both laminin and collagen.
In addition, the basal lamina is composed of glycoproteins, adhesion molecules
(laminin, fibronectins, entactin, and thrombospondin), proteoglycans (heparin sulfate), and
fibrils (type IV and V collagen) (Schnittler et al. 1993). The reticular layer of the endothelium
is composed of type I and III collagen, which are deposited by both vSMCs and endothelial
cells. While, type IV collagen is produced exclusively by endothelial cells.
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Figure 1.3. Diagram depicting the layers of the vessel wall specific to vessel hierarchy. The
composition of the vessel wall and the specific layers that it comprises provides physical
attributes to the vessels related to their function.
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Cellular and Molecular Biology of the Cerebrovascular
System
Endothelial Cell Regulation of the Coagulation Cascade
Arguably, the most important function mediated by the vascular endothelial cell is the
inhibition of the coagulation cascade for the prevention of thrombus formation. The
coagulation cascade can be triggered by various forms of physiological stress including;
vascular wall injury, circulatory stasis, and hypercoagulable state. For instance, the
vasoconstriction caused by a vascular spasm can result in injury to the lining of blood vessels,
exposing collagen fibers of the basal lamina to circulating platelets in the lumen of blood
vessels. Platelet adherence to collagen fibers forms a ‘platelet plug’ followed by the deposition
of fibrin that forms a mesh (clot).
Initiation of the coagulation cascade is mediated by an enzyme complex consisting of
factor VIIa and the tissue factor (TF) catalytic accelerator, which catalyzes the conversion of
clotting factor IX and X to coagulation factor IXa and Xa, respectively. Coagulation factor X
conversion to activated coagulation factor Xa can occur by the binding of factor IXa to cofactor
VIII. Factor Xa is a prothrombin-converting enzyme to active thrombin, a protease that cleaves
fibrinogen, liberating fibrin. Self-assembly of fibrin results in the formation of a mesh, the
initial structure of a clot and the core of a thrombus. The fibrin lattice forms on the surface of
blood vessels, where it captures circulating erythrocytes and platelets furthering the growth of
the thrombus. The fibrin lattice at the core of the thrombus is the therapeutic target of the tissue
plasminogen activator (tPA) intervention.
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Interestingly, the head group moiety of the phospholipid, phosphatidylserine is an
essential catalytic substrate that is required by the various protease complexes of the
coagulation cascade. However, healthy cells stringently maintain phosphatidylserine
exclusively to the inner leaflet of the cell membrane. Therefore, the phosphatidylserine must
be sourced by a readily available and rapidly modulated mechanism.
Degranulation of platelets provides the phosphatidylserine-rich substrate for the
coagulation cascade to occur. For essentially every mechanistic step of the coagulation
cascade, vascular endothelial cells provide an inhibitory mechanism that prevents clot
formation. Endothelial cells can prevent platelet activation by inhibiting several signaling
mechanisms that initiate platelet degranulation: (1) production of ectoenzymes that catabolize
the purine nucleotides ATP and ADP; (2) inhibition of thrombin; (3) and prevent the exposure
of collagen from the basal lamina. In addition, the release of prostacyclin and nitric oxide (NO)
also inhibit platelet activation by antagonizing the activity of the factor VIIa-TF complex,
preventing the proteolytic activation of clotting factor IX and X, respectively.
Thrombomodulin is an endothelial surface protein that alters the conversion of fibrinogen to
fibrin by binding and modifying thrombin, causing it to instead, proteolytically activate protein
C. Activated protein C binding to endothelial cell derived protein S inactivates factor VIII and
V, inhibiting the actions of coagulation factor IXa and Xa, respectively. Lastly, the liberation
of fibrin from fibrinogen can be halted by thrombin inhibition via endothelial cell-derived
heparin sulfate-mediated activation of plasma-derived antithrombin III.
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Endothelial Cell Death Mechanisms
Oxidative Stress
Reactive oxygen species (ROS) are highly reactive molecules that are generated from
the partial reduction of molecular oxygen. Endothelial cells produce several protein catalysts
of ROS production; phagocyte oxidase (Phox), NADPD-dependent oxidase (Nox); and in
rodents, xanthine oxidase. In endothelial cells, ROS generation may serve as a second
messenger signaling molecule that participate in endothelial cell proliferation, barrier
formation, vasorelaxation, and vascular remodeling (Rhee et al. 2000). The Nox enzyme has
been implicated in the dysfunction of endothelial cell in pathology, including heart failure,
cardiac hypertrophy, atherosclerosis, hypertension, and Alzheimer’s disease (Keaney 2005).
At low concentrations, H2O2 can increase the expression of ICAM-1 and the major
histocompatibility complex (MHC) class I, but not E-selectin or the vascular cell adhesion
molecule-1 (VCAM-1) on the endothelial cell membrane (Bradley et al. 1993). Large amounts
of H2O2 can trigger endothelial cell apoptosis and necrosis. The molecular events leading to
endothelial cell apoptosis are mediated by p38 mitogen-activate protein kinase (MAPK) and
the c-Jun N-terminal kinase (JNK). Both of which are activated by apoptosis-signaling kinase1 (ASK1)-mediated cascade.
ROS-induced activation of ASK1 can occur via several actions. (1) ROS can lead to a
reduced amount of glutathione and thioredoxin in endothelial cells, both of which keep ASK1
inactive upon binding (Song and Lee 2003; Liu and Min 2002). (2) Protein 14-3-3 binds and
inhibits ASK1 in endothelial cells that are not activated. Upon activation, ROS can release
ASK1 from protein 14-3-3, allowing apoptotic signal transduction (Zhang et al. 1999). (3)
Activation of ASK1 can occur by the ROS-mediated activation of protein kinase D (PKD).
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ROS induces the phosphorylation of PKD, triggering its translocation form the surface of the
endothelial cell membrane and into the cytosol where is interacts with ASK1 resulting in the
autophosphorylation and oligomerization for the activation of ASK1. Experimental inhibition
of PDK prevents the ROS-induced activation of ASK1 and JNK, preventing endothelial cell
apoptosis (Zhang et al. 2005).
JNK activation via ASK1 is an essential step in the signaling mechanism for endothelial
cell apoptosis. The activation of JNK induces the proteolytic activation of Bid, causing its
insertion into the mitochondrial membrane where it interacts with the protein Bax. Binding of
Bax, causes it dimerization and the initiation of mitochondrial release of several effector
molecules. Cytochrome c release from the mitochondria can bind to apoptotic proteaseactivating factor (APAF1), resulting in the activation of procaspase-9. The active caspase-9
results in the activation of effector caspase-3 and -6 that leads to apoptotic cell death. In
addition to cytochrome c, mitochondria release second mediator of apoptotic cell death
(SMAD), which augments caspase-9 activation of caspase-3 by inhibiting the X-linked
inhibitor of apoptosis protein, a regulation molecule of caspase-3. Overall, these signaling
pathways for endothelial cell apoptosis during oxidative stress indicate a central role for ASK1
in the activation of JNK-Bid/Bax-cytochrome c-dependent apoptosis.

Endoplasmic Reticulum Stress
The accumulation of misfolded proteins in the endoplasmic reticulum (ER) can trigger
a stress response (Marciniak and Ron 2006). Unfolded proteins are sensed by ER resident
proteins PKR-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositolrequiring enzyme 1 (IRE1). These transmembrane proteins contain ER stress sensing domains
within the ER lumen and cytosolic domains that transduce signaling that initiate the expression
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of genes involved in protein degradation or apoptotic cell death (Lin et al. 2008). Activation
of PERK, a serine/threonine protein kinase, phosphorylates eukaryotic initiation factor 2α
(eIF2α) that serves as a cofactor to the 80S ribosome assembly, thereby preventing ER protein
loading by attenuating the synthesis of new proteins. The activation of eIF2α can also induce
the translation of ATF4, which increases the expression of CHOP, a transcription factor that
promotes apoptotic cell death. Activated IRE1 cleaves XBP-1 mRNA, producing a
transcription factor of genes involved in protein degradation. Activation and binding of IRE1
to TNF receptor-associated factor 2 (TRAF2) couples ER stress to the activation of ASK1JNK (Urano et al. 2000; Matsuzawa et al. 2002).

Metabolic Stress
Hyperglycemia or the metabolism of free fatty acids can elicit common
proinflammatory and oxidative stress signaling. Such as, hyperglycemia can cause the
glycation of extracellular plasma proteins and cellular proteins resulting in the formation of
advanced glycation end products. Advanced glycation end products bind to the putative
receptor on endothelial cells that activate protein kinase C signaling pathways. In addition,
hyperglycemia can upregulate the expression of extracellular matrix and procoagulation
proteins, decrease endothelial cell proliferation, inhibit fibrinolysis, and increase endothelial
cell apoptosis. Metabolism of sphingolipids results in the production of ceramide that causes
endothelial cell death, at low concentrations. The PI3K-Akt pathway is a major pathway in
insulin signaling that regulates metabolic function. In endothelial cells, Akt activation causes
the phosphorylation of eNOS at Ser-1177, resulting in the release of NO (Fulton et al. 1999;
Dimmeler et al. 1999). Mice with dysfunctional Akt-eNOS pathway signaling demonstrate
impaired endothelium-dependent vasodilation (Abe et al. 1998). This suggests that metabolic
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stress can have direct consequences on endothelial cell function, including the regulation of
blood flow.

The Calcium Channels of Endothelial Cells
Non-selective Cation Channels
Non-selective cation channels (NSCC) allow many types of cations through the channel
(Na+, K+, Ca2+). A recent report documents NSCC members of the purinergic ligand-gated
receptor channel family in cultured vascular endothelial cells. The P2X4 receptors have been
observed in primary cultures of endothelial cells from the microvasculature (Yamamoto et al.
2000b). The P2X4 receptor is functionally involved in ATP and shear stress induced Ca2+
influx (Yamamoto et al. 2000a).
Receptor-activated cation channels (RACC) have been described in endothelial cells.
The larger number of these channels are activated by signaling mechanism involving
phospholipase C. RACCs that are activated by Ca2+ signaling are also permeable to Ca2+,
therefore forming a positive feedback loop for intracellular [Ca2+]. There is a number of Ca2+permeable NSCCs that are activated by vasoactive compounds (Nilius 1990; Nilius et al.
1993a; Nilius and Riemann 1990; Nilius et al. 1993b). The channel-mediated current is slow
activating and is only observed under physiological intracellular [Ca2+] and is not observed
when Ca2+ is buffered (Kamouchi et al. 1999). Additionally, experimentally loading cells with
Ca2+ via pipette injection does not cause channel activation and current. NSCC can be activated
by the depletion of store operated Ca2+ using store-depletion inhibitor of sarcoplasmic
reticulum Ca2+-ATPase (SERCA) pumps with thapsigargin and tert-butyl-benzohydroquinone.
The production of inositol 1, 4, 5-triphosphate is critical for NSCC-mediated influx of Ca2+
(Kamouchi et al. 1999).
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Redox-sensitive NSCC respond to oxidative stress-produced superoxide anions, which
in turn, activates 28-pS NSCC in cultured endothelial cells. The activated channel produces a
current that is equally permeable to Na+, K+, and Ca2+. In a study aimed to characterize the
mechanism of redox-sensitive NSCC activation in cultured arterial endothelial cells,
demonstrated that the administration of the cytosolic oxidant metabolite, oxidized glutathione
(GSSG) resulted in channel activation and membrane depolarization, suggesting that
membrane depolarization of endothelial cells in vivo occurs during oxidative stress (Koliwad
et al. 1996a). In vascular endothelial cell that were exposed to oxidative stress resulted in an
increase in intracellular Na+ content and abolished an agonist-stimulated influx of external
Ca2+ (Koliwad et al. 1996b). However, in quiescent vascular endothelial cells, oxidative stress
induced an increase uptake of Ca2+ when no agonist was administered (Koliwad et al. 1996b).
The study noted that the discrepancy of Ca2+ influx may be a direct cause of the membrane
depolarization that occurs during oxidant-induced activation of the channel, which may limit
Ca2+ influx. Furthermore, the activation and opening of the channel occurs in two states,
independent of intracellular [Ca2+] and stores (Koliwad et al. 1996b).

Hemodynamics and Hemorheology of the Vascular
Hierarchy
Hemodynamic Force Transduction and Cytosolic Calcium Transients
Hemodynamic shear stress induces an increase in intracellular [Ca2+], which serves as
a key regulator of many flow-associated biochemical and physiological processes of the
vascular endothelium (Kwan et al. 2003). Furthermore, endothelial cells respond differently to
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varying flow conditions at the level of single-cell oscillations of intracellular [Ca2+], which
may indicate an endothelial-dependent modulation of cerebrovascular physiology (Helmlinger
et al. 1996). The rise in intracellular [Ca2+] induced by flow-associated shear stress can
potentially originate from the influx of Ca2+ (Yao et al. 2000; Parekh and Penner 1997) or from
intracellular Ca2+ stores through activated IP3 or arachidonic acid signaling (Nilius and
Droogmans 2001; Parekh and Penner 1997; Prasad et al. 1993; Oike et al. 1994). In a study
using rat endothelial cells, chelation of extracellular Ca2+ with EGTA completely attenuated
the flow-induced rise of intracellular [Ca2+], suggesting that Ca2+ influx alone is responsible
for the hemodynamic shear stress-induced Ca2+ transient (Kwan et al. 2003). This observation
was consistent with other studies measuring the same phenomenon (Kanai et al. 1995; Schwarz
et al. 1992a; Jow and Numann 1999). When intracellular Ca2+ stores are experimentally
depleted with inhibitors of endoplasmic reticulum Ca2+-ATPase, flow-induced Ca2+ influx
became sensitized (Kwan et al. 2003). This sensitization resulted in an exaggerated increase
of Ca2+ influx in response to a relatively modest exposure to shear stress (Kwan et al. 2003).
Whereas, the experimental increase of intracellular Ca2+ stores resulted in a reduced flowinduced Ca2+ influx (Kwan et al. 2003).

Hemodynamic Forces Regulate Angiogenesis and Vascular Maintenance
Signaling
Cerebrovascular endothelial cells are continually exposed to shear stress imposed by
blood flow, compressive forces exerted by blood pressure, and to tension transmitted through
the extracellular matrix (Freund et al. 2012). Laminar flow occurs when movement of a fluid
is unidirectional whereas non-laminar flow occurs when the flow of fluid becomes disturbed
or turbulent. Physiological levels of shear stress that occur during laminar flow are generally
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thought to be protective of the vasculature (Dimmeler et al. 1996; Yoshizumi et al. 2003).
Under physiological conditions, shear stress falls within the range of 1-7 Pa, whereas in veins
shear stress ranges 0.1 – 0.6 Pa (Malek et al. 1999). Under physiological conditions, shear
stress maintains the endothelial lining of blood vessels in a mitotically quiescent state.
Mechanosensory signal transduction of shear stress is thought to be mediated by ion
channels (Ando et al. 1988; Nilius and Droogmans 2001; Nilius et al. 1997), cation channels
(Schwarz et al. 1992b), and stretch sensitive channels (Nilius et al. 1997). Recent evidence has
demonstrated that perturbation of shear stress result in a transient wave of intracellular calcium
(Ando et al. 1988) that occur alongside a considerable increase of nitric oxide (NO) production.
A study has documented that cultured human umbilical vascular endothelial cells (HUVEC)
cell migration along a VEGF gradient is reduced under physiological shear stress equal to what
is experienced in the venous system (Song and Munn 2011). Initial gradients of VEGF induced
vessel sprouting whereas negative gradients inhibited sprouting but instead assumed a sheetlike growth pattern. This suggests that vascular endothelial cells integrate signals from VEGF
gradients and signaling from hemodynamic forces to obtain proper growth and caliber (Song
and Munn 2011).The study demonstrated that cells treated with an NOS inhibitor result
endothelial cell migration that are insensitive to shear stress. This suggests that NO production
under a physiological range serves to maintain vascular endothelial cell in a non-angiogenic
state. However, when shear stress exceeds physiological range, endothelial cells respond by
entering a state of activated angiogenesis that is mediated by nitric oxide synthase modulation
(Zhou et al. 1998; Williams et al. 2006). Experimental inhibition of NOS in vivo has been
demonstrated to increase vascular density (Pipili-Synetos et al. 1993).

27

Flow-dependent Transcriptional Regulation
Endothelial cell transcriptome can dramatically change in response to shear stress (Chiu
et al. 2005; Ohura et al. 2003; Sun et al. 1993). Cultured HUVEC exposed to different levels
of shear stress have shown to alter the regulation of up to 350 genes. Of these, 190 genes were
upregulated under laminar flow and 166 genes were found to be down regulated compared to
cells maintained under static conditions (Wragg et al. 2014). Of these genes, a pattern of proangiogenic gene expression emerged that was dependent on cell exposure to laminar or stasis
flow shear stress. This pattern of gene expression seemed to contrast each other via analogous
signaling molecules. Such as, under laminar flow shear stress, VEGF-A is upregulated while
shear stress during flow stasis, VEGF-B was upregulated (Carmeliet et al. 1996; Ferrara et al.
1996).
Cultured HUVEC exposed to 1.2 Pa or 0 Pa for a period of 24-hours demonstrated as
many as 35 microRNA (miRNA) species to be upregulated and as many as 26 miRNAs to be
downregulated (Sun et al. 1993), albeit a shear stress force of 1.2 is above physiological range.
This shear stress-dependent change in miRNAs is likely contributing to the shift in the
transcription profile in these cells after the exposure to shear stress forces.

Flow-dependent Transcription in Pathology
Several genes regulated by shear stress have been directly linked with vascular
pathology. C-type lectin sub family 14 member CLEC14A is expressed 10-fold higher in
HUVEC cultured in static conditions compared to cells exposed to shear stress of laminar flow
of 2.0 Pa for 24-hours, suggesting it to be a shear stress regulated gene (Mura et al. 2012).
CLEC14A is a highly angiogenic molecule that also participates in endothelial cell migration
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and the tube formation of a vessel (Mura et al. 2012). The pathological upregulation of
CLEC14A expression has been linked to the development of atherosclerotic plaques and to
tumors in the ovaries, bladder, liver, and breast (Khan et al. 2019).
ROBO4 is a vascular specific analogue of the roundabout axon guidance receptor
family and has been implicated in tumor development. The function of ROBO4 at the
cerebrovasculature is dependent on the activation state of the endothelium (Huminiecki and
Bicknell 2000). In cultured HUVEC maintained under static conditions contained a 50-fold
greater expression of ROBO4 compared to cells maintained under laminar shear stress at 2 Pa
for 24-hours (Mura et al. 2012; Sheldon et al. 2009). In activated endothelium, ROBO4 is proangiogenic, participating in endothelial cell migration and vascular tube formation by its
expression at the angiogenic sprout in tip cells where it contributes to the formation of filopodia
(Sheldon et al. 2009). In contrast, a number of studies have accumulated evidence suggesting
that ROBO4 promotes the quiescent state of the endothelium by inhibiting VEGF signaling
via ROBO4 interactions with the vascular netrin receptor UNC5B (Marlow et al. 2010). In one
study, the inhibition of ROBO4 and UNC5B with antibodies resulted in elevated angiogenesis
and structural integrity defects (Marlow et al. 2010). These observations were supported
further in a study that documented an elevated level of angiogenesis and degraded vascular
barrier integrity in ROBO4 -/- knockout mice (Koch and Haustein 1983). It appears that when
endothelial cell are maintained under a shear stress-dependent activated state the function of
ROBO4 is antiangiogenic but when endothelial cells are maintained under a static state of low
shear stress, ROBO4 functions in a proangiogenic fashion.
TIE1 is an angioprotein receptor that is exclusively expressed on the surface of
endothelial cells (Partanen et al. 1992). The pro-inflammatory role of TIE1 is mediated by
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signaling the upregulation of cell adhesion molecules VCAM-1, E-selectin, and ICAM-1 to
the lumenal surface of vascular endothelial cells (Chan et al. 2008). TIE1 has been implicated
in inflammatory diseases of the endothelium, such as atherosclerosis (Chan et al. 2008; Woo
and Baldwin 2011) but also in arthritis and in the pathogenic angiogenesis that occurs in tumors
(Kaipainen et al. 1994; Lin et al. 1999; Shahrara et al. 2002). Observations made both in vitro
and in vivo suggest TIE1 to be negatively regulated by shear stress caused by laminar flow
(Woo and Baldwin 2011; Porat et al. 2004). During angiogenesis, TIE1 is thought to activate
endothelial cells causing these cells to exit their quiescent state. Endothelial quiescence and
integrity is partially maintained by TIE2 signaling (Papapetropoulos et al. 2000). During
angiogenesis, TIE1 dimerizes with TIE2 resulting in the functional inhibition of TIE2 mediated
signaling, including the maintenance of endothelial cell quiescence (Seegar et al. 2010).

Cerebrovasculature Malformations
Hemodynamic Forces of Blood Flow
The flow of blood through the cerebrovasculature exerts mechanical forces on the
wall(s) of blood vessels. The characteristic mechanical force is dependent of the direction in
that the redistribution of force occurs on the surface of the vessel wall. A stress is defined as
the force per unit area, acting on a surface. The cerebrovasculature is subjected to several forms
of stress including, (Aaron and Gosline 1981) longitudinal stress, (Aelvoet et al. 1992) radial
stress, and (Albelda and Buck 1990) circumferential stress that result directly by the transport
of blood through the vessel (Patrick and McIntire 1996; Nerem and Girard 1990). The
composition of the vascular wall allows blood vessels to accommodate for these mechanical
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disturbances within large vessels. Of larger vessels, the circumferential arrangement of elastic
fibers in the tunica media provides structural stability and ductility to the vascular wall (Aaron
and Gosline 1981; Dobrin et al. 1990). However, small vessels, such as capillaries do not
contain the medial or adventitial layers of the vessel wall. In capillaries including microvessels,
structural resilience of the vessel wall is provided by the basal lamina of the intimal layer,
containing high levels of type IV collagen (Davies et al. 1994; Dobrin et al. 1990). In addition,
endothelial cells of all vessels can mitigate mechanical stress by forming specialized protein
complexes that anchor to the cytoskeleton. In vascular endothelial cells, stress fibers are rigid,
formed of myosin II and actin filaments that are anchored to the plasma membrane by integrin
via linker proteins at regions of tight contact mediated by focal adhesions (Pavalko and Otey
1994). The result of this specific configuration of structural, junctional, and anchoring proteins
is the assembly of an intracellular retiform structure that is no longer limited by the structural
resilience of the plasma membrane, but by the cytoskeletal protein having the lowest affinity.
In response to acute fluctuations of mechanical stress, such as the stretching of the
endothelial cell monolayer, the cytoskeleton and support structures can undergo a realignment
to fortify the integrity of the vessel wall and adapt to changes in the direction of mechanical
stress (SF et al. 1990; Patrick and McIntire 1996). Blood flow can exert a shear stress on the
lumenal surface of vessels and can stimulate endothelial cell elongation, alignment of the cell
in the direction of flow, cytoskeletal reorganization, upregulate adhesion molecules, and vessel
dilation (Davies et al. 1994; Thurston and Baldwin 1994; Davies and Tripathi 1993; Patrick
and McIntire 1996; Nerem and Girard 1990; Resnick and Cimbrone 1995).
In response to chronic states of stress, the size of the vessel lumen and wall thickness
can be modulated to the rate of blood flow specific to the vessel (Woollard and Harpman;
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Holman 1965; Hughes 1935). The literature suggests that the modulation of lumen size and
wall thickness of vessels occurs to maintain a constant shear stress between 15 – 20 dynes/cm2
for vessel segments and approximately 100 dynes/cm2 at branch points (Kamiya and Togawa
1980; Nerem and Girard 1990).

Vascular Tortuosity
The capillary network provides the greatest fluidic resistance to blood flow (Gould et
al. 2017; Schmid et al. 2017), reducing the velocity of blood and intralumenal pressure of
venous supply. If the hemodynamic forces of blood flow is not dampened and allowed to reach
venous circulation, pathogenic manifestations to venous vessels may occur. High flow rates in
veins and venioles can injure the vessel wall, causing abnormal deposition of the basement
membrane and dysmorphic vascular structure. Degradation of elastin in arterial and arteriolar
wall causes aneurysmal dilation and vessel elongation, resulting in vessels becoming tortuous
(Dobrin et al. 1988). Elastin deficiency has been implicated in the formation of tortuous vessels
in patients with arterial tortuosity syndrome and in transgenic mice (Taarnhøj et al. 2008;
Nakamura et al. 2002; Coucke et al. 2006; Yanagisawa et al. 2002; Carta et al. 2009).
Interestingly, the degradation of type IV collagen from the basal lamina causes vessels to
rupture, but does not cause vessels to become tortuous (Dobrin et al. 1988).
Vessel tortuosity can have deleterious effects to cerebral blood flow. The degree of
curvature of a tortuous vessel is proportional to the magnitude of disturbance it imparts to the
flow of blood through the affected vessel. The exaggerated curvature of tortuous vessels causes
blood flow to become turbulent, increasing the shear stress to local vascular wall. The
glycocalyx is a layer of glycoprotein complexes that are formed on the innermost surface of
vascular endothelial cells where it comes into direct contact with the flow of blood. A major
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function of the glycocalyx is the formation of an RBC exclusion zone that maintains the
laminar flow of blood by repulsing RBC from the surface of endothelial cells. The shear stress
resulting from the turbulent flow of blood causes the attrition of the glycocalyx, exposing the
surface of endothelial cell membranes. Exposure of the endothelial cell membrane to blood
allows recruitment of circulating leukocytes by binding to cell-adhesion molecules on the
endothelial cell surface. Binding to cell-adhesion molecules causes leukocyte stalling and
inflammation at the site of leukocyte attachment. This localized inflammation initiates several
deleterious events; (1) increases vascular permeability; (2) stimulation of the coagulation
cascade; (3) and focal damage to tissue.

Capillary-Venous Malformations
Capillary-venous malformations (CVMs) are collections of enlarged capillaries with
irregular structure. The thin walls of CVMs and their apparent lack of elastic component cause
leakiness of the malformed network. These capillary networks lack both feeding and draining
vessels but instead are contiguous to other malformed capillaries that constitute the network
(Rigamonti et al. 1988). The weak structural integrity of these vascular formations results in
cerebral hemorrhage in 41% of persons and focal neurologic deficits in 35 – 50% of patients
(Brunereau et al. 2000; Siegel 1998; Zabramski et al. 1994; Rigamonti et al. 1987).

Arteriovenous Malformations
Arteriovenous malformation (AVM) is the pathogenic development of an
arteriovenous anastomosis, which is a common configuration of the vascular network, often
found in vascular beds of the skin and gut (Hadley 2007). Pathogenic AVMs occur from the
improper connection between an artery and a vein, in which blood flow bypasses the capillary
33

network; and instead is feed directly into venous supply (Yakes 2004; Frey et al. 2018).
Anomalous AVMs form pathways of low fluidic resistance for blood flow between arteries
and veins (Yakes 2004). These low resistance pathways permit high velocity blood flow,
increasing the shear stress burdened by the vessel wall (Yakes 2004). As fluid tends to flow
through the pathway of least resistance, and due to the pressure differential between the feeding
artery and vein, a complete lack of capillary perfusion occurs. Low capillary network perfusion
can instigate adverse events; including, the degranulation of platelets, initiating the coagulation
cascade; the attrition of the glycocalyx, exacerbating blood clot initiation and stimulating local
inflammation; and reducing blood flow-dependent gene transcription, causing the
destabilization and regression of capillary vessels.

Introduction to Alzheimer’s Disease
Alzheimer’s disease is a devastating neurodegenerative disease that affects our most
human nature, our cognition. To our current knowledge, AD is the most complex disease to
have ever affected our society. Presently, no effective treatment exists to halt or slow the
progression or prevent manifestation of AD.

Amyloid Precursor Protein Processing
Synthesis of amyloid-β occurs via the proteolytic cleavage of the amyloid precursor
protein (APP). The gene encoding APP is located on chromosome 21 and contains 18 exons.
The APP is a single transmembrane spanning preproprotein that occurs in three major isoforms
that are determined by alternative splicing and are identified by the number of amino acids the
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protein contains (695, 751, and 770) (Chasseigneaux and Allinquant 2012). While APP is a
ubiquitously expressed protein, there seems to be a cell type specific bias for the particular
production of an isoform. Such as, the 695 isoform of APP lacks the encoding regions from
exon 7 and 8, is found highly expressed in neuronal cells and relatively low in non-neuronal
cells (Haass et al. 1991; Sandbrink et al. 1994). Whereas, in non-neuronal cell types the
predominant variants of APP is the 751 and 770 isoform, which lack exon 8 or the latter contain
all 18 exons, respectively (Yoshikai et al. 1990). Noteworthy, the two homologs of APP termed
APP like protein 1 and 2 (APLP1 and APLP2) show similar cell type bias, where APLP1 is
only found in the brain while APLP2 is ubiquitous (Wasco et al. 1992; Wasco et al. 1993;
Coulson et al. 2000). Sequencing data of APP cDNA led to predictions indicating that the
protein functions as a 695 amino acid glycosylated integral membrane cell surface receptor
protein (Kang et al. 1987). Although, the precise physiological role of this protein is yet to be
identified, empirical evidence indicates a possible role in nervous system development,
transcription regulation, cell adhesion, synaptic plasticity, axonal transport, and
synaptogenesis (Gralle and Ferreira 2007; Chasseigneaux and Allinquant 2012).
The APP protein is classified as a type 1 integral membrane protein characterized by
its large extracellular domain, hydrophobic domain, and a relatively short c-terminal
intracellular domain (AICD). The large extracellular domain contains several subdomains
including, an E1 and E2 region and a Kunitz protease inhibitor (KPI) domain, which is
characteristically missing in the 695 isoform of APP (Kang and Müller-Hill 1990; Rohan de
Silva et al. 1997). Interestingly, APP isoforms containing the KPI domain are found elevated
in AD (Menéndez-González et al. 2005), likely caused by modulated splicing in neurons from
isoform 695 of APP to a KPI domain-containing isoform of the protein (Bordji et al. 2010).
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The shift to KPI-containing APP isoforms in neurons is observed following NMDA receptor
activation and is temporally associated with elevated Aβ production by neuronal cells (Bordji
et al. 2010).

APP Posttranslational Processing
APP processing can occur via two alternate pathways involving secretases and
proteases, each pathway producing a different final product. In the non-amyloidogenic
pathway, α-secretase cleaves APP at amino acid number 17 that is located within the Aβ
sequence, resulting in the secretion of the soluble APP (sAPPα) extracellular domain and an
83 amino acid c-terminal (C83) fragment associated with the membrane. The C83 fragment is
further processed by γ-secretase to produce the P3 peptide fragment and APP AICD.
Processing of APP via the amyloidogenic pathway involves sequential cleavage by β-secretase
and γ-secretase. Processing by β-secretase is decisive to whether APP processing occurs
through the amyloidogenic or non-amyloidogenic pathway. Cleavage by β-secretase occurs
within the Aβ sequence at amino acid residue number 1 and 11 of APP resulting in the
formation of a soluble APPβ (sAPPβ) product and a membrane-associated 99 amino acid cterminal fragment (C99) (Cole and Vassar 2007). The C99 fragment is further processed by γsecretase producing AICD and the pathogenic Aβ peptide (Hartmann et al. 1997).
sAPPα
sAPPα has been found to participate is a number of physiological functions, including
neurite outgrowth, synaptogenesis, and cell adhesion (Mattson 1997; Gakhar-Koppole et al.
2008). In vivo studies with APP deficient mice has shown that administration of sAPPα is
effective at ameliorating the abnormalities caused by reduced APP signaling (Ring et al. 2007),
indicating that the activity of sAPPα is exerted extracellularly. In addition, studies have found
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that sAPPα functions as a growth factor (HERZOG et al. 2004; Siemes et al. 2006) which
regulates adult and embryonic neural stem cell proliferation (Ohsawa et al. 1999; Caille et al.
2004). In vivo, sAPPα is neuroprotective (Mattson et al. 1993; Furukawa et al. 1996; Han et
al. 2005; Ma et al. 2009) and can promote learning and memory in animals (Meziane et al.
1998; Taylor et al. 2008).
sAPPβ
Unlike sAPPα, the sAPPβ exerts no neuroprotective effects (Furukawa et al. 1996).
Cytotoxicity is also observed from the cleavage product of the N-terminal fragment of sAPPβ,
where is serves as a ligand for cell surface death receptor 6, initiating apoptosis via caspase 6
activation (Nikolaev et al. 2009).

Neurofibrillary Tangles
Neurofibrillary tangles (NFT) are intracellular basophilic aggregates of filaments in
paired helical conformation (PHF) (Kidd 1963). The PHF conformation has a diameter of 10
– 15 nm and a periodicity of 160 nm (Kidd 1963). NFTs acquire a morphology that is
dependent of the neuron in which it resides. In addition to AD, NFT are found in the CNS of
patients affected with subacute sclerosing panencephalitis, postencephalitic Parkinsonism,
dementia pugilistica, and the parkinsonian-amyotrophic lateral sclerosis-dementia complex of
Guam (Wisniewski et al. 1979). In AD, NFT are composed primarily of the microtubuleassociated protein (MAP) tau (Grundke-Iqbal et al. 1986; Kosik et al. 1986). The
hyperphosphorylation of the tau protein causes its polymerization into a filamentous structure.
The density of tau inclusions correlates with cognitive decline in AD.
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Microtubule-associated protein(s) are proteins that interact with the microtubules of the
cytoskeleton. The MAP tau protein is found abundant in the axons of neurons where it
participates in the regulation of axonal transport and stabilizes the tubulin protofilament
polymer (Barbier et al. 2019; Binder et al. 1985; Black et al. 1996). Tauopathies are a group
of related diseases caused by the loss of function of the tau protein. In addition to AD,
tauopathies have been implicated in a number of neurodegenerative diseases including, frontal
temporal dementia and progressive supranuclear palsy (Brion et al. 1986).

The native

conformation of the tau protein is an essentially unfolded state that resembles a random coil
configuration (Binder et al. 2005). For tau to undergo polymerization, the protein must undergo
major conformational changes. One such conformational states that is able to polymerize is the
Alz50 conformation.
In AD-vulnerable neurons, aggregated tau is initially found in the Alz50 state, in which
the conformation of the peptide sequence places the amino-terminus in contact with the third
microtubule-binding domain (aa 312 – 322). A second conformational change occurs
following NFT assembly, in which the Alz50 state undergoes a conformational change to the
tau-66 fold state. The tau-66 conformation is attained when the proline-rich region of the tau
peptide sequence makes contact with the microtubule-binding repeats (MTBR) and partially
overlaps the N-terminal binding site (Ghoshal et al. 2001; García-Sierra et al. 2003). Studies
suggest that the phosphorylation of tau serves as an inducer for the conformational shift in
favor of Alz50 state (García-Sierra et al. 2003). Whereas, C- and/or N-terminal truncation of
the peptide favors tau attaining the tau-66 fold state (Binder et al. 2005).
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Vascular Risk Factors
Past research has firmly documented that vascular related factors increase the risk of
developing AD and other dementias (Mazza et al. 2011). During the previous years, a number
of large-scale and long-term population-based clinicopathologic studies have delineated the
significant contribution of vascular related risk factors in AD (Kivipelto et al. 2001; Hofman
et al. 1997; Skoog et al. 1996; Chui et al. 2006). These studies include Goteborg Study of 70
Year Olds; The Rotterdam Study (Hofman et al. 1997); Honolulu-Asia Aging Study (Launer
et al. 2000); The National Heart, Lung, and Blood Institute Twin Study; Studies in Uppsala,
Sweden, and Kuopio; Zutphen Elderly Study; Halian Longitudinal Study on Aging; The
Framingham Study; The Washington Heights Columbia Aging Study; Nun Study; Chicago
Health and Aging Project, and the Bronx Aging Study. Together, these population studies have
highlighted the contribution of vascular risk factors to the development of AD and other
dementias, including smoking, diabetes mellitus, hypertension, lipids, hyperinsulinemia,
homocysteine, physical inactivity, and fat intake in the development of AD (Santos et al.
2017). The Rotterdam Study was one of the first large-scale studies to investigate the
relationship between atherosclerosis and the apolipoprotein E ε4 allele (ApoE4) with the
etiology of AD and other dementias. The Rotterdam Study revealed an interaction of
atherosclerosis with ApoE4 and an association between atherosclerosis and the two major
subtypes of dementia, AD and VaD, but not other forms of dementia (Hofman et al. 1997).
The Honolulu-Asia Aging Study (Launer et al. 2000) demonstrated that the risk of developing
late-age AD in patients untreated for hypertension during middle-age increased by 40%, higher
than 20% attributable risk of carrying the ε4 allele of the APOE gene (Farrer et al. 1997;
Slooter et al. 1998). An association between hypertension and the development AD has also
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been reported in a population study in Kuopio and Joensuu, eastern Finland (Kivipelto et al.
2001) and in a 15-year follow up study (Skoog et al. 1996). Postmortem histopathological
analysis of patients with AD and hypertension demonstrate increased deposition of senile
plaques and neurofibrillary tangles (Sparks et al. 1995).
The majority of these vascular risk factors have shown to be associated with subcortical
lesions, white matter hyperintensities (WMH) (de Leeuw et al. 1999; Liao et al. 1997;
Longstreth et al. 1996; Veldink et al. 1998), lacunar infarcts (Bernick et al. 2001; Fisher 1982;
Kazui et al. 2000), and cerebral microhemorrhages (Viswanathan and Chabriat 2006).
Evidence suggests that therapeutic intervention of hypertension may delay the progression of
WMH (Dufouil et al. 2005). Population-based studies have clearly linked cognitive
impairment with cognitive decline and the onset of dementia (Longstreth et al. 1996; Burton
et al. 2004; de Groot et al. 2000; Swan et al. 1998).
Strong evidence suggests that in the largest group of patients with dementia, VaD and
AD, vascular factors contribute to the disease etiology. Because clinical dementia presents
itself as a combination of neurodegenerative and vascular features, the classification criteria
used to distinguish VaD and AD apart is difficult. Therefore, it is urgent that further research
is conducted which aims to identify diagnostic markers in patients with diverse vascular
components contributing to the major dementias.

Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) is a term that describes the pathologic deposition
of amyloid-β on the walls of cerebral blood vessels. As many as 90% of patients diagnosed
with AD have comorbid CAA and an estimated 30% of non-demented aged individuals are
affected with CAA (Attems 2005; Love et al. 2009; Weller et al. 2009). CAA can occur both
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hereditarily and sporadically and is classified based on the presence or absence of accumulated
amyloid-β on cerebral capillaries. Different pathological features affect the vasculature
depending on the presence or absence of capillary deposition. CAA type 1, common in AD
patients, is strongly associated with the apoE4 allele, demonstrates capillary deposition of
amyloid-β, while CAA type 2 does not affect capillaries and only affects larger blood vessels
(Attems and Jellinger 2004; Thal et al. 2008).
The precise origin of amyloid-β in CAA is unknown. One theory suggests that the
source of amyloid-β is blood (Glenner et al. 1984). Smooth muscle cells are also thought to be
a potential source of amyloid-β (Wisniewski and Wegiel 1994). Yet, cerebral capillaries, which
lack smooth muscle cells, also present amyloid-β accumulation (Herzig et al. 2006). Increasing
evidence suggests a neuronal source of amyloid-β that accumulates on the vasculature via the
perivascular lymphatic fluid where under pathological conditions accumulates (Weller et al.
1998; Burgermeister et al. 2000; Van Dorpe et al. 2000; Herzig et al. 2004; Weller et al. 2008;
Vidal et al. 2009).
In human and animal studies have demonstrated pathological alterations of the
cerebrovasculature, such as fibrinoid necrosis, microaneurysms, dilation of arteries, and
thickening of the tunica media (Maeda et al. 1993; Zekry et al. 2003; Auriel and Greenberg
2012). Blockage of perivascular drainage pathway due to amyloid-β may alter the elimination
of metabolites from the brain and impair transport of nutrients across the BBB (Weller et al.
2008; Carrano et al. 2012; Hartz et al. 2012). Dyshomeostasis of brain metabolites may lead
to cognitive impairment. Vascular damage in proximity to amyloid-β deposition is associated
with cerebral microbleeds (Verbeek et al. 2009; Schrag et al. 2010).
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In transgenic mice overexpressing human amyloid-β in neurons, develop CAA
(Calhoun et al. 1999). Experimental evidence suggests that the ratio of Aβ1-40/Aβ1-42 is
influential to the overall severity of CAA (Herzig et al. 2007; Herzig et al. 2004). In mice
constitutively expressing the Dutch type APP mutation, display a high ratio of Aβ1-40/ Aβ1-42,
go on to develop severe CAA (Herzig et al. 2004) while a lower ratio of Aβ1-40/Aβ1-42 results
in a relatively less severe CAA development (Herzig et al. 2004), indicating that Aβ1-40 and
Aβ1-42 can cause CAA onset and that the majority of vascular deposition is from Aβ1-40.
Although, contrasting data has been reported demonstrating in mice producing solely Aβ1-42
develop CAA while mice producing Aβ1-40 do not (Kim et al. 2007). These findings may
indicate a possible synergistic role of both Aβ1-40 and Aβ1-42, where the pathogenic interactions
of these peptides compromise amyloid-β clearance in a self-propagating manner, which causes
the development and progression of CAA.

Alignment of Study Aims with Project Goals
Our motives for conducting this research is to address the shortcomings in the scientific
field that focuses on investigating cerebrovascular involvement in the pathogenesis and
progression of AD. We have conducted a series of studies that elaborate on the; (1) cellular
regulation of mitochondrial dynamics and metabolism after ischemic injury; (2) neuronal
injury and degeneration during cerebrovascular hypoperfusion; (3) mechanisms involved in
mediating the cytotoxic properties of the Aβ peptide on the vascular endothelium; (4)
methodology and analyses necessary for a thorough evaluation of the cerebrovasculature in
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adult mice; and (5) age- and disease-related changes to the cerebral angioarchitecture in the
triple transgenic mouse model of AD.

Study 1: Described in chapter 2, we performed a series of experiments to better understand
the cellular response to metabolic stress after hypoxia. We focused on the cellular regulation
of mitochondrial fission-fusion dynamics and the effects these changes have on mitochondrial
function and mitophagy. The aims of this study are in line with the overarching goals of the
proposed research project in that the data produced by the study will provide important
information regarding the cellular adaptation and deleterious changes to mitochondria during
conditions of oxygen deprivation, such as during cerebrovascular hypoperfusion.
Age-related deficiencies in the ability of cells to maintain homeostatic proteostasis can
contribute to the sensitivity of cells to protein aggregates present in the extracellular
microenvironment (Labbadia and Morimoto 2015). The proteostasis network is facilitated by
the lysosomal and endosomal system, where autophagy is a central regulator that maintains
homeostatic regulation of this system (Nixon 2013). Neurons with disrupted proteostatic
regulation display tau inclusion similar to those in AD (Lambert et al. 2013). Disruptions in
autophagy are linked to the pathology of tau. Thus, understanding the mechanistic link between
age-related deficiencies in autophagy and the increased burden to the proteostasis network by
hypoperfusion-related hypoxia in AD would provide important insight into the early events in
the development of AD. These fundamental observations will provide a critical perspective of
the transition of a potentially early reversible event to a chronic, irreversible disease that
transcends its dependents on initial factors favoring its development and propagation.
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Astrogliosis is an early event that occurs before the deposition of Aβ-plaques in AD
(Heneka et al. 2005). However, the relationship between dysfunctional astrocytes and the
amyloidosis and tau pathology in AD remain poorly characterized. Astrocytes are heavily
involved in Aβ catabolism. In vitro studies have demonstrated that the exposure of astrocytes
to Aβ causes the astrocytes to become activated resulting in the transition of metabolic
phenotype, increased inflammatory marker expression, and coordinated calcium signaling
(Heneka et al. 2005; Kuchibhotla et al. 2009). Preventing astrocytic activation in APP/PS1
mice accelerates the development of Aβ-plaques (Kraft et al. 2013). Damage to the brain can
cause reactive astrogliosis (Burda and Sofroniew 2014) that is characterized by abnormal
proliferation and hypertrophy. In AD, astrogliosis is associated with downregulated aquaporin
4, which can compromise Aβ clearance via glymphatic flow (Heneka et al. 2005). In the triple
transgenic mouse model of AD, astrocytes are atrophied, containing reduced number of
branches in the entorhinal cortex at 1-month of age and in the frontal cortex at 3-months of age
(Kulijewicz-Nawrot et al. 2012).
The data presented in study 1 provides a description of the changes to astrocytes that
can be attributed to hypoperfusion during the early stages of AD, including the induction of
autophagy, dysregulated metabolism, and astrocytic activation. These key events are especially
important to document, as the pre-symptomatic changes to cellular function that participate in
the early pathophysiology of AD remain largely unknown.

Study 2: Chapter 3 describes an in vivo study in mice that aimed to elucidate the
neurodegeneration that occurs from the gradual induction of cerebrovascular hypoperfusion.
To achieve cerebrovascular hypoperfusion that progresses gradually, we developed a
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procedure that involves the insertion of a microcoil and an ameroid constrictor ring around the
common carotid arteries. This surgical procedure resulted in cerebrovascular hypoperfusion
that developed over a period of 34-days. We focused on characterizing the damage to the gray
and white matter of the brain in hypoperfused mice. The aims of this study were in line with
the overarching goals of this research project in that the data provided will inform us of the
neurodegeneration in AD that is attributed to hypoperfusion.
A substantial reduction of cerebral blood flow occurs in humans and in rodents with
AD. It is understood that cerebral blood flow begins to decline during the early stages of AD,
prior to the deposition of Aβ-plaques and neurofibrillary tangles. The magnitude of
hypoperfusion correlates well with the severity of cognitive decline in patients diagnosed with
dementia. Although cerebrovascular hypoperfusion is closely associated with cognitive decline
in patients, no relationship exists linking region-specific cerebrovascular hypoperfusion with
the density of Aβ-plaque deposition and NFT formation. This differential association with
behavioral phenotypes of AD and the histopathology of the brain may indicate regional
differences of vascular competency and the spare capacity of blood vessels to ‘ramp-up’
cellular processes during a state of stress. The unique status of age-associated changes to
normal cellular efficiency and perseverance of functions performed by blood vessels in an
individual may determine if/when a milestone is reached favoring the development of agerelated diseases, such as AD.

Study 3: The study described in chapter 4 aimed to elaborate on the mechanisms of
cytotoxicity of Aβ on cerebrovascular endothelial cells. We focused on the metabolic function
of endothelial cells following the exposure to Aβ then evaluated mitochondrial function,
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reactive oxygen species production, and calcium dysregulation involved in endothelial cell
death. The aims of this study were in line with the research goals of this project in that the data
will provide critical information describing the deleterious effects of vascular endothelial cells
interaction with Aβ. These observations will also provide an account of the pathogenic changes
to vascular endothelial cells following the initial exposure to Aβ.
Age-related deficiencies in the ability of the vascular endothelium to maintain
physiological function during cell stress can provide the initial sensitivity required to initiate a
pathogenic mechanism for the development of age-related diseases. The extent of the agerelated deficiencies of the endothelium may determine the probability of developing AD later
in life. This initial insult to the vascular endothelium late in life is likely caused by the Aβ
peptide. Endothelial cell injury can result in compromised vascular function, including
transendothelial transport. Deficient transendothelial cell transport will lead to a progressive
accumulation of Aβ in the parenchyma and on walls of blood vessels, enhancing endothelial
cell stress and progressing cellular dysfunction. Obtaining a description of these initial insults
to vascular endothelial cells following exposure to Aβ will provide insight into the early
insufficiencies of cellular function and reveal reversible events that can lead to the
development of novel therapies for the prevention and treatment of clinically diagnosed AD.

Study 4: Described in chapter 5, we performed a study that aimed to develop a procedure that
can be used to acquire volumetric data of the cerebrovasculature from the whole-brain. We
developed a procedure using a corrosion cast paradigm to create replicas of the cerebrovascular
network of the adult mouse brain. Additionally, we optimized an imaging routine that produced
a single volumetric dataset of the cerebrovasculature of the entire brain at a resolution
46

compatible with the investigation of the microvasculature. We focused on developing the
methodology and analyses required to perform a thorough investigation of the
cerebrovasculature in adult mice. Our analyses of the angioarchitecture provided a description
of the morphometric, topological, and organization of the cerebrovascular network.
Previous methodology applied for the investigation of the cerebrovasculature have
largely been limited to relatively small volumetric datasets. This limitation arises from
technological constraints that are associated with optical imaging approaches. Common to
most imaging paradigms is the tradeoff between resolution and field of view. Therefore, the
constraint of acquiring useful imaging data can either be limited in the ability of detecting
small structures or limits to the maximum size (x, y, z) of the data set. Additionally, the
physical properties of tissue can severely restrict the transmission of light into the deep
structures of the specimen but can also cause light scattering that reduces the accuracy of image
acquisition. Using the corrosion cast method for the cerebrovasculature allowed for the
complete removal of tissue around vessels, which considerably enhanced the quality of images
collected. These methodological developments described in study 4 are essential for a
sufficient assessment of the cerebrovasculature during normal aging and disease.

Study 5: Described in chapter 6 is a study that applied the methodological developments
outlined above and covered in detail in chapter 4 to investigate the age- and disease-related
changes to the cerebrovasculature. We assessed changes to the angioarchitecture in a triple
transgenic mouse model of AD during age and the progression of the disease. Our analyses
focused on characterizing the changes to the microvasculature over the whole-brain and in key
brain regions that function in the known cognitive deficits observed in patients with AD. We
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provided a detailed assessment of the fine-scale changes to the microvasculature by measuring
the topological and network properties of these vessels. The aims of this study are in line with
the overarching goals of this research project by providing information regarding the onset,
severity, and pattern of progression of the cerebrovascular degeneration in the triple transgenic
mouse model of AD with age.
Although vascular dysfunction and associated factors are will know to occur at some
point during the development of AD, the precise time-course of these changes in AD remains
poorly characterized. These important observations will provide a perspective to how the
cerebrovasculature changes during aging and in disease. These details may provide useful
biomarkers to identify nascent pathology towards the development of AD where it can be used
to identify abnormal form normal age-related changes to the cerebrovasculature.
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Abstract
Astrocytes serve to maintain proper neuronal function and support neuronal viability,
but remain largely understudied in research of cerebral ischemia. Astrocytic mitochondria are
core participants in the metabolic activity of astrocytes. The objective of this study is to assess
astrocyte mitochondrial competence during hypoxia and post-hypoxia reoxygenation and to
determine cellular adaptive and pathological changes in the mitochondrial network. We
hypothesize that during metabolic distress in astrocytes; mitochondrial networks undergo a
shift in fission-fusion dynamics that results in a change in the morphometric state of the entire
mitochondrial network. This mitochondrial network shift may be protective during metabolic
distress by priming mitochondrial size and facilitating mitophagy. We demonstrated that
hypoxia and post-hypoxia reoxygenation of rat primary astrocytes results in a redistribution of
mitochondria to smaller sizes evoked by increased mitochondrial fission. Excessive
mitochondrial fission corresponded to Drp-1 dephosphorylation at Ser 637, which preceded
mitophagy of relatively small mitochondria. Reoxygenation of astrocytes marked the initiation
of elevated mitophagic activity primarily reserved to the perinuclear region where a large
number of the smallest mitochondria occurred. Although, during hypoxia astrocytic ATP
content was severely reduced, after reoxygenation ATP content returned to near normoxic
values and these changes mirrored mitochondrial superoxide production. Concomitant with
these changes in astrocytic mitochondria, the number of astrocytic extensions declined only
after 10-hours post-hypoxic reoxygenation. Overall, we posit a drastic mitochondrial network
change that is triggered by a metabolic crisis during hypoxia; these changes are followed by
mitochondrial degradation and retraction of astrocytic extensions during reoxygenation.
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Introduction
Stroke is a cerebrovascular event characterized by severe cerebral ischemia that is the
fifth leading cause of death and is the primary contributor of adult disability in the U.S.
(Kochanek et al., 2014; Mozaffarian et al., 2015). During stroke there is a cerebral cellular
energy crisis caused by a decline in the delivery of the substrates, glucose and molecular
oxygen, resulting in a compromised synthesis of ATP through a collapse of oxidative
phosphorylation and glycolysis (Rossi et al., 2007). Insufficient cellular ATP content interrupts
a wide range of indispensable ATP-dependent processes, including ion balances across
neuronal membranes (Hansen and Nedergaard, 1988; Silver et al., 1997). An elevation of free
cytosolic Ca2+ levels via voltage-gated and receptor-gated calcium channels is the central
effector initiating the massive release of extracellular glutamate, and the primary cause of
excitotoxicity in ischemia (Katayama et al., 1991; Duffy and MacVicar, 1996; Parpura and
Haydon, 2000). Clearance of synaptic glutamate is a core function of astrocytes that helps
protect against glutamate toxicity (Rothstein et al., 1996).
Also, astrocytes are critical for providing neurons with a source of glutamine necessary
for glutamate production through a process known as the glutamate-glutamine cycle
(Waniewski and Martin, 1986; Chaudhry et al., 2002). Embargo of glutamine delivery to
neurons by the blockade of astrocytic conversion of glutamate to glutamine has been reported
to reduce the potassium-evoked glutamate release in experimental models of focal ischemia,
reducing infarct size (Paulsen and Fonnum, 1989; Swanson et al., 1990). Astrocytic
mitochondria are key organelles that allow astrocytes to participate in such extensive metabolic
activities (Nehlig et al., 2004; Lovatt et al., 2007).
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Here we investigated the effects of hypoxia and post-hypoxia reoxygenation on
astrocytic mitochondrial structure, including mitochondrial dimensions and content, as well as
the underlying mechanism(s) and functions of these dynamic changes. This research provides
evidence of early mitochondrial fission during hypoxia-reoxygenation that may participate in
the damaging effects of ischemic insult to the central nervous system.

Materials and Methods
Preparation of Primary Astrocytic Cultures
Primary astrocytic cultures were prepared using a method previously reported, which
generated an 85% yield of astrocytes, and a 15%, and <1% yield of progenitor cells and
microglia, respectively (Almeida and Medina, 1998). Embryonic day 19 pregnant rats were
deeply anesthetized with isoflurane. After confirming deep anesthetization via tail pinch, rats
received a 3-inch vertical incision to the lower abdomen. Once the incision was made, the
embryos including the placenta and amniotic sacks were extracted from the uterus. Each
embryo was removed from the amniotic sack by creating a small 0.5-centimeter incision and
gently palpating the fetus out. As the fetuses were extracted from the amniotic sack, the heads
were removed with sharp scissors and placed in ice cold HBSS buffer (HyClone, Thermo
Fisher Scientific, Waltham, MA) while the remaining fetus were prepared. Fetal brains were
removed by making a small incision across the sagittal suture. Once the brains were removed,
the cerebellum was removed and discarded. The remaining brain tissue was removed from the
meninges with small forceps. The meninges free tissue was placed into a 50 milliliter
centrifuge tube containing ice cold Dulbecco’s modified Eagle’s medium (DMEM) (HyClone,
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Thermo Fisher Scientific, Waltham, MA). Once all fetal brains were removed, the tissue was
centrifuged at 10,000 times gravity for 3 minutes and subsequently resuspended in ice cold
DMEM (HyClone, Thermo Fisher Scientific, Waltham, MA). Tissue was then minced by
pipetting to dissociate aggregations of cells. Dissociated cells were then filtered through a 40micron filter then cultured in DMEM (HyClone, Thermo Fisher Scientific, Waltham, MA)
supplemented with 10% fetal bovine serum and 1% penicillin streptomycin for 7 days to allow
sufficient time for cellular differentiation. After the growth phase, primary astrocytes were
plated on 6 centimeter culture dishes, 96-well plates, or 6-well culture plates containing
sterilized 22 X 22mm glass coverslips at a seeding density of 200,000, 10,000, and 50,000 cells
per well, respectively. Primary astrocytes were allowed 24-hours of growth before labeling
procedure.
Hypoxia Treatment and Imaging Preparation
Mitochondrial labeling preceded experimental treatment. Mitochondrial labeling in all
three experimental conditions was done at the same time so that any time-relevant effects of
the labeling procedure would occur uniformly. Mitochondrial labeling was performed with
70nM of MitoTracker Red CMXRos (Invitrogen, Molecular Probes, Eugene, OR) diluted in
prewarmed (37 ᵒC) DMEM culture medium then allowed to incubate with primary astrocytes
for 20 minutes before washing 2 times with prewarmed DMEM. Hypoxic treatment was
administered as 0.4% oxygen in nitrogen gas balance (Airgas USA, LLC, St. Louis, MO) for
3 hours while incubated at 37 ᵒC. After the 3 hours of hypoxia, primary astrocytes were
removed from the hypoxic enclosure and allowed a 10-hour reoxygenation period at normoxic,
atmospheric oxygen level. The experimental timeline was designed so that all experimental
groups completed treatment at the same time. After treatment, coverslips containing astrocytes
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were washed once with 0.1M phosphate buffer saline (PBS) at physiological pH then fixated
with 3.7% paraformaldehyde at physiological pH for 15 minutes then subsequently washed 3
times with 0.1M PBS for 5 minutes. After washing, free aldehyde groups were quenched with
0.3M glycine in 0.1M PBS at 7.4pH for 10 minutes followed by washing 2 times for 5 minutes.
Coverslips containing astrocytes were mounted on glass specimen slides with a medium
containing 3% polyvinyl alcohol/ glycerin/ Tris-HCl / DABCO.
Image Acquisition and Analysis
Microscopy images were acquired with a Zeiss LSM 510 violet confocal microscope
with a 63X magnification oil objective running on a Zen platform. Several criteria were
developed to select astrocytes for inclusion in the study. First, astrocytes were inspected and,
astrocytes that did not show signs of imminent death or nascent apoptosis were selected;
second, astrocytes had to show canonical morphology, including well-developed extensions
and appropriate size; and third, astrocytes had to be adequately spaced apart so that a single
astrocyte’s boundaries could easily be determined. Seven normoxic, six hypoxic, and six
hypoxic-reoxygenation astrocytes were selected from 3 cultures per group for a detailed
assessment of mitochondria structure features. Image analysis was conducted with ImageJ
software (ImageJ 1.48v, Wayne Rasband, National Institutes of Health, USA) using the
particle analysis function to provide mitochondrial estimates. The following parameters were
determined: area distributions, length, diameter, area, total mitochondrial mass, and roundness.
Mitochondrial size distributions were calculated by sorting the entire content of astrocytic
mitochondria into specific area categories (0.004-0.79, 0.80-1.59, 1.60-2.39, 2.40-3.19, > 3.20
µm2). Once the total number of mitochondria have been sorted into their respective size
categories, the number of mitochondria that fell within each size range was counted; these
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numbers were used to calculate the percentage of total mitochondria that fall within each size
range by dividing the sum of mitochondria per size range by the total number of mitochondria
in the astrocyte. Mitochondrial mass was calculated by summating the total area of
mitochondria for each astrocyte then dividing this by the number of astrocytes for that group.
Mitochondrial aspect ratio (AR = major axis/ minor axis) and form factor (FF = 1 / 4x (area /
perimeter2)) were used to describe the full array of mitochondrial size and complexity as
previously reported (Koopman et al., 2005b).

Average astrocytic area and astrocytic

extensions were calculated to determine the effects of hypoxia and post-hypoxic reoxygenation
on astrocytic morphology. Astrocytic extensions were classified into three categories, primary,
secondary, and tertiary. Extensions with origins of the soma were deemed primary extensions,
extensions with origins of primary extensions were termed secondary extensions, and
extensions with origins of secondary extensions were termed tertiary extensions.
Three-Dimensional Surface Reconstruction
Three-dimensional surface reconstructions of deconvolved primary z-stack data sets
collected by confocal microscopy were generated by Imaris (Bitplane). Z-stacks were collected
on a Zeiss LSM 710 confocal microscope running on the Zen 2 platform with a C-Apochromat
63x/ 1.20 objective. Parameters for z-stack image collection were as follows, a pinhole set to
0.7 Airy units, a frame size of 4096 X 4096, and a pixel dwell of 0.79μs to generate 16-bit
images with a digital zoom of 1. Images in z-stacks were set to be collected at a step size of
0.100μm for the entire thickness of the cell.
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Western Blots
Primary astrocytes were cultured in 6 centimeter culture dishes (n = 5/ group) in
DMEM supplemented with 10% FBS and 1% penicillin streptomycin at a seeding density of
≈ 200,000 cells per dish. After 72-hours, astrocytes were either maintained at normoxia,
exposed to 3-hours of hypoxia, or 3-hours hypoxia then 10-hours reoxygenation. To determine
autophagic flux, an LC3 turnover assay was performed (Mizushima et al., 2010). Lysosomal
degradation of LC3 II was inhibited by treating cells with 30 μM Chloroquine (Sigma-Aldrich,
St. Louis, MO) diluted in DMEM prior to hypoxic exposure. Astrocytes treated with 10 μM
forskolin or 10 μM rolipram were used as positive controls for phosphorylated Drp-1 at Ser637.
After exposure, cells were lifted from culture dishes in 4mL of 0.1M PBS then collected into
15mL conical tubes. Suspended cells were pelleted by centrifugation at 3000 rpm for 2minutes. After centrifugation, supernatant was decanted and discarded. Primary astrocyte
pellets were lysed with 250µL RIPA buffer (0.5% deoxycholate/ 0.1% sodium dodecyl sulfate/
150mM sodium chloride/ 50mM (pH 8.0) Tris-HCl) supplemented with 2µL/mL protease and
phosphatase inhibitors (EMD Millipore, Billerica, MA). Astrocytic lysates were then briefly
sonicated then centrifuged at 12,000 rpm for 20-minutes to pellet cellular debris, supernatant
was collected in new 2mL microcentrifuge tubes. Protein concentrations were estimated using
Pierce Protein Assay Reagent (Thermo Scientific, Rockford, IL) to normalize protein content
variability between culture dishes. Lysates were prepared in 4X Laemmle buffer containing
10% β mercaptoethanol and placed in a heated water bath for 10-minutes to denature the
protein samples. Protein samples were resolved by SDS-PAGE 4-20% precast gels, MiniPROTEAN TGX (Bio Rad, USA) then transferred onto a PVDF Immunobilon membrane
(EMD Millipore, Billerica, MA). Membranes were blocked with blocking buffer (LI-COR
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Bioscience, Lincoln, NE) supplemented with 0.1% Tween 20 for 45-minutes. Membranes were
incubated with affinity purified primary antibodies raised in rabbit or mouse targeted against
phosphorylated-dynamin related protein 1 at Ser 637 (pDrp-1), Drp-1 (Cell Signaling,
Danvers, MA), microtubule-associated 1A/1B-light chain 3 (LC3) (Sigma-Aldrich, St. Louis,
MO), and β-actin (Santa Cruz Biotechnology, Dallas, TX) at a dilution of 1:500 for 24-hours
at 4ᵒ C. Membranes were washed 3 times for 15-minutes with TBST (20mM Tris-HCl/ 500mM
NaCl/ 0.1% Tween 20) solution then incubated with IRDye 800CW and IRDaye 680RD (LICOR Biosciences, Lincoln, NE) secondary goat antibodies targeted against rabbit or mouse
IgG (Molecular Probes, Eugene, OR) for 4-hours. Blots were washed 5 times for 15-minutes
with TBST then fluorescence imaged with an Odyssey imaging system (LI-COR Biosciences,
Lincoln, NE). Blot images were analyzed using Image Studio Lite 4.0 (LI-COR Biosciences,
Lincoln, NE) then analyzed for fluorescence intensity normalized to β-actin.
Mitochondrial Autophagy Measurement
Primary astrocytes were plated in 6-well culture plates containing 22mm X 22mm glass
cover slips at a seeding density of 50,000 cells per well and incubated at 37 ᵒC for 24-hours.
Prior to hypoxic treatment, astrocytic mitochondria were labeled with 70nM of MitoTracker
Red CMXRos for 20-minutes then washed twice with pre-warmed (37ᵒ C) DMEM culture
medium. After receiving hypoxic or hypoxic reoxygenation treatment, cells were rinsed with
ice-cold 0.1M PBS at physiological pH then quickly fixated with 3.7% paraformaldehyde at
physiological pH. Post-fixation, cells were washed 3 times for 5-minutes with 0.1M PBS. Free
aldehyde groups were quenched with 0.3M glycine in 0.1M PBS at a pH of 7.4 followed by
washing 2 times for 5-minutes with 0.1M PBS. Cells were then permeabilized with 0.025%
Triton X-100 in PBS for 20-minutes and washed 3 times for 5-minutes with PBS. After
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permeabilization, cells were blocked with 2% BSA for 45-minutes. Cells were then incubated
with affinity purified IgG primary antibodies targeted against LC3 raised in rabbit (SigmaAldrich, St. Louis, MO) at a dilution of 1:500 in a solution containing 1% BSA, 0.01% Tween
20 in 0.1M PBS for 24-hours. After incubation with primary antibodies, cells were washed 3
times for 5-minutes with PBS containing 0.01% tween 20. Cells were then incubated with
Alexa 488 secondary goat antibodies targeted against rabbit IgG (Invitrogen, Carlsbad, CA).
Alexa 488 secondary antibodies were diluted to 1:1000 in a solution containing 10% goat
serum, 0.01% Tween 20 in PBS and allowed to incubate with the cells for 4-hours followed
by 3 times wash for 5 minutes. Cells were counterstained with DAPI nuclear stain (Molecular
Probes, Eugene, OR) then mounted with a medium containing 3% polyvinyl alcohol/ glycerin/
Tris-HCl/ DABCO. Primary astrocytes were then imaged on a Zeiss LSM 710 violet confocal
with a 63X magnification oil objective running on the Zen 2 platform. Confocal micrographs
were analyzed for immunofluorescence colocalization of LC3 with MitoTracker labeled
mitochondria as an indication of nascent mitophagy. LC3-MitoTracker colocalization was
used to calculate the percentage of mitochondria in each mitochondrial size range undergoing
mitophagy. Confocal micrographs were also used to calculate immunofluorescence intensity
as a function of distance from the nucleus as an indication of LC3 localization.
Mitochondrial ATP Production
Mitochondrial ATP production was quantified using the CellTiter-Glo luminescent
ATP assay kit (Promega, Madison WI) according to manufacturer’s guidelines. Astrocytes
were plated on 96-well black-walled assay plates and seeded at a density of 10,000 cells per
well. After 24-hours of growth phase, cells received hypoxic treatment with or without
reoxygenation and were allowed to equilibrate at room temperature for 30-minutes before the
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ATP assay was implemented. Luciferase luminescence was measured with a plate reader
(BioTek). ATP was calculated in ng per 10,000 cells using an ATP standard curve. The
standard curve was created immediately prior to running the assay to prevent ATP degradation.
Standard curve was prepared by serial tenfold dilutions of ATP in DMEM.
Mitochondrial Superoxide Production
Time-dependent pre- and post-hypoxic reoxygenation associated superoxide (O·̄2 )
production by mitochondria was measured with MitoSOX Red (Invitrogen), in accordance to
manufacturer’s guidelines. Measurements of O·̄2 were recorded at 3-hours before hypoxic
exposure and 0, 0.5, 1, 2, 4, 8, and 12-hours post-hypoxia, during the reoxygenation period.
Primary astrocytes were plated on 96-well assay plates containing DMEM at a seeding density
of 15,000 cells per well. Astrocytes were then cultured to 95-100% confluency before
experimentation. 5-minutes prior to receiving MitoSOX Red, astrocyte DMEM media was
replaced with HBSS media to conduct the assay. Each well containing astrocytes received 5μM
MitoSOX Red and allowed to incubate at 37° for 16-minutes. Fluorescence indication of O·̄2
levels were detected via an excitation of 510nm and emission of 580nm with a plate reader
(BioTek). Fluorescence intensity was detected by the plate reader and computed into mean
fluorescence values, these values were then used to calculate the percentage change from
normoxia for each time point.
Statistics
All data were obtained using cells from at least four different animals/preparations.
Results are depicted as means +/- SEM for the number of determinants (n) for each of the three
experimental groups (normoxia, 3-hours hypoxia, and 3-hours hypoxia then 10-hours
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reoxygenation). Statistical analysis used was either student’s t-test or ANOVA, with
Bonferroni or Dunnett post-hoc tests. Specific statistical analysis used in each experiment is
noted in the individual figure legends. Bonferroni’s multiple comparison analysis was used to
compare all combinations of the three experimental groups. Dunnett’s post hoc test was used
for the comparison of the experimental groups with the normoxia group (control group). P <
0.05 was considered significant. The following number of astrocytes’ mitochondria were
quantified: 7 normoxic astrocytes, 6 hypoxic astrocytes, and 6 hypoxic-reoxygenation
astrocytes. For LC3 colocalization studies, the following number of astrocytes’ mitochondria
were quantified: 7 normoxic astrocytes, 5 hypoxic astrocytes, and 6 hypoxic-reoxygenation
astrocytes.

Results
Mitochondrial Size Measurements
Astrocytic exposure to hypoxia demonstrated the dynamic ability of mitochondria to
undergo fission and fusion in response to changes in environmental oxygen pressure (Figure
2.1A and B). Hypoxic exposure for 3-hours with or without 10-hours reoxygenation resulted
in a redistribution of mitochondrial size to a larger number of smaller mitochondria.
Primary astrocytes that were exposed to 3-hours hypoxia with no reoxygenation
showed the largest redistribution to smaller sized mitochondria compared to the 3-hours
hypoxia then 10-hours reoxygenation and normoxia groups (Figure 2.1C). In the normoxia
group, 35.86% of mitochondria fell within the 0.004 – 0.79 μm2 range. After 3-hours of
hypoxia these values increase to 64.59% (p=0.0004) and after 10-hours of post-hypoxic
reoxygenation the percentage of mitochondria that fell within the 0.004-0.79 μm2 range
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Figure 2.1. Hypoxic exposure induces excessive mitochondrial fission. (A and B)
Micrographs depicting a 63X magnification of labeled mitochondria with MitoTracker Red
CMXRos (Red) in primary rat astrocytes incubated under normoxia, 3-hours hypoxia and
no reoxygenation, and 3-hours hypoxia then 10-hours reoxygenation. Row (B) contains
magnified images of row (A). Scale bar 10μm. Panel (C) contains a bar graph (mean +/SEM) depicting data of individual mitochondrial area (μm2) as percent of the total
mitochondria per astrocyte for each experimental group; normoxia (n = 550), 3-hours
hypoxia (n = 743), 3-hours hypoxia then 10-hours reoxygenation (n = 312). Two-way
ANOVA, Bonferroni’s multiple comparison test was used to determine the level of
significance between the experimental groups: (*, p < 0.05; **, p < 0.01).
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remained significantly elevated at 54.03% (p=0.01) compared to normoxia. This observed
increase in smaller mitochondria was associated with an observed reduction of larger
mitochondria falling within 1.6 – 2.39, 2.4 – 3.19, and > 3.2 μm2 range (Figure 2.1C). The
average mitochondrial area differed between the groups; the normoxia group contained
mitochondria with an average area of 1.69μm2 compared with 0.86 μm2 (p<0.01) and 1.08 μm2
(p<0.05) for the 3-hours hypoxia and 3-hours hypoxia then 10-hours reoxygenation groups,
respectively (Figure 2.2A). Mitochondrial swelling is a known phenomenon associated with
calcium-induced cytochrome-c release from mitochondria during instances of mitochondrialinduced apoptosis (Kobayashi et al., 2003; Ichimura, 2011). To further make it clear that
nascent cell death was absent during data collection and to determine if mitochondrial swelling
contributes to the reported mitochondrial measurements, mitochondrial length and diameter
were measured. Mitochondrial length was measured as the maximum distance between any
two points within the mitochondrial boundaries. Mitochondrial diameter was measured as the
minimum distance between two opposing points of mitochondrial boundaries. Astrocytes that
were maintained under normoxia demonstrated a mean length of 2.70 μm compared to 1.29
μm (p<0.0001) and 2.05 μm (p<0.0001) after 3-hours of hypoxia and 10-hours post-hypoxic
reoxygenation, respectively. Additionally, these data demonstrate a significant amelioration of
mean mitochondrial length after 10-hours post-hypoxic reoxygenation (p<0.0001) compared
to 3-hours hypoxia, albeit significantly reduced compared to normoxia (Figure 2.2B). In
contrast to measurements of mitochondrial length, mitochondrial diameter did not depict any
notable change between normoxia, 3-hours hypoxia, and 10-hours post-hypoxic reoxygenation
(Figure 2.2C).
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Dephosphorylation of Drp-1 at Ser 637 by calcineurin is an essential step in
mitochondrial fission (Cereghetti et al., 2008), and phosphorylation of Drp-1 at Ser 637 by
PKA favors mitochondrial fusion (Chang and Blackstone, 2007; Cribbs and Strack, 2007). We
therefore assessed Drp-1 phosphorylation at Ser 637 as percentage of total Drp-1 via Western
blot analysis in primary astrocytes maintained under normoxia, 3-hours of hypoxia, and 10hours post-hypoxia reoxygenation. Our Western blot data revealed that astrocytes maintained
under normoxic conditions contained 3.27 % of total Drp-1 phosphorylated at Ser 637 whereas,
astrocytes exposed to 3-hours of hypoxia contained 2.17% (p=0.0492) of Drp-1
phosphorylated at Ser 637 compared to normoxia. After 10-hours of post-hypoxia
reoxygenation, Drp-1 phosphorylation at Ser 637 increased to 4.92% (p = 0.0058) of control
Drp-1 phosphorylation (Figure 2.2D).
Mitochondrial Population and Mass
Interestingly, the total number of mitochondria per astrocyte was different among all
three groups. In the normoxic control group, there were 79 mitochondria per astrocyte whereas
the 3-hours hypoxia with no reoxygenation contained 124 mitochondria per astrocyte.
However, after 10-hours of reoxygenation the number of mitochondria decreased to 52 per
astrocyte (p=0.046) compared to normoxia (Figure 2.3A). To determine if the changes in
mitochondrial population after hypoxia and reoxygenation affect the total mitochondrial
content in astrocytes, we calculated the total mitochondrial area per astrocyte. Astrocytes that
were maintained at normoxia contained a total mitochondrial area of 123 μm2; however,
following 3-hours of hypoxia the total mitochondrial area was reduced to 102 μm2 and after
10-hours reoxygenation the total mitochondrial area was further reduced to 57 μm2 (p=0.0218)
compared to normoxia (Figure 2.3B).
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Figure 2.2. Measurements of mitochondria dimensions in astrocytes (A-C) after exposure
to hypoxia and post-hypoxia reoxygenation. Bar graph (mean +/- SEM) depicting data of
(A) mitochondrial area, (B) mitochondrial length, and (C) mitochondrial diameter as
average of total mitochondria per astrocyte for each experimental group; normoxia (n =
550), 3-hours hypoxia (n = 743), 3-hours hypoxia then 10-hours reoxygenation (n = 312).
(D) Characterization of Drp-1 phosphorylation after hypoxia and reoxygenation. SDSPAGE immunoblots indicate a reduced Drp-1 phosphorylation after hypoxic treatment and
a subsequent increase with reoxygenation. Western blot analysis of whole cell lysates were
determined by anti-pDrp-1 (Ser 637) antibodies (red) and anti-Drp-1 (green) for normoxia
(n = 11), 3-hours hypoxia (n = 14), and 3-hours hypoxia then 10-hours reoxygenation (H +
R, n = 16). Bar graph (mean +/- SEM) depicting pDrp-1 data as the percentage of total Drp1. Panels A-C were analyzed with a one-way ANOVA, Bonferroni’s multiple comparison
test to determine the level of significance between the experimental groups (*, p < 0.05; **,
p < 0.01; ***, p < 0.0001). Panel D was analyzed with a one-tailed t-test to determine the
level of significance between the experimental groups (*, p < 0.05; **, p < 0.01).
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Mitochondrial Fragmentation
Rounded mitochondria are indicative of fragmentation (Brustovetsky et al., 2009) and
cellular stress (Dubinsky and Levi, 1998). Therefore, we measured mitochondrial roundness
to assess the extent of mitochondrial fragmentation. These data are depicted on a scale from 0
to 1; 1 being a perfect circle. Notably, astrocytes exposed to hypoxia displayed an alteration of
mitochondrial morphology to a more rounded shape. Astrocytes that were maintained under
normoxia contained mitochondria that scored an average of 0.36 on the roundness index. After
3-hours of hypoxia this score increased to 0.53 (p=0.0001) then decreased to 0.50 (p=0.0001)
after 10-hours of reoxygenation (Figure 2.4A). A reduction of mitochondrial network
complexity can result from fragmented mitochondria and increased mitochondrial fission.
Therefore, mitochondrial aspect ratio (AR) and form factor (FF) was calculated to describe
mitochondrial network complexity. Mitochondria that measure greater AR are larger
mitochondria whereas mitochondria that score greater on FF contain more complex branching
(Koopman et al., 2005a; b). Under normoxic conditions, mitochondria demonstrated an AR
and FF of 4.49 and 2.58, respectively. After hypoxia exposure, the AR and FF decreased to
2.06 and 1.44, respectively indicating less complex mitochondrial networks. Furthermore, 10hours of post-hypoxic reoxygenation resulted in a slight amelioration of both AR (3.03) and
FF (1.83) (Figure 2.4A-D).
Mitochondrial Autophagy
Excessive mitochondrial fragmentation may predispose mitochondria to loss of
membrane potential and buffering capacity resulting in mitochondria being targeted for
autophagy (Ishihara et al., 2003; Legros et al., 2003). Therefore, we next determined the extent
of mitochondrial autophagy after exposure to hypoxia and post-hypoxia reoxygenation and
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Figure 2.3. Astrocytic mitochondrial content fluctuates in response to hypoxia and
reoxygenation. Bar graphs (mean +/- SEM) depicting the average total number of
mitochondria per astrocyte (A) and total area (μm2) occupied by mitochondria per astrocyte
(B) for each experimental group, normoxia (left, n = 7), 3-hours hypoxia (center, n = 6),
and 3-hours hypoxia then 10-hours reoxygenation (right, n = 6). One-way ANOVA,
Bonferroni’s multiple comparison test was used to determine the level of significance
between the experimental groups (*, p < 0.05).
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further to determine if smaller mitochondria are targeted for autophagy. During autophagy,
cytosolic LC3 I is cleaved then lipidated before being inserted as LC3 II into the
autophagosome membrane (Tanida et al., 2004). We first measured the conversion of LC3 I
into LC3 II by calculating the ratio of LC3 II/ (LC3 I + LC3 II) (Mizushima and Yoshimori,
2007) via Western blot to determine the effects of hypoxia and post hypoxia reoxygenation on
the number of autophagosomes. Astrocytes exposed to 3-hours hypoxia then 10-hours
reoxygenation showed an RFU (relative fluorescence unit) of 0.436 (p<0.0001) conversion to
LC3 II compared to 0.316 and 0.194 LC3 II conversion in the 3-hours hypoxia and normoxia
groups, respectively (Figure 2.5A-B). Changes in LC3 II corresponded with a decrease in
VDAC to 0.728 (p < 0.02) and 0.803 (p < 0.05) fold of normoxia in astrocytes exposed to 3hours hypoxia and 3-hours hypoxia then 10-hours reoxygenation, respectively (Figure 2.5C).
We next performed an LC3 turnover assay to determine autophagic flux as an indication of
autophagic induction (Mizushima and Yoshimori, 2007; Klionsky et al., 2008; Rubinsztein et
al., 2009; Mizushima et al., 2010). The measurement of autophagic flux is centered on the
notion that LC3 II is degraded in the autolysosome during autophagy. The LC3 turnover assay
was performed by inhibiting lysosomal acidification with 30 μM chloroquine prior to cells
receiving hypoxic exposure. Astrocytes maintained at normoxia demonstrated an LC3 II
turnover at 2.54 compared to 4.01 (p<0.006) and 7.91 (p<0.0001) in astrocytes exposed to 3hours hypoxia and 3-hours hypoxia then 10-hours reoxygenation, respectively (Figure 2.5D).
In addition, under normoxic conditions, LC3 II was 204.04 % (p<0.0009) greater in astrocytes
treated with 30 μM chloroquine compared to astrocytes that were not treated with chloroquine
(Figure 2.5E). These data demonstrating differences in LC3 II levels under basal conditions
(normoxia) between astrocytes treated with chloroquine and without chloroquine rule out
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Figure 2.4. Hypoxia induces mitochondrial remodeling into a more rounded morphology
and a loss of network complexity. (A) Bar graph depicting roundness values for each
experimental group; normoxia (left, n = 550), 3-hours hypoxia (center, n = 743), and 3hours hypoxia then 10-hours reoxygenation (right, n = 312). (B-D) Scatter plots
representing mitochondrial network complexity. Scatter plot of mitochondrial aspect ratio
as a function of form factor for (B) normoxia (n = 550), (C) 3-hours hypoxia (n = 743), and
(D) 3-hours hypoxia then 10-hours reoxygenation (n = 312). Increasing value of aspect ratio
indicates larger size while increasing form factor value indicates greater mitochondrial
network complexity. Panel A was analyzed with a one-way ANOVA, Bonferroni’s multiple
comparison test to determine the level of significance between experimental groups (***,
p < 0.0001).
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blocked autophagic processing as a contributor to LC3 II accumulation in our data (Figure
2.5E).
Mitochondrial autophagy was assessed via immunofluorescence colocalization of LC3
and MitoTracker after hypoxia and post hypoxia reoxygenation. Confocal micrographs were
collected from astrocytes maintained at normoxia, 3-hours hypoxia, and 10-hours post-hypoxic
reoxygenation. As a positive control group, astrocytes maintained under normoxia were treated
with 10uM FCCP to induce mitochondrial autophagy (Figure 2.5F). The confocal micrographs
were used to create colormap representative images demonstrating colocalized mitochondria
with LC3. The colormap images were used to calculate the percentage of mitochondria targeted
for autophagy (Figure 2.5G), the size of mitochondria primarily affected by mitophagy (Figure
2.5H), and the cellular localization of mitochondrial autophagic activity (Figure 2.5I). Our
colocalization analysis indicated that under normoxic conditions 26.4% of total mitochondria
are targeted for mitophagy compared to 24.9% and (p < 0.01) 43.7% of mitochondria in
astrocytes incubated under hypoxia for 3-hours and 3-hours hypoxia then 10-hours
reoxygenation, respectively. In the positive control group, astrocytes treated with FCCP and
maintained under normoxia contained 56.1% of their total mitochondria targeted for
mitophagy. Our data indicate that the smallest mitochondria ranging in size of 0.004-0.79μm2
were most targeted by mitophagy. Astrocytes maintained under normoxia contained 3.68% of
the smallest mitochondria targeted for mitophagy. Whereas, astrocytes exposed to 3-hours of
hypoxia contained 7.23% (p<0.0001) of the smallest mitochondria targeted for mitophagy.
After 10-hours post-hypoxic reoxygenation the percentage of smallest mitochondria targeted
for mitophagy increased to 17.45% (p<0.0001). Mitochondria falling within the size rage of
0.80-1.59μm2 contained the second largest number of mitochondria targeted for mitophagy;

95

these mitochondria represented the second-to smallest mitochondria. Astrocytes maintained
under normoxia contained 6.59% of small mitochondria targeted for mitophagy. Whereas,
astrocytes exposed to 3-hours of hypoxia contained 5.63% of small mitochondria targeted for
mitophagy. After 10-hours of post-hypoxic reoxygenation the percentage of small
mitochondria targeted for mitophagy significantly increased to 12.65% (P<0.05). Additionally,
our data suggests that the majority of mitochondrial autophagic activity occurs at specific
cellular locations during hypoxia and post-hypoxic reoxygenation. Astrocytes exposed to 3hours of hypoxia then 10-hours reoxygenation showed increased LC3 fluorescence intensity
near the nucleus compared to the approximate homogenous distribution of LC3 fluorescence
intensity in astrocytes exposed to 3-hours of hypoxia or normoxia.
Mitochondrial ATP Production
Hypoxia induces mitochondrial respiratory inhibition resulting in a rapid decline of
astrocytic ATP production. Astrocytes maintained under normoxia contained 52.89ng of ATP
per 10,000 cells. After 3-hours of hypoxic exposure astrocytic ATP content declined to 23.1ng
(p<0.0001) per 10,000 cells. Interestingly, after 10-hours of post-hypoxic reoxygenation,
astrocytes demonstrated a significant amelioration of ATP content to 47.12ng per 10,000
(p<0.0001) although still significantly below ATP content of astrocytes maintained under
normoxia (p< 0.0001) (Figure 2.6A).
Mitochondrial Superoxide Production
Mitochondrial superoxide production is a major contributor of cellular damage via
oxidation of lipids, proteins, and other biomolecules. Mitochondrial superoxide production
occurs at complex I and III of the mitochondrial electron transport chain, with the majority of
superoxide production occurring at complex I via reversal of electron transport during cerebral
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Figure 2.5. Expression and colocalization of LC3 with mitochondria in astrocytes. SDSPAGE immunoblots indicate an increased LC3 II content after hypoxia and reoxygenation
(A) Western blot analysis of whole cell lysates were used to determine the magnitude of
(B) LC3 II conversion, (C) cellular VDAC content, (D) autophagic flux, and (E) basal
autophagic efficiency. Western blots of lysates from normoxia (n = 5), 3-hours hypoxia (n
= 5), and 3-hours hypoxia then 10-hours reoxygenation (H + R, n = 5) were labeled with
anti-LC3 (red, green), VDAC (green), and β-actin (red) antibodies. (F) Representative
three-dimensional reconstructions of z-stacks depicting mitochondria (red), LC3 (green),
and colocalized areas (white) in astrocytes, incubated at normoxia (FCCP), normoxia, 3hours hypoxia, and 3-hours hypoxia then 10-hours reoxygenation. Scale bar 10μm. (G) Bar
graph (mean +/- SEM) depicting the percentage of total mitochondria colocalized with LC3
in astrocytes incubated under normoxia (FCCP) (n = 7), normoxia (n = 7), 3-hours hypoxia
(n = 5), and 3-hours of hypoxia then 10-hours reoxygenation (n = 6). (H) Bar graph (+/SEM) depicting percentage of mitochondria colocalized with LC3 as a function of
mitochondrial size (μm2). (I) Line graph depicting the percentage of extranuclear LC3 (+/SEM) as a function of nuclear distance for astrocytes incubated at normoxia (circle, n = 7),
3-hours hypoxia (square, n = 5), and 3-hours hypoxia then 10-hours reoxygenation (triangle,
n = 6). One-way ANOVA, Bonferroni’s multiple comparison test was used to determine
the level of significance between the experimental groups (*, p < 0.05; **, p < 0.01; ***, p
< 0.0001).
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ischemia (Liu et al., 2002; Talbot et al., 2004). To determine the levels of superoxide
generation by mitochondria, a fluorescence probe, MitoSOX Red, was used during normoxia,
hypoxia, and subsequent time-periods of post-hypoxia reoxygenation. Our data indicates that
astrocytes maintained under normoxia contained the highest levels of mitochondrial
superoxide relative to hypoxia and post-hypoxia reoxygenation. At the conclusion of 3-hours
hypoxic exposure, superoxide content reduced to 27.39% of the superoxide observed in
normoxic astrocytes. After the first 30-minutes of post-hypoxic reoxygenation, astrocytic
superoxide content increased to 56.71% of normoxic values. Furthermore, as post-hypoxic
reoxygenation progressed, astrocytic superoxide production continued to increase to 60.72%,
67.65%, and 73.34% of normoxic superoxide content after 1-, 2, and 4-hours of reoxygenation,
respectively. Interestingly, after 8-hours of post-hypoxic reoxygenation, astrocytic superoxide
production reached a peak of 89.65% of normoxic values followed by a decline to 82.55%
after 12-hours of post-hypoxic reoxygenation (Figure 2.6B).
Astrocytic Extensions and Swelling
Astrocytic extensions are structures that participate in critical cellular processes that
mediate metabolic support to neurons, neurovascular coupling, and neurotransmitter recycling.
Hypoxia and post-hypoxia reoxygenation induced a loss of astrocytic extensions. Astrocytes
maintained under normoxia contained an average of 40 extensions. However, after exposure
to 3-hours of hypoxia, astrocytic extensions declined to an average of 31 and after 10-hours of
post-hypoxic reoxygenation, astrocytic extensions further declined to an average of 21
(p<0.05) (Figure 2.7A-D). We next determined the specific branch level of extension loss in
these astrocytes. To determine the specific branch level of extension loss, each astrocytic
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Figure 2.6. Bar graph (mean +/- SEM) depicting astrocytic ATP content (ng) per 10,000
cells for astrocytes incubated under normoxia (n = 18), 3-hours hypoxia (n = 12), and 3hours hypoxia then 10-hours reoxygenation (n = 24) (A). Mitochondrial superoxide
production during normoxia, after hypoxia and throughout post-hypoxia reoxygenation (B).
Quasi bar graph and line graph (mean +/- SEM) depicting the time-dependent superoxide
production by mitochondria during normoxia (n = 24), hypoxia (n = 21), and for 0.5, 1, 2,
4, 8, and 12-hours reoxygenation (n = 22). Panel A was analyzed by a one-way ANOVA,
Bonferroni’s multiple comparison test was used to determine the level of significance
between the experimental groups (***, p < 0.0001). Panel B was assessed by one-way
ANOVA, Dunnett’s post-hoc test was used to determine the level of significance between
the experimental groups (*, p < 0.05; ***, p < 0.0001).

100

extension was categorized based on branch origin. Extensions with origins of the soma were
deemed primary extensions, extensions with origins on primary extensions were termed
secondary extensions, and extensions with origins on secondary extensions were termed
tertiary extensions. Our data revealed significant secondary and tertiary astrocyte extension
loss. Astrocytes maintained under normoxia demonstrated the most complex branch patterning
indicated by a higher number of secondary and tertiary extensions (Figure 2.7A and D).
Normoxic astrocytes contained an average of 15 primary, 20 secondary, and 4 tertiary
astrocytic extensions. However, after exposure to 3-hours of hypoxia, astrocytes demonstrated
marked loss of extension density (Figure 2.7B and E). Astrocytes exposed to 3-hours of
hypoxia contained 16 primary, 12 secondary, and 2 tertiary astrocytic extensions. After 10hours of post-hypoxic reoxygenation, astrocyte extension loss was clearly recognizable, in both
density and complexity (Figure 2.7C and E). Astrocytes exposed to 3-hours hypoxia then 10hours reoxygenation contained 10 primary (p=0.0432), 8 secondary (p=0.0063), and 0.5
tertiary (p=0.0145) astrocytic extensions (Figure 2.7C and E). Lastly, we observed evidence
of astrocyte swelling during hypoxic exposure. This swelling did not persist throughout the
reoxygenation phase of hypoxic exposure. Astrocytes maintained under normoxia contained
an average astrocytic area of 1677.03 μm2. However, after hypoxic incubation, astrocytic area
significantly increased to 3076.01 μm2 (p=0.0425). Following 10-hours post-hypoxia
reoxygenation, astrocytic area reduced to 1487.22 μm2. These changes in astrocytic area
indicate astrocyte swelling during hypoxic exposure that does not persist on to the
reoxygenation phase of exposure (Figure 2.7F). Furthermore, our cell death assay of astrocytes
exposed to 3-hours of hypoxia and 10-hours post-hypoxic reoxygenation (Figure 2.7G)
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indicated no change in astrocyte viability, suggesting that these observed changes in astrocytic
swelling did not result in cellular death.

Discussion
In this study, we have demonstrated that hypoxia and post-hypoxia reoxygenation of
primary astrocytes results in a redistribution of mitochondria to smaller sizes evoked by an
increase in mitochondrial fission. Excessive mitochondrial fission corresponded to Drp-1
dephosphorylation at Ser 637, which preceded mitophagy of relatively small mitochondria.
Post-hypoxia reoxygenation of astrocytes marked the initiation of elevated mitophagic activity
particularly in the perinuclear region where a large number of the smallest mitochondria were
undergoing nascent degradation. Although, during hypoxia astrocytic ATP content severely
reduced, after reoxygenation ATP content returned to near normoxic values; these changes
were observed in mitochondrial superoxide production as well. Concomitant with these
mitochondrial morphological and functional changes in astrocytes, the number of astrocytic
extensions declined particularly after 10-hours post-hypoxic reoxygenation. Overall, we posit
a drastic mitochondrial network change that is triggered by a metabolic crisis during hypoxia;
these changes are followed by mitochondrial degradation and retraction of astrocytic
extensions.
Reports concerning mitochondrial fusion and fission as being beneficial or detrimental
to cell function and viability have been considerably disparate (Chang and Blackstone, 2007;
Estaquier and Arnoult, 2007; Parone et al., 2008; Ong et al., 2010; Gomes et al., 2011; Chou
et al., 2012; Papanicolaou et al., 2012; Qi et al., 2013). However, it is well established that
asymmetric mitochondrial fission is an important event central to mitochondrial quality control
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Figure 2.7. Hypoxic exposure and post-hypoxic reoxygenation results in a loss of astrocytic
extensions. Confocal micrographs depicting 63X magnification binary images of primary
astrocytes incubated under (A) normoxia (n = 7), (B) 3-hours hypoxia (n = 5), and (C) 3hours hypoxia then 10-hours reoxygenation (n = 7). Scale bar 10μm. (D) Bar graph (mean
+/- SEM) depicting total number of astrocytic extensions for each experimental group. (E)
Bar graph (mean +/- SEM) depicting the number of astrocytic extensions categorized into
primary, secondary, or tertiary extensions per each experimental group. (F) Bar graph
(mean +/- SEM) depicting total astrocytic area (μm2) for each experimental group normoxia
(n = 7), 3-hours hypoxia (n = 6), 3-hours hypoxia then 10-hours reoxygenation (n = 6). (G)
Bar graph (mean +/- SEM) depicting cell death indicated by Propidium iodide fluorescence
intensity for each experimental group normoxia (n = 24), 3-hours hypoxia (n = 24), 3-hours
hypoxia then 10-hours reoxygenation (n = 24). One-way ANOVA, Bonferroni’s multiple
comparison test was used to determine the level of significance between the experimental
groups (* p < 0.05; ***, p < 0.0001).
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that eliminates damaged or dysfunctional parts of mitochondria (Twig et al., 2008). We
demonstrated that hypoxia results in a rapid redistribution of mitochondria to smaller sizes
(Figure 2.1). Mitochondrial damage is an event of the reoxygenation phase of ischemic injury
(Kowaltowski and Vercesi, 1999). Accordingly, our data indicated no increase in LC3 II
conversion or elevations in LC3-targeted mitochondria in astrocytes maintained under
hypoxia. In addition, the absence of mitophagic activity during hypoxia in astrocytes further
suggests that the observed fission is independent of the organelle recycling that occurs during
conditions of macromolecule depletion (Kristensen et al., 2008; Hailey et al., 2010; Egan et
al., 2011). The most probable cause of mitochondrial fission during hypoxia is the onset of a
metabolic crisis resulting from a rapid and severe ATP depletion. An inverse correlation
between mitochondrial size and metabolic competence has been described in the rat brain
(Bertoni-Freddari et al., 2003). This may explain our data suggesting that larger mitochondria
predominantly undergo fission, increasing the number of smaller mitochondria during hypoxia
and throughout reoxygenation. Therefore, we predict that during hypoxia an astrocytic
metabolic crisis triggers mitochondrial fission as a functional means of increasing energy
production by mitochondria.
It is well accepted that considerable cellular damage occurs during the reperfusion
phase of ischemic injury (Kalogeris et al., 2012). A major contributor to ischemic-reperfusion
injury is the mitochondrial production of superoxide at complex I (Arroyo et al., 1987; Bolli
et al., 1989; Chouchani et al., 2013). Mitochondrial ROS production during initial ischemia
reperfusion is driven by the rapid oxidation of succinate by the mitochondrial respiratory
complex succinate dehydrogenase and reversal of electron transport (Chouchani et al., 2014).
While this may devastate neuronal viability, astrocytes demonstrate increased tolerance to
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oxidative stress relative to neurons (Sochocka et al., 1994; Bolaños et al., 1995). Astrocyte
tolerance to oxidative stress has been suggested to be an effect of greater metabolic plasticity
(Escartin et al., 2007; Halim et al., 2010), more robust antioxidant buffering capacity (Dringen
et al., 2000; Shih et al., 2003; Belanger and Magistretti, 2009), and a lesser dependence of ATP
production via oxidative phosphorylation (Marrif and Juurlink, 1999; Solaini and Harris,
2005). Our data depict a progressive increase in mitochondrial superoxide production
throughout the reoxygenation phase of astrocytes exposed to hypoxia, which occurred with no
notable ROS burst. This gradual recovery of superoxide production parallels the oxidative
phosphorylation rate of these mitochondria (Perez-Campo et al., 1998; Balaban et al., 2005).
The absence of an ROS burst may explain astrocyte resistance to hypoxia-reoxygenationinduced cell death.
We provide evidence for two morphological responses of astrocytes to hypoxia. First,
during hypoxia, we observed astrocytic swelling that did not persist throughout the
reoxygenation phase. Astrocytic swelling is a known phenomenon of cerebral ischemia and
possibly contributes to ischemic injury, including excitotoxicity, extracellular ionic
dysregulation, and compressive damage to dendrites (Kimelberg et al., 1995; Kimelberg, 2004;
Risher et al., 2012). This astrocytic swelling has been attributed to elevated cytosolic calcium
concentration independent of mitochondrial depolarization (Kahlert and Reiser, 2002) in
models of cerebral ischemia (Duffy and MacVicar, 1996; Brookes et al., 2004). The
maintenance of homeostatic parameters of ion concentrations in astrocytes is dependent on
ATP availability. Accordingly, our data show both a decline in astrocytic ATP content and
swelling of astrocytes during hypoxia suggesting insufficient ATP availability for maintaining
ionic homeostasis. Ultimately, astrocytic swelling and its regulatory mechanism render
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astrocytes depolarized (Kimelberg and O’ Connor, 1988). This in mind, astrocyte morphology
is clearly intimately coupled and acutely sensitive to the competence of cellular ATP
production.
In addition to swelling, we also provide evidence for a robust retraction of secondary
and tertiary astrocytic extensions after hypoxia-reoxygenation exposure. Astrocytic extensions
are key structures enriched in excitatory amino acid transporters such as GLT-1, along with
other surface receptors participating in homeostatic processes such as neurovascular coupling,
translocation of specific molecules across the blood brain barrier, and maintenance of
extracellular milieu.
During the energy crisis following ischemia, astrocytic ATP content is insufficient to
support astrocyte relevant processes let alone fulfilling the energy requirement for astrocytemediated processes to neurons, which may account for some of the pathophysiological
mechanism that degenerate neurons which are strongly thought to be prevented by astrocytic
function.
A report by O’Donnell et al (O’Donnell et al., 2016) provided work consistent with our
data in that, oxygen glucose deprivation (OGD) of hippocampal slice cultures resulted in a
reduction of astrocytic mitochondrial length and occupancy (area). Furthermore, in agreement
with our measurements of LC3 II (LC3 B) after hypoxia with no reoxygenation, O’Donnell
and colleagues provide similar observations of a negligible change in LC3 B content with as
much as 24-hours of OGD (O’Donnell et al., 2016). Importantly, our data depict a strong
increase of LC3 B content occurring only with post-hypoxia reoxygenation suggesting that the
bulk of mitochondrial autophagy occurs during the reoxygenation phase with hypoxic
exposure. Therefore, pharmacological inhibition of mitochondrial autophagy in studies

107

designed to investigate the effects of OGD on mitochondria occupancy would best be
administered during a reoxygenation phase of OGD insult.
In summary, our data indicate a rapid metabolic crisis that ensues during hypoxia of
astrocytes that is associated with reduced ATP production, a shift in mitochondrial distribution
to smaller sizes, a loss of mitochondrial complexity, a reduction in mitochondrial superoxide
production, and astrocytic swelling. During post-hypoxic-reoxygenation, there is a reduction
in mitochondrial number mediated by smaller mitochondria targeted by mitophagy, a recovery
of ATP production, restoration of mitochondrial superoxide production, and a general loss of
astrocytic extensions.
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Abstract
Chronic cerebrovascular hypoperfusion results in vascular dementia and increases
predisposition to lacunar infarcts. However, there are no suitable animal models. In this study,
we developed a novel model for chronic irreversible cerebral hypoperfusion in mice. Briefly,
an ameroid constrictor was placed on the right carotid artery to gradually occlude the vessel,
while a microcoil was placed on the left carotid artery to prevent compensation of the blood
flow. This procedure resulted in a gradual hypoperfusion developing over a period of 34 days
with no cerebral blood flow recovery. Histological analysis of the brain revealed neuronal and
axonal degeneration as well as necrotic lesions. The most severely affected regions were
located in the hippocampus and the corpus callosum. Overall, our paradigm is a viable model
to study brain pathology resulting from gradual cerebrovascular hypoperfusion.
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Introduction
Chronic cerebral hypoperfusion is the primary cause of vascular dementia (Kynast et
al., 2017), and has been implicated in the development of white matter disease and lacunar
infarcts (Black et al., 2009). During the progression of the disease, cerebral arteries harden,
resulting in a deficient nutrient delivery to the cerebral parenchyma. This in turn, causes
metabolic distress and bioenergetic disturbances that contribute to cerebral degeneration
(Vasquez and Zakzanis, 2015). There are several models to induce hypoperfusion in
experimental animals based on the occlusion of two (Bottiger et al., 1998; Bottiger et al., 1999),
three (Carmichael, 2005; Thal et al., 2010; Onken et al., 2012) or four (Pulsinelli and Buchan,
1988; Traystman, 2003) vessels. However, all these models are based on either permanent or
temporal reduction/blockade of blood flow. Therefore, there is a need for a more clinically
relevant model that would induce a gradual reduction of cerebral blood flow, and therefore,
simulate chronic cerebral hypoperfusion in humans.
In this study, we developed a novel murine model to gradually, and irreversibly reduce
cerebral blood perfusion over time. Our paradigm is advantageous because it circumvents the
hypoxic/ischemic damage associated with a rapid reduction in CBF observed in other
hypoperfusion models (Shibata et al., 2004; Kitamura et al., 2016).
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Materials and Methods
Animals
12-14 week-old male C57BL/6Jmice were used. Mice were housed in accordance to
Institutional Animal Care and Use Committee (IACUC) guidelines in the West Virginia
University (WVU) Health Sciences Center vivarium. Animals were maintained under a
light/dark cycle (12 : 12 h) with food and water available ad libitum. All procedures conducted
were approved by IACUC at WVU.

Implantation of Ameroid Constrictor Ring and Microcoil
The ameroid constrictor is a device used in veterinary medicine for the treatment of
hepatic shunts whereby it induces collateral circulation via blood vessel occlusion. The
constrictor ring is composed of a surgical steel ring and an inner layer composed of casein. The
hygroscopic property of casein causes its gradual swelling at a predictable rate, wherein the
surgical steel ring that surrounds the casein layer forces this swelling inward, resulting in a
shrinking inner diameter that gradually occludes blood vessels.
Mice were anesthetized with 4-5% isoflurane and maintained under 1-2% isoflurane in
a 30% O2:70%N2 mixture and placed on a feedback controlled heating pad to maintain the
body temperature at 37 °C. Ophthalmic ointment was placed on the eyes; the surgical area was
prepared by trimming the fur and sanitizing the skin with isopropanol pads followed by
betadine. Both common carotid arteries (CCAs) were exposed through a midline cervical
incision, and an ameroid constrictor ring (cat. MC-0.50-55, Research Instruments SW, CA)
was placed around the right CCA following a published protocol (Hattori et al., 2015). A
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microcoil (cat. SWPA ID 0.18, Wuxi Samini Spring Co., LTD, China) was placed around the
left CCA to prevent CBF compensation. The entire surgical procedure was completed within
20 minutes. The sham group received a sham surgery including an incision exposing the
common carotid arteries but did not receive the implantation of the ameroid constrictor ring
and placement of the microcoil. All further experimentation was performed blinded to surgical
group.

Cerebral Blood Flow Measurement
Before the placement of the ameroid constrictor ring and microcoil, baseline CBF was
measured. Briefly, the skull was exposed with a 1.5 cm incision. Ten consecutive
measurements of CBF were acquired with a MoorFLPI laser Doppler system (Moor
Instruments, England) over the course of 5 minutes with an exposure of 200 ms. The incision
was closed with sutures and the animals were subcutaneously injected with a local anesthetic,
bupivacaine (1 mg/kg), once a day for 3 days. Implantation surgery was performed (see above).
To make certain that the implantation surgery did not cause damage to the CAA, a second CBF
measurement was performed. Subsequent CBF measurements were performed by reopening
the scalp at the same incision site, followed by suturing and bupivacaine injections.

Histochemistry
On day 34, mice were anesthetized and transcardially perfused with 20 mL 0.01M
phosphate buffered saline followed by 20 mL of 4% paraformaldehyde, pH of 7.45. Brains
were extracted, placed in 4% paraformaldehyde and incubated at 4 °C overnight. Fixed brains
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were sliced into 2 mm coronal sections, embedded in paraffin, sliced into 10 μm coronal
sections and mounted onto specimen slides. Deparaffinized and rehydrated tissue sections were
stained with Haemotoxylin and Eosin (H&E) to assess general brain pathology (Xiong et al.,
2008) and silver stained to assess axonal damage (Uchihara, 2007). The sections were imaged
on a MIF Olympus VS120 Slide Scanner at 20X magnification.

Statistical Analysis
Statistical comparisons were performed using either Student’s t-test or ANOVA (with
or without repeated measures, where appropriate). Dunnett’s post-hoc test was used for
comparison of the experimental groups relative to a control group, or for comparison within a
given group at one time point post-surgery (sham or surgical hypoperfusion) relative to the
pre-surgery time point. p < 0.05 was considered significant.

Results
Cerebral Blood Flow
Out of the initial seven mice in the hypoperfusion group, two died on day 15 and 17,
post-surgery. There was no mortality in the sham group. The impact of surgical hypoperfusion
was assessed by measuring changes in global CBF over time (Figure 3.1). To account for group
differences in pre-hypoperfusion CBF values, we calculated the percent change at each
experimental time point (day 1, 3, 7, 13, 27, and 34) relative to the average of the values at the
pre-surgery time point within each surgical intervention group individually (sham or
hypoperfusion) (Figure 3.1B). One sham animal was excluded from the analyses due to
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inaccurate CBF measurements at the pre-surgery time point. Using these values, we conducted
repeated measures ANOVA with surgical intervention as the independent factor and time point
as the repeated factor. There was a significant interaction between these factors [F(6,63) =
4.967, p < 0.0005]. To determine the extent to which our surgical hypoperfusion model induced
a gradual constriction that progressively reduced CBF, we probed the significant interaction
by evaluating temporal CBF changes within each surgical intervention group separately using
the repeated measures ANOVA where time was the repeated factor. For the sham group, the
ANOVA was not significant (p = 0.43), indicating that there was no change in CBF in this
group during the time interval evaluated. However, the repeated measures ANOVA for the
surgical hypoperfusion group was significant [F(6,34) = 10.26, p < 0.005]. To determine
critical time points at which CBF was altered in this group, and to control for multiple posthoc two-group comparisons because we were primarily interested in change in CBF relative to
the pre-surgery time point, we applied the Dunnett’s multiple comparisons approach to assess
change in CBF across time. We found no CBF differences at day 1 (p = 0.07), day 3 (p = 0.99),
or day 7 (p = 0.47) from the pre-surgery time point in the hypoperfusion group. However, CBF
in the hypoperfusion group was significantly decreased from the pre-surgery time point by
28% on day 13 (p = 0.04), 43% on day 27 (p = 0.04) and 40% on day 34 (p = 0.02). The gradual
reduction in CBF was further supported by a significant drop in CBF in the hypoperfusion
mice as compared to sham mice at day 13 (p = 0.0001), day 27 (p = 0.02), and day 34 (p =
0.0008). There were no differences in CBF between these groups on days 1, 3 and 7 postsurgery.
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Figure 3.1. Cerebral blood flow following induction of surgical hypoperfusion. (A)
Laser speckled flowmetry flux images depicting CBF over time. Red color indicates areas

of high CBF while blue color indicates areas of low CBF. (B) Temporal changes in CBF
measured by the laser Doppler system. Points represent means ± SEM, sham n = 6,
hypoperfusion n = 5. # = p < 0.05 for the hypoperfusion group at each time point versus
pre-surgical time point; * = p < 0.05; ** = p < 0.001 between treatment groups at each time
point.
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Histological Assessment of Cerebral Injury
H&E staining of cerebral tissue from hypoperfused animals revealed a variety of
hallmark pathologies of gray and white matter (Figure 3.2). Thus, there was striking neuronal
loss in the stratum pyramidale of the Cornu Ammonis 1 (CA1) and Cornu Ammonis 3 (CA3)
region of the hippocampus, and loss of neurons in the stratum granulosum in the dentate gyrus
(DG). We noticed hemisphere asymmetry in hippocampal and cortical injury in hypoperfused
mice.

Hypoperfusion is known to induce lesions that are formed by localized intense

vacuolization (Wells and Wells, 1989). We observed lesions of intense vacuolization in the
stratum oriens, stratum pyramidale, and stratum radiatum in the CA1 and CA3 regions of the
hippocampus. There were overt degenerative lesions in the fimbria of the fornix (FF), external
segment of the globus pallidus (GPe), and internal segment of the globus pallidus (GPi). These
lesions contained an elevated number of nuclei, suggesting infiltration of inflammatory cells.
No pathology was evident in the sham group.
Silver staining revealed severe axonal injury, identified as punctate staining observed in the
stratum oriens and stratum radiatum of the CA1 region of the hippocampus of hypoperfused
mice (Figure 3.3). A similar observation was made in the CA2 region. Axonal injury in both
the stratum oriens and stratum radiatum of the CA3 region of the hippocampus appeared to be
less affected.
Silver staining also revealed prominent injury of the corpus callosum in hypoperfused
mice (Figure 3.4). Severe atrophy of the body of the corpus callosum was apparent in the
hypoperfused mice. Intense silver staining of axons projecting through the corpus callosum
indicated axonal damage. The appearance of gaps between axons in the corpus callosum
indicated their degeneration. Additionally, axonal disorganization was a common observation
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Figure 3.2. Cerebrovascular hypoperfusion causes brain tissue injury. Brightfield
micrographs of H&E stained coronal tissue sections from sham and hypoperfused group
mice. Cornu ammonis 1 (CA1); cornu ammonis 3 (CA3); dentate gyrus (DG); fimbria fornix
(FF); globus pallidus externus (GPe); globus pallidus internus (GPi). Arrows indicate
regions of neuronal degeneration. In the magnified panel insert, arrowheads indicate
vacuolization. Scale bars indicate 100μm.
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in regions with extensive axonal injury. No axonal injury was apparent either in the
hippocampus or in the corpus callosum of the sham mice.

Discussion
Numerous studies of cerebral pathophysiology of hypoperfusion in animal models have
led to the identification of hundreds of potential therapeutic compounds. However, in clinical
trials, all of these compounds have proven ineffective, or less effective than the already
clinically available interventions. The lack of adequate experimental models of
cerebrovascular hypoperfusion with pathophysiology analogous to humans is likely the
primary cause of the loss of translation from laboratory to clinical practice. A major limitation
of the current animal models is variable severity of ischemic damage that weakens the
statistical power of experimental research making the identification of effective therapeutics
difficult.
There are several paradigms to induce cerebrovascular hypoperfusion in mice.
Essentially all of the current paradigms involve the occlusion of two (Bottiger et al., 1998;
Bottiger et al., 1999), three (Carmichael, 2005; Thal et al., 2010; Onken et al., 2012) or four
(Pulsinelli and Buchan, 1988; Traystman, 2003) vessels. These paradigms include, bilateral
common carotid artery stenosis (Shibata et al., 2007; Matin et al., 2016; Patel et al., 2017),
permanent carotid artery ligation (Ohta et al., 1997) and sequential common carotid artery
occlusion (Cechetti et al., 2010). Limitations of other procedures used to induce hypoperfusion
in mice include a high mortality rate (Longa et al., 1989; Connolly et al., 1996; Kitagawa et
al., 1998) and inconsistency in the severity and localization of cerebral damage (Connolly et
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Figure 3.3. Cerebrovascular hypoperfusion causes hippocampal injury. Sliver stained

tissue depicting histological changes in sham and hypoperfusion group mice. Cornu
ammonis 1 (CA1); cornu ammonis 2 (CA2); cornu ammonis 3 (CA3); dentate gyrus (DG).
The magnified panel insert shows degenerated axons and their punctated appearance (black
arrow). Scale bars indicate 100μm.
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al., 1996; Clark et al., 1997; Ohta et al., 1997; Takano et al., 1997; Matin et al., 2016; Patel et
al., 2017). Using the present paradigm, we were able to induce a consistent time-dependent
reduction of cerebral blood flow that resulted in limited mortality and relatively conserved
damage severity and localization.
Models of cerebrovascular hypoperfusion that use bilateral CCA stenosis with
microcoils have demonstrated pathology to white matter without gray matter damage after 30
days of chronic reduction of CBF (Shibata et al., 2004). However, in studies where microcoils
are placed on both common carotid arteries in mice have demonstrated a maximum reduction
of CBF to a substantial 51% of baseline within 2 hours followed by a progressive recovery of
CBF that reached 82% by day 30 (Shibata et al., 2004). Other models of hypoperfusion that
utilize stenosis of CCA have demonstrated an acute reduction of CBF to ~55% on the first day
(Kitamura, et al., 2016; Srinivasan et al., 2015; Hattori et al., 2016). Growth of collateral
vessels occurs only after a few days of hypoperfusion resulting in a recovery of CBF over time
(Srinivasan et al., 2015). This suggests that the greatest damage occurs during the first days
after surgery, and once CBF is restored, the tissue recovers. This makes it difficult to gauge
accurately the extent of damage caused by permanently reduced blood flow as in cerebral
hypoperfusion in humans. In our model, the stenosis of the CCA develops gradually over time.
The irreversibility of CBF reduction prevents the recovery of cerebral tissue, which may
explain the injury of both the white and gray matter.
In a study on hypertensive rats using a two-vessel gradual occlusion with ameroid
constrictor rings on both common carotid arteries reduced CBF to 78% of baseline within 3
hours post-surgery and after one day reached a maximum reduction of 70% that persisted to
day seven, before recovering to 80 and 82% by day 14 and 28, respectively (Kitamura et al.,
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Figure 3.4. Cerebrovascular hypoperfusion causes corpus callosum injury. Silver
stained whole coronal tissue sections of the brain and magnified regions of the medial and
lateral corpus callosum in sham and hypoperfused mice. Black arrow in the medial and
lateral corpus callosum indicate axonal degeneration (threadlike) and disorganization
(intense and non-bundled), respectively. Scale bars indicate 1mm (whole coronal sections)

and 20μ.m (magnified panels).
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2016). In contrast, we found no CBF differences at day 1, 3, and 7 from the pre-surgery time
point in the hypoperfusion group. However, CBF in the hypoperfusion group was significantly
reduced to 72% on day 13 and 57% by day 27. Additionally, we observed little to no recovery
of CBF over the 34 days of hypoperfusion, which was maintained at 60% on the final day of
the experiment. In agreement with the findings of Kitamura et al. (2016) that found lesion in
the corpus callosum after 28 days of hypoperfusion, our data demonstrate similar injury to the
corpus callosum. In addition, we observed severe damage to the hippocampus, cortex and
subcortical regions, albeit asymmetric to the hemispheres. Noteworthy, these differences in
findings compared to our study using normotensive mice may be attributed to the characteristic
hemodynamic properties of hypertensive rats.
In conclusion, we have established a novel murine model of irreversible hypoperfusion
that develops gradually and progressively. The model results in a substantial reduction of CBF
and produces consistent localization and severity of cerebral injury in the CA1, CA3, DG, FF,
GPe, GPi, and corpus callosum with a relatively low mortality rate. The model provides a tool
for investigating cerebral vascular disease with chronic cerebral hypoperfusion, which is
implicated in the development of white matter disease and lacunar infarcts.
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Abstract
Cerebrovascular pathology is pervasive in Alzheimer’s disease (AD), yet it is unknown
whether cerebrovascular dysfunction contributes to the progression or etiology of AD. In
human subjects and in animal models of AD, cerebral hypoperfusion and hypometabolism are
reported to manifest during the early stages of the disease and persist for its duration. Amyloidβ (Aβ) is known to cause cellular injury in both neurons and endothelial cells by inducing the
production of reactive oxygen species (ROS) and disrupting intracellular Ca2+ homeostasis.
We present a mechanism for mitochondrial degeneration caused by the production of
mitochondrial superoxide, which is driven by increased mitochondrial Ca2+ uptake. We found
that persistent superoxide production injures mitochondria and disrupts electron transport in
cerebrovascular endothelial cells. These observations provide a mechanism for the
mitochondrial deficits that contribute to cerebrovascular dysfunction in patients with AD.
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Introduction
Alzheimer’s disease (AD) is the most common form of senile dementia and is
characterized by progressive neurodegeneration and cognitive decline. Parenchymal plaques
are a hallmark of AD and are formed by the deposition of amyloid-β polymers (Querfurth and
LaFerla 2010; Castellani et al. 2010). The contribution of amyloid-β deposition to the
manifestation and progression of AD has been the focus of investigation since the discovery
of the peptide. Remarkably, 90% of patients with AD demonstrate cerebral amyloid angiopathy
(CAA), a neuropathological disease characterized by the deposition of amyloid-β on the walls
of cerebral vasculature (Janson 2015; DeSimone et al. 2017; Vinters 1987; Han et al. 2015).
Cerebrovascular comorbidities are common in AD, as many as 92% of AD patients
demonstrate ischemic white matter lesions that resemble arteriosclerosis of small vessels.
Microvascular degeneration can have obvious detrimental consequences to cerebral tissue. A
number of reports show regional hypoperfusion, hypometabolism, and blood-brain barrier
hyperpermeability in subjects with AD (de la Torre 2004; Brundel et al. 2012a; Brundel et al.
2012b). To date, a large prevalence of patients with AD are at risk for developing severe
vascular conditions that include: hemorrhagic stroke, spontaneous cerebral emboli, cerebral
microinfarctions, and microhemorrhages (Brundel et al. 2012a; Chi et al. 2013; Purandare and
Burns 2009; Tolppanen et al. 2013). A growing body of evidence has emerged documenting
cerebrovascular dysfunction preceding cognitive decline in AD patients, (de la Torre 2010;
Jellinger 2010; Kalaria 2010) suggesting that vascular dysfunction may play a causative role
in the emergence of AD. However, the mechanism(s) by which amyloid-β exerts it cytotoxic
effects on the cerebrovasculature are not yet known.
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It is known that bioenergetic deficits occur in neurons exposed to Aβ and that
mitochondrial dysfunction precedes the onset of pathology in AD (Yao et al. 2009; Behl et al.
1994). These observations suggest that mitochondrial dysfunction during the early stages of
AD (non-symptomatic) compromise cerebrovascular function resulting in cerebral Aβ
retention, vascular degeneration, and hypoperfusion, which together may initiate the cognitive
decline and symptomatic phase of AD. Observations of postmortem brain tissue from AD
patients have revealed extensive mitochondrial network disruption, presenting as evidence of
excessive mitochondrial fission and fragmented cristae (Trimmer et al. 2000; Hirai et al. 2001;
Manczak et al. 2011; Wang et al. 2017). In cultured cortical neurons, Aβ exposure results in
deficits of synaptic mitochondria and reduced mitochondrial transport, likely contributing to
the synaptic dysfunction in AD (Du et al. 2010). Together, these observational studies indicate
a pivotal role for mitochondrial injury in the cytotoxicity of Aβ. Cellular production of reactive
oxygen species (ROS) has been shown to result in S-nitrosylation of Drp-1 resulting in aberrant
mitochondrial fission, synaptic loss, and neuronal damage (Cho et al. 2009). Increased
production of Aβ-induced ROS has also been demonstrated in cerebrovascular endothelial
cells and causes cell dysfunction, BBB disruption, and degeneration (Han et al. 2015; Park et
al. 2004). The mechanism by which Aβ induces the production of ROS in endothelial cells is
thought to involve the activation of the NADPH oxidase membrane-bound subunit, Nox
(Drummond et al. 2011; Miller et al. 2005). Genetic ablation of vascular endothelial cell Nox2
or inhibiting NADPH assembly abrogates ROS and vascular dysfunction induced by Aβ (Park
et al. 2004; Park et al. 2007; Park et al. 2005).
In the present study, we describe a mechanism for Aβ-induced cerebrovascular
endothelial cell injury. We provide experimental evidence from primary cultures of vascular
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endothelial cells and a bEnd.3 cell line exposed to Aβ, which showed increased production of
mitochondrial superoxide via direct Aβ1-42 interaction with mitochondria. Aβ induced a dosedependent increase in mitochondrial superoxide production that paralleled an increase in
mitochondrial oxygen consumption and ATP production, suggesting mitochondrial stress. We
found that Aβ exerts these effects by increasing mitochondrial Ca2+ concentration, driving
hyper-oxidative metabolism and increasing ROS production by mitochondria. Furthermore,
removal of extracellular Ca2+ abrogates the Aβ1-42-induced increase of mitochondrial oxygen
consumption, ATP production, Ca2+ accumulation, superoxide production and cerebrovascular
endothelial cell death. These Aβ-induced effects on mitochondrial function may provide a
mechanism for the mitochondrial dysfunction and deficits observed in AD and provide
evidence for a therapeutic intervention that targets extracellular calcium.

Materials and Methods
Study Design
All experiments were performed using either primary cerebrovascular endothelial cells
from mice or the bEnd.3 [BEND3] (RRID: CVCL_0170, ATCC® CRL-2299) mouse brain
capillary endothelial cell line. The brain endothelial cell line is not listed as a commonly
misidentified cell line by the International Cell Line Authentication Committee. Initial
authentication of the bEnd.3 cell line was performed by the vendor; no further authentication
was performed in the laboratory. Cells were cultured with Dulbecco’s modified Eagles medium
(DMEM) (Cat. No. SH30022.01 (2019), HyClone GE) supplemented with 10% fetal bovine
serum (Cat. No. S12450 (2019), Atlanta Biosciences) and 1% penicillin streptomycin (Cat.
No. SV30010 (2019), HyClone GE) (DMEM+). Cells were plated in either 96-well assay
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plates (1.5x104 cells/well), 24-well culture plates (3.5x104 cells/well), or 10-cm culture dishes
(1.5x105 cells/dish) and incubated at 37°C in a humidified incubator under 5% CO2. Primary
cerebrovascular endothelial cells were subcultivated every 4 days (ratio = 1:2) and bEnd.3 cells
every 3 days (ratio = 1:8). The first and second passage of primary cell cultures were retained
for cryopreservation. For experimental purposes, primary endothelial cell subcultures were
utilized beginning at passage 3 up until a maximum passage number of 6. For experiments that
used the bEnd.3 cell line were performed on cells at passage 15 – 20. This study was not preregistered or blinded. Stratified randomization was employed in all experiments that utilized
cultured cells to prevent any experimental condition to be statically positioned across all
experiments.
Animal Usage
Three-month old C57BL6 (National Institutes on Aging) pregnant female mice (n = 4)
were used to produce primary cerebrovascular endothelial cell cultures for the purposes of this
study. Primary cell cultures were prepared from embryos at gestational day 19 from each of
the pregnant mice. Primary cells cultures were prepared from each mouse over four separate
occasion, around 12:00pm eastern time. Pregnant mice produced an average of 6 embryos that
were harvested and pooled together to produce a culture of primary cerebrovascular endothelial
cells. Therefore, each mouse produced a single culture of primary cells and each of the four
instances of prepared primary cultures was used to replicate the experiments described in the
study. Power analysis for ANOVA designs indicated a sample size of 3 pregnant mice (power
= 0.999) for an effect size of Δ = 1.25. Mice were housed in accordance to IACUC guidelines
of West Virginia University (protocol #: 13-0704). Animals were maintained under a light /
dark cycle (12: 12) with food and water available ad libitum. For all procedures performed in
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this study that involved the use of laboratory animals were carried out in accordance with the
National Institutes of Health guide for the care and use of laboratory animals (NIH Publication
No. 8023, revised 1978) and in compliance with the ARRIVE guidelines.
Preparation of Primary Cerebrovascular Endothelial Cell Cultures
Primary cerebrovascular endothelial cells were prepared from embryonic mice. At
embryonic day 19, pregnant mice were deeply anesthetized with 4% isoflurane diffused into
70% nitrogen and 30% oxygen mixture. After confirming deep anesthetization via tail pinch,
mice were euthanized by cervical dislocation. Mice received a vertical incision to the abdomen.
Through the incision, each fetus was extracted, removed from the amniotic sack, and
decapitated. The collected fetal heads were immediately immersed in ice-cold HBSS buffer
(Cat. No. 14025-092 (2019), Gibco). Each brain was extracted through an incision made along
the superior sagittal suture followed by the removal of the cerebellum for discard. The
remaining tissue was placed into a 50 mL centrifuge tube containing ice-cold DMEM. The
brain tissue from each fetus was consolidated into a single 50 mL centrifuge tube containing
20 mL of ice-cold DMEM then centrifuged at 2500 times gravity for 3 min. The supernatant
was decanted and the tissue pellet was resuspended in 1 mL of ice-cold DMEM. The suspended
tissue was then transferred to a Dounce homogenizer that was kept on ice. After
homogenization, the tissue was transferred into a 50 mL tube containing 1.5 % HEPES 1M
(Cat. No. H0887-100ML (2019), Sigma Aldrich) in 20 mL HBSS. The tissue was briefly
vortexed followed by centrifugation at 2000 times gravity for 10 min at 4 ° C. Supernatant was
decanted and the pellet was resuspended in a solution of 18% (w/v) dextran (Cat. No. 3139250G (2018), Sigma Aldrich) and 1.5% HEPES 1M in 20 mL HBSS. The tube was mixed by
inverting then centrifuged at 5000 times gravity for 10 min at 4 ° C. Once centrifuged, the
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supernatant along with the cholesterol interphase was discarded; the pellet was then
resuspended in 20 mL of warm DMEM containing 10% FBS and 1% penicillin streptomycin.
Vessels were isolated from the suspension by passing the solution through a 50 μm filter, and
rinsed with 3 mL of DMEM. Isolated vessels were removed from the filter by immersion in
warm DMEM containing 10% FBS and 1% penicillin streptomycin. Collected vessels were
centrifuged in a 50 mL tube at 2000 times gravity for 3 min, resuspended in 1 mL of DMEM
and plated in 10 cm culture dishes. Vessels were allowed to reach 65 % confluence before
passaging and several passages were performed before experimental use. This procedure yields
cerebrovascular endothelial cell cultures primarily of capillary in origin.
Mitochondria Isolation from Cerebrovascular Endothelial Cells
Mitochondrial isolation was performed on primary cerebrovascular endothelial cells
via a previously reported technique (Lampl et al., 2015). Briefly, cells were cultured to 85%
confluence then harvested with a cell scraper and collected into a 50 mL centrifuge tube.
Endothelial cells were pelleted by centrifugation at 2000 times gravity for 3 min, supernatant
was discarded and pellet resuspended in 8 mL. With a Dounce homogenizer, cell membranes
were fractured, releasing the mitochondria into the medium. The homogenate was transferred
into a 15 mL centrifuge tube then aspirated several times using a 10 mL syringe with a 27
gauge needle. The homogenate was centrifuged at 800 times gravity to pellet the cell debris.
After centrifugation, the supernatant was decanted into a new 15 mL tube then distributed into
2 mL microcentrifuge tubes. Microcentrifuge tubes were centrifuged at 10000 times gravity
for 5 min at 5 ° C to pellet the mitochondria. Once centrifugation completed, the supernatant
was discarded and the mitochondrion pellet was resuspended in a solution of 10 mM TrisMOPS (Cat. No. M-8899 (2019), Sigma Aldrich) at pH 7.4, 1 mM EGTA-Tris (Cat. No.

147

E8145-10G (2019), Sigma Aldrich), and 200 mM sucrose (Cat. No. S5-12 (2018), Fisher
Scientific).
Aβ1-42 Preparation
Four separate preparations of Aβ1-42 (Cat. No. 03112 (2019), Thermo Fisher Scientific)
were performed over the duration of the study. For each preparation, 1 mg of lyophilized Aβ142

monomers was suspended in 167 μL of HPLC grade water (Cat. No. AM9937 (2018),

Ambion) and incubated at room temperature (RT) for 5 min. The dissolved Aβ1-42 was then
diluted to 230 μM by adding 833 μL of Ca2+-free phosphate buffered saline (PBS) (Cat. No.
P4417-100TAB (2019), 0.01M, Sigma Aldrich) and incubated for 48h at 37°C for
polymerization. After polymerization, Aβ1-42 was separated into 50 μL aliquots and stored at 80°C. The final product produced 230 μM Aβ1-42 at mixed polymerization states.
Endothelial Cell Death Assay
To assess Aβ1-42 – induced cell death, bEnd.3 cells were seeded in 24-well plates at a
density of 2.5x104 and allowed to reach 70 – 85% confluency. Then, vascular endothelial cells
were rinsed with pre-warmed DMEM containing 10% FBS and 1% penicillin streptomycin.
Aβ1-42 was prepared in 5-, 9-, and 18-μM solutions diluted in DMEM+ then added to the wells
containing the vascular endothelial cells. Cerebrovascular endothelial cells were exposed to
Aβ1-42 for a duration of 24h. After exposure, cells were rinsed 3 times with 0.1M PBS, and
then fixed with paraformaldehyde (PFA) 4% (Cat. No. 15714 (2018), Electron Microscopy
Sciences) for 15 min at room temperature (RT). After fixation, endothelial cells were washed
2 times for 5 min with 0.1M PBS containing 0.045% Tween-20 (Cat. No. P1379-500ML
(2018), Sigma Aldrich). Residual detergent was removed with an additional 2 washes, each for
5 min. Nuclei were stained with 50 nM 4’, 6-diamidino-2-phenylindole (DAPI) (Cat. No. D-
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21490 (2017), Molecular Probes) counter stain. After nuclear staining, cells were washed 3
times for 5 min with 0.1M PBS and imaged on an EVOS2 FL Auto microscope (Invitrogen).
Cells were imaged at 10x magnification and fluorescence excitation using a mercury arc lamp
and a DAPI filter set. Three images were acquired for each well and saved as tiff-formatted
images. The number of nuclei in each of the three images were averaged and the average
number of nuclei was multiplied by the area of the well floor divided by the microscope frame
size, yielding the total number of cells per well. Cell death by chronic exposure to Aβ 1-42 was
assessed using the live-dead probe (Cat. No. R37609 (2019), Invitrogen). Cells were plated on
96-well assay plates and allowed 24h of growth before receiving 9 μM Aβ1-42 in DMEM+ for
48, 72, 96, 122 h. After exposure, dead and live cells were labeled and quantified.
Mitochondrial Superoxide Assay
Mitochondrial superoxide production in response to Aβ1-42 exposure was quantified using
MitoSOX Red (Cat. No. M36008 (2019), Molecular Probes) according to the manufacturer’s
guidelines. Cerebrovascular endothelial cells were seeded on 96-well plates at a density of
1.5x104 cells per well. Endothelial cells were allowed to proliferate for 24h (~ 85%
confluency). Cells were rinsed twice with pre-warmed DMEM and then exposed to 0-, 5-, 9-,
and 18- μM Aβ1-42 for 24h. After exposure to Aβ1-42, cells were rinsed 3 times with warm
DMEM+ and endothelial cells were loaded with 5 μM MitoSOX Red diluted in DMEM+ for
10 min at 37 ° C. After incubation, cells were rinsed 3 times with warm DMEM+. MitoSOX
fluorescence was measured with a spectrophotometer by endpoint kinetic set to an excitation
of 510 nm and an emission of 580 nm. Each well was measured in relative fluorescence units
(RFU). The RFU measurement from each well per group (n = 12) was normalized to the
average RFU of the control (0 μM Aβ1-42) group to produce a fold-change value.
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Endothelial Cell ATP Content Assay
Endothelial cell ATP content was quantified using the CellTiter-Glo luminescent assay
kit (Cat. No. G7571 (2018), Promega) according to the manufacturer’s guidelines. The bEnd.3
cells were seeded on 96-well plates at a density of 1.5x104 cells per well then allowed to
proliferate for 24h (~85% confluency). Endothelial cells were rinsed twice with warm
DMEM+ then exposed to 5-, 9-, and 18- μM Aβ1-42 for 24h. Cells were allowed to equilibrate
to RT for ~ 30 min before the ATP assay was implemented. The luciferase-based solution was
measured with a spectrophotometer (BioTek) by endpoint kinetic set to measure luminescence.
ATP was estimated in nM per well using a standard curve. To prevent ATP degradation, the
standard curve was created immediately prior to running the assays. The standard curve was
prepared by serial tenfold dilutions of ATP in DMEM+.
Mitochondrial Respiration Assay
Mitochondrial respiration was measured using a Seahorse XFe (Seahorse Biosciences)
bioanalyzer using the MitoStress Kit (Cat. No. 101706-100 (2018), Seahorse Bioscience)
according to the manufacturer’s guidelines. Cultured bEnd.3 cells were seeded on 96-well XF
Cell Culture Microplates at a density of 1.5x104 cells per well and allowed to proliferate for
24h. Endothelial cells were exposed to 5-, 9-, and 18- μM Aβ1-42 for 24h. Three hours prior to
running the procedure, the sensor cartridges were hydrated and the instrument parameters set
to run the assay. Endothelial cells were rinsed with XF assay medium and placed in the
bioanalyzer for calibration. After calibration, each well was measured via the MitoStress Test
protocol that used a base measurement of oxygen consumption (pmol/min) to calculate basal
respiration, maximal respiration, ATP production, spare capacity, proton leak, and nonmitochondrial respiration.
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Cellular Calcium Assay
Cytosolic and mitochondrial Ca2+ levels were measured with Fluo-4AM (Cat. No.
F14201 (2018), Molecular Probes) or Rhod-2AM (Cat. No. R1245MP (2018), Molecular
Probes) according to the manufacturer’s guidelines, respectively. Endothelial cells were seeded
on either 96-well assay plates at a density of 1.5x104 or glass-bottom culture dishes at a density
of 3.5x104 cells. Cells were exposed to 5-, 9-, and 18- μM Aβ1-42 for 24h. Before conducting
the experiment, cells were rinsed twice with DMEM+. To enhance dispersion of the Ca2+
indicators, an equal volume of dimethyl sulfoxide (DMSO) (Cat. No. D2650-100ML (2019),
Sigma Aldrich) containing 20% pluronic F-127 (Cat. No. P2443-1KG (2018), Sigma Aldrich)
was added to the Fluo-4AM or Rhod-2AM stock solution. The Fluo-4AM or Rhod-2AM
solution was diluted to 5 μM in DMEM and added to each well. Cells were loaded for 45 min
at 37 °C. After loading, endothelial cells were washed 3 times with DMEM+ and allowed to
incubate for an additional 30 min for complete de-esterification. Rhod-2AM was incubated for
an additional 24h to allow for mitochondrial (non-cytosolic) Ca2+ indication. Fluorescence was
measured with a spectrophotometer (BioTek) by area scan routine using an excitation of 494
or 552 and an emission of 506 or 581 to measure Fluo-4AM or Rhod-2AM, respectively. Each
well was measured in RFU and normalized to the average of the control group to produce a
fold change value. For cells that were plated on glass-bottom culture dishes, dynamic Ca2+
indication was measured via confocal microscopy. Cells were imaged over a period of 94 min
at 30 sec intervals.
Calcium Pathway Inhibitors
The IP3R inhibitor, 2-aminoethoxydiphenylborate (2-APB) (Cat. No. 100065-100MG
(2020), Sigma Aldrich) was prepared as a 100 mM stock solution in DMSO; subsequent
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dilution to 50 μM working concentration was prepared in DMEM+. The MCU antagonist, 4Quinolinecarboxamide (ER-000444793) (Cat. No. 50-193-1971 (2020), Fisher Scientific) was
prepared as a 5 mM stock solution in DMSO; working concentration was prepared in DMEM+
at

5

μM.

The

mNCX

inhibitor,

2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl

carbamimidothioate (KB-R7943) (Cat. No. 12-441-0 (2020), Fisher Scientific) stock solutions
was prepared in DMSO at a concentration of 5 mM; subsequent dilution to 7 μM working
concentration was prepared in DMEM+. All compounds used in the following studies were
prepared at working concentration immediately before use.
Statistics
All experiments were performed on either primary cerebrovascular endothelial cells
from mice or the bEnd.3 cell line. Experiments involving isolated mitochondria were derived
from primary cerebrovascular endothelial cells. Quantitative experiments were repeated a
minimum of three times. Qualitative experiments were repeated a minimum of two times. Data
are reported as the mean value of the experimental group across all replicates plus or minus
the standard deviation (mean ± SD). The criteria for sample exclusion consisted of human error
or instrument failure. No data was excluded from the statistical analysis of the study. Statistical
comparison was performed on GraphPad Prism version 8.0 (RRID: SCR_002798) by one-way
ANOVA (Supplemental Table 1) to assess normality of data and with either Bonferroni’s
multiple comparison analysis (to compare each group to all other groups), Dunnett’s post hoc
analysis (to compare all groups to control group), or linear trend analysis (linear trend to
determine dose-dependency) (Supplemental Table 2). All p-values less than 0.05 were
considered significant (*, p < 0.05; **, p < 0.001; ***, p < 0.0001).
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Results
Acute and chronic exposure to amyloid-β is cytotoxic to cerebrovascular endothelial cells
Previous studies have shown that, in neuronal cultures, exposure to Aβ1-42 is cytotoxic,
causing cellular death at relatively high concentrations (Ferreira et al. 2010; Takuma et al.
2004; Bastianetto et al. 2000). However, these experiments describe an unsustainable cellular
environment at late stages of AD, when Aβ1-42 is found at significantly elevated concentrations
in the brain compared to the early stages of AD. We constructed an experimental paradigm
that describes the early changes to cells during the disease progression, when Aβ1-42 is found
at lower levels in the brain. To determine the cytotoxicity of acute exposure of Aβ1-42 to
cerebrovascular endothelial cells, we used brightfield microscopy to visualize live bEnd.3 cells
exposed to 18 μM Aβ1-42. We observed marked changes in cell morphology that resembled
apoptosis, characterized by an initial retraction of cellular processes after 120 minutes that
progressed and resulted in a spherical cellular morphology after only 240 minutes of exposure
to 18 μM Aβ1-42 (Figure 4.1A). To provide a quantitative measure of the bEnd.3 cell death we
observed via live cell imaging, we counted the number of nuclei of cells exposed to 5-, 9-, and
18- μM Aβ1-42 for 24h and compared this to the number of nuclei of bEnd.3 cells exposed to
vehicle control. We found no significant difference in the number of nuclei between bEnd.3
cells that were exposed to Aβ1-42 and cells that were not (Figure 4.1B). Although, we found
some evidence of cytotoxicity for acute exposure to Aβ1-42, we next evaluated whether
prolonged exposure of cerebrovascular endothelial cells to Aβ1-42 could induce cytotoxicity.
We assessed this by exposing bEnd.3 cells to 9 μM Aβ1-42 over a period of 48 – 144h. In order
to account for differences in the number of cells between the latency-groups, we normalized
our cell death measurement by counting the total number of nuclei of both dead and live cells
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to produce a dead-to-live ratio (FD/FL), and this value was converted to fold-change from the
latency-matched non-exposed control group. We found that cell death caused by 9 μM Aβ1-42
begins after 96h of exposure. Specifically, cell death was increased by 1.56 ± 0.15 (p < 0.0001)
–fold and 1.52 ± 0.21 (p < 0.0001) –fold by 96h and 120h of exposure, respectively (Figure
4.1C).

Cerebrovascular endothelial cell exposure to amyloid-β results in mitochondrial
dysregulation characterized by accelerated mitochondrial oxidative phosphorylation
Most cells respond to stress by increasing oxidative phosphorylation. For example,
cellular damage originating from starvation (Mookerjee et al. 2017; Dias Zeidler et al. 2017),
inflammation (Brace et al. 2016), membrane rupture (Yajima et al. 2009), thermal limitations
(Jarmuszkiewicz et al. 2015; Downs and Heckathorn 1998), and ionic imbalance (Garlid and
Paucek 2003; Pilchova et al. 2017) can result in increased oxidative phosphorylation, which
may provide additional metabolic resources that are needed to repair damage incurred. We first
assessed mitochondrial oxidative phosphorylation after exposure to Aβ1-42. We used an
extracellular flux bioanalyzer XFe 96 to assess changes in mitochondrial oxygen consumption
following Aβ1-42 exposure. Oxygen consumption in cultured bEnd.3 cell was measured for 14
min to obtain a baseline metabolic oxygen consumption rate. After 14 min, bEnd.3 cells were
exposed to either 9 μM Aβ1-42 or DMEM (control) for a total of 589 min, to determine if Aβ142 modulates

mitochondrial oxygen consumption. Our analysis revealed a progressive increase
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Figure 4.1. Cerebrovascular endothelial cell exposure to amyloid-β results in cell
death. (A) Brightfield micrographs depicting bEnd.3 cell death (black arrows) following
exposure to 18 μM Aβ1-42 for 0, 60, 120, 140, 160, 180, and 240 minutes. (B) Bar graph
(mean ± SD) demonstrating the average number of nuclei per well after exposure to vehicle,
5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42 (n = 11 wells per group). (C) Bar graph (mean
± SD) depicting endothelial cell death after chronic exposure to 9 μM Aβ1-42 for 48, 72, 96,
120, and 144h (n = 7 wells per group). One-way ANOVA with Dunnett’s post analysis was
used to determine the level of significance between the exposure groups (***, p < 0.0001).
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in mitochondrial oxygen consumption that began 397 min post-Aβ1-42 exposure, which
increased 1.81 ± 1.77 –fold (p < 0.001) above the control group after 461 min and continued
to increase up to 3.76 ± 1.41 –fold (p < 0.001) above the control group over the duration of the
experiment (Figure 4.2A). These observations were in contrast to bEnd.3 cells maintained in
DMEM without Aβ1-42, which demonstrated an essentially unchanged oxygen consumption
rate for the duration of the experiment (Figure 4.2A, black).
Since our results demonstrated a clear increase in mitochondrial oxygen consumption
in response to Aβ1-42 exposure, we characterized specific indices of mitochondrial oxygen
consumption. To determine this, we measured cellular basal respiration, maximum respiration,
spare capacity, and proton leak after bEnd.3 cells were exposed for 24h to 5-, 9-, and 18- μM
Aβ1-42. We found that Aβ1-42 dose-dependently increased mitochondrial basal respiration,
maximal respiration, spare capacity, and proton leak after 24h of exposure. For all evaluated
parameters of oxidative phosphorylation, the maximum effect was measured for bEnd.3 cells
exposed to 18 μM Aβ1-42. Specifically, exposure to Aβ1-42 resulted in an increased oxygen
consumption to 67 ± 5.6 (p < 0.0001), 159 ± 13.5 (p < 0.0001), 88 ± 14.9 (p < 0.0001), and 15
± 1.6 (p < 0.0001) pmol/min of oxygen used for basal respiration, maximum respiration, spare
capacity, and proton leak, respectively (Figure 4.2B-E).
We then repeated this experiment on primary cerebrovascular endothelial cells to
determine if Aβ1-42 exposure results in similar mitochondrial bioenergetic hyperactivity. We
observed a similar dose-dependent upregulation of mitochondrial oxygen consumption. The
maximum effect was measured from cells exposed to 18 μM Aβ1-42, which caused oxygen
consumption to increase to 167 ± 11.2 (p < 0.0001), 311 ± 45.3 (p < 0.0001), 144 ± 44.9 (p <
0.001), and 48 ± 11.5 (p < 0.0001) pmol/min of oxygen used for basal respiration, maximum
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respiration, spare capacity, and proton leak, respectively (Figure 4.2F-I). Thus, both primary
cerebrovascular endothelial cells and bEnd.3 cells responded to Aβ1-42 by increasing cellular
respiration in a dose-dependent manner.

Amyloid-β exposure results in an increased mitochondrial Ca2+ concentration
It is firmly established that mitochondrial activity is modulated by Ca2+. Since
mitochondrial oxygen consumption was increased in both primary cerebrovascular endothelial
cells and in bEnd.3 cells that were exposed to Aβ1-42, we hypothesized that mitochondrial Ca2+
dyshomeostasis participated in the Aβ1-42-induced mitochondrial dysregulation. We next
measured mitochondrial matrix Ca2+ concentration in bEnd.3 cells after exposure to 5-, 9-, and
18- μM of Aβ1-42 for 24h and compared this to the Ca2+ concentration in cells that were not
exposed to Aβ1-42. We found a dose-dependent increase of mitochondrial matrix Ca2+
concentrations after 24h exposure to Aβ1-42. Compared to vehicle-treated controls (100%), our
data demonstrated that Aβ1-42 increased mitochondrial Ca2+ levels to 119 ± 30.1 % (p < 0.001)
at 9 μM Aβ1-42 and 153 ± 24.7 % (p < 0.0001) at 18 μM Aβ1-42 (Figure 4.3A).
Because mitochondrial uptake of Ca2+ is a critical process required to clear cytosolic
Ca2+, we assessed the concentration of cytosolic Ca2+ after exposure to Aβ1-42. Cytosolic Ca2+
was measured via Fluo-4AM fluorescence intensity after exposure to 5-, 9-, and 18- μM Aβ142

for 24h. We found a dose-dependent decrease in cytosolic Ca2+ concentration following Aβ1-

42 exposure.

In bEnd.3 cells exposed to 18 μM Aβ1-42, cytosolic Ca2+ declined to nearly 64 ±

4.9 % (p < 0.0001) of the Ca2+ measured in non-exposed cells (Figure 4.3B).
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Figure 4.2. Exposure to amyloid-β for 24-hours results in a dose-dependent increase
in mitochondrial oxygen consumption. (A) Line graph (mean ± SD) depicting the foldchange of oxygen consumption to baseline as a function of time from bEnd.3 cells exposed
to vehicle and 9μM Aβ1-42. Bar graph(s) (mean ± SD) demonstrating oxygen consumption
(pmol/min) by (B, F) basal respiration, (C, G) maximum respiration, (D, H) spare capacity,
and (E, I) proton leak from (B-E) bEnd.3 cells and (F-H) primary cerebrovascular
endothelial cells after 24h exposure to vehicle, 5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42.
One-way ANOVA with Dunnett’s post analysis and linear trend analysis was used to
determine the level of significance between the treatment groups (*, p < 0.05; **, p < 0.001;
***, p < 0.0001), (B-E, n = 12 wells per group; F-I, control = 10, all other conditions = 6
wells per group).
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Cellular ATP content increases dose-dependently following exposure to Aβ1-42
Cellular ATP production is stringently coupled to the cell’s ATP requirements.
Following the observation, that Aβ1-42 exposure leads to mitochondrial Ca2+ accumulation and
because intra-mitochondrial Ca2+ can modulate ATP production, we questioned whether
changes to ATP production result from exposure to Aβ1-42. We evaluated mitochondrial ATP
production by calculating the oxygen consumption used to produce ATP by summing the
oxygen consumed by proton leak and mitochondrial respiration then subtracting this value
from the oxygen consumed by the cell’s basal respiration. This produced an estimate for
oxygen in pmol/min that was used for ATP production. Our analysis indicated that cells
exposed to Aβ1-42 dose-dependently increased ATP production after 24 hours of exposure.
bEnd.3 cells exposed to 18 μM Aβ1-42 consumed as much as 51 ± 4.6 (p < 0.0001) pmol/min
of oxygen for ATP production compared to only 33 ± 3.0 pmol/min of oxygen by non-exposed
cells (Figure 4.4A).
We next repeated the experiment on primary cerebrovascular endothelial cells to
determine if Aβ1-42 mediates similar alterations to oxygen consumption for ATP production.
Primary cerebrovascular endothelial cells demonstrated a dose-dependent increase of oxygen
consumed for ATP production. Specifically, cells exposed to 9 μM and 18 μM Aβ1-42
consumed 121 ± 13.8 (p < 0.05) and 130 ± 7.6 (p < 0.0001) pmol/min of oxygen, respectively
(Figure 4.4B). These data indicate that primary cerebrovascular endothelial cells respond to
Aβ1-42 exposure similarly to bEnd.3 cells.
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Figure 4.3. Exposure to amyloid-β for 24-hours causes a dose-dependent increase in
mitochondrial Ca2+ content and a dose-dependent decrease of cytosolic Ca2+. (A) Bar
graph (mean ± SD) depicting mitochondrial Ca2+ content as percentage of vehicle treated
cells, after 24h exposure to 5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42 (n = 11 wells per
group). (B) Bar graph (mean ± SD) demonstrating cytosolic Ca2+ content as percentage of
vehicle treated cells after 24h exposure to 5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42 (n =
10 wells per group). One-way ANOVA with Dunnett’s post analysis and linear trend
analysis was used to determine the level of significance between the treatment groups (**,
p = 0.001; ***, p = 0.0001).
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An increase in mitochondrial oxidative phosphorylation is often indicative of a cellular
ATP deficit. This may result from cellular injury, increased cellular activity, or as a response
to cell signaling. Because we observed an increase in mitochondrial oxygen consumption for
ATP production, we next measured cellular ATP content in bEnd.3 cells to determine if the
changes in oxygen consumption reflect ATP availability. We found that 24h of exposure to
Aβ1-42 resulted in a dose-dependent increase in intracellular ATP content. Exposure to 18 μM
Aβ1-42 resulted in an increase in the intracellular ATP concentration to 1922 ± 41.4 (p < 0.0001)
nM compared to 1683 ± 46.2 nM in cells that were not exposed to Aβ1-42 (Figure 4.4C).
Interestingly, the dose-dependent increase of intracellular ATP content occurred alongside a
dose-dependent decrease in extracellular ATP. We found that the medium from cell that were
not exposed to Aβ1-42 contained 7.8 ± 1.3 nM of ATP which decreased as low as 5.6 ± 0.5 (p
< 0.0001) nM of ATP in the medium from cell exposed to 18 μM Aβ1-42 (Figure 4.4D). These
data suggest that dysregulated mitochondria metabolism is characterized by aberrant ATP
production that surpasses ATP utilization.

Mitochondrial superoxide production is driven by amyloid-β -induced acceleration of
mitochondrial oxygen consumption
Mitochondrial production of superoxide is the primary contributor to the oxidative
damage during aging and degenerative diseases (Brand et al. 2004). We next assessed whether
the Aβ1-42 –induced increase in mitochondrial oxygen consumption in both primary
cerebrovascular endothelial cells and bEnd.3 cells results in elevated mitochondrial superoxide
production. Mitochondrial superoxide was probed with a fluorescence indicator after bEnd.3
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Figure 4.4. Exposure to amyloid-β causes a dose-dependent increase in cellular ATP
production and cytosolic ATP content. Bar graph(s) (mean ± SD) depicting
mitochondrial oxygen consumption (pmol/min) for ATP production in (A) bEnd.3 (n = 12
wells per group) and (B) primary cerebrovascular endothelial cells after 24h exposure to
vehicle control, 5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42 (control = 15, else = 6 wells per
group). Bar graph(s) (mean ± SD) demonstrating the (C) intracellular (n = 12 wells per
group) and (D) extracellular (n = 5 wells per group) ATP content (nM) in bEnd.3 cells after
exposure to vehicle control, 5μM Aβ1-42, 9μM Aβ1-42, and 18μM Aβ1-42. Statistical analysis
was performed by One-way ANOVA with Dunnett’s post analysis and linear trend analysis
to determine the level of significance (*, p = 0.01; **, p = 0.001; ***, p = 0.0001).
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cells were exposed to Aβ1-42 for 24h. The fluorescence intensity of the superoxide indicator
was converted into fold-change relative to vehicle treated cells. Cultured bEnd.3 cells
demonstrated a remarkable dose-dependent increase in mitochondrial superoxide production
following 24h exposure to Aβ1-42. Mitochondrial superoxide production increased 9.2 ± 3.9
(p < 0.0001) –fold and 12.1 ± 3.8 (p < 0.0001) –fold above vehicle treated cells after 24h
exposure to 9 μM and 18 μM Aβ1-42, respectively (Figure 4.5D).
We next assessed the effects of increased extracellular Ca2+ on mitochondrial
superoxide production and compared this with superoxide production following Aβ1-42
exposure. To determine this, bEnd.3 cells were probed with a fluorescent superoxide indicator
then imaged via confocal microscope after 5 min to obtain a baseline and measurement (Figure
4.5A). After baseline measurement, cells were exposed to either 5 mM of Ca2+ or 9 μM of Aβ142

and incubated for 30 min before obtaining an outcome measurement. Our time series image

analysis revealed a 1.6 ± 0.2 (p < 0.0001) –fold increase above baseline in mitochondrial
superoxide production after 30 min exposure to 9 μM Aβ1-42 (Figure 4.5B). Similarly, cells that
were exposed to an additional 5 mM of Ca2+ demonstrated a 1.4 ± 0.1 (p < 0.0001) –fold
increase above baseline in superoxide production after 30 min of exposure (Figure 4.5C).
These data suggest that increased Ca2+ concentration can drive superoxide production in
bEnd.3 cells at a magnitude similar to cells exposed to Aβ1-42 for the same amount of time.
We were unsure if direct interaction between Aβ1-42 and mitochondria produce the
mitochondrial changes we observed. To answer this question, we isolated the mitochondria
form primary cerebrovascular endothelial cells and measured superoxide production following
Aβ1-42 exposure for 1h. Isolated mitochondria exposed to Aβ1-42 for 1h resulted in a dosedependent increase in mitochondrial superoxide production. Exposure to 1-, 3-, 6-, and 9- μM
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Aβ1-42 demonstrated a 1.35 ± 0.07 (p < 0.001), 1.95 ± 0.10 (p < 0.0001), 3.10 ± 0.13 (p <
0.0001), and 4.29 ± 0.27 (p < 0.0001) –fold increase in superoxide production relative to
control, respectively (Figure 4.5E).

Amyloid-β mediates mitochondrial dysregulation by increasing mitochondrial matrix Ca2+
that accelerates mitochondrial oxidative phosphorylation and superoxide production
Mitochondrial influx of Ca2+ has been shown to accelerate oxidative phosphorylation
and ATP production by increasing the activity of mitochondrial dehydrogenase enzymes.
Therefore, we hypothesized that the increased oxygen consumption and production of
superoxide by cerebrovascular endothelial cell mitochondria following exposure to Aβ1-42 is
mediated by the Aβ1-42-induced Ca2+ accumulation in mitochondria. To determine if the
increased Ca2+ in the mitochondrial matrix following the exposure of bEnd.3 cells to Aβ1-42
mediates the hyperoxidative state of mitochondria, we reduced the Ca2+ available to
mitochondria

by

chelation.

Extracellular

Ca2+

was

chelated

with

1

mM

ethylenediaminetetraacetic acid (EDTA) supplemented in cell culture medium with or without
exposure to Aβ1-42. We first assessed whether chelation of extracellular Ca2+ results in reduced
Aβ1-42-induced mitochondrial Ca2+ accumulation. Cultured bEnd.3 cells were plated in 96-well
assay plates at a density of 1.5x104 cells per well and grown for 24h. Cells were then exposed
to either vehicle or 9 μM Aβ1-42 with or without 1 mM EDTA for 24h and then assessed for
changes in mitochondrial Ca2+ levels. Our results indicated that 1 mM EDTA effectively
abolished the Aβ1-42-induced accumulation of Ca2+ in the mitochondrial matrix (Figure 4.6A).
Specifically, cells exposed to 9 μM Aβ1-42 without EDTA (9 μM Aβ1-42 / 0 mM EDTA)
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Figure 4.5. Exposure to amyloid-β or Ca2+ results in an increase in mitochondrial
superoxide production. (A) Time-lapse confocal micrographs depicting mitochondrial
superoxide production in bEnd.3 cells at baseline (left) and after 30 min of exposure to 9
μM Aβ1-42 (right). Bar graph(s) (mean ± SD) demonstrating superoxide production from
time-lapse images as fold-change from baseline for bEnd.3 cells exposed to (B) 9 μM Aβ142

(n = 8 cells) and (C) 5 mM CaCl2 (n = 8 cells) for 30 minutes. (D) Bar graph (mean ±

SD) demonstrating mitochondrial superoxide production as fold-change in bEnd.3 cells
after 24h of exposure to vehicle, 5 μM Aβ1-42, 9 μM Aβ1-42, and 18 μM Aβ1-42 (n = 10 wells
per group). (E) Bar graph (mean ± SD) depicting superoxide production as fold-change by
isolated mitochondria from primary cerebrovascular endothelial cells after 1h exposure to
0, 1, 3, 6, and 9 μM Aβ1-42 (n = 5 wells per group). Statistical analysis was performed by
one-way ANOVA with Dunnett’s post analysis and linear trend analysis to determine the
level of significance (***, p = 0.0001).
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increased mitochondrial Ca2+ to 1.8 ± 0.4 –fold (vs. control, p < 0.0001) above cells exposed
to vehicle (control). Whereas, cells exposed to 9 μM Aβ1-42 with 1 mM EDTA (9 μM Aβ1-42 /
1 mM EDTA) completely abolished the Aβ1-42 –induced accumulation of mitochondrial Ca2+
to 0.9 ± 0.4 (mean ± SD) –fold (vs. Aβ only, p < 0.0001) compared to control cells (p = 0.65)
(Figure 4.6A). These data indicate that extracellular Ca2+ chelation with EDTA is effective at
reducing mitochondrial Ca2+.
We next assessed the effectiveness of reducing mitochondrial Ca2+ accumulation with
EDTA at ameliorating elevated mitochondrial oxygen consumption after exposure to Aβ1-42.
To determine this, we measured the oxygen consumption rate of bEnd.3 cells exposed to either
0 or 9 μM Aβ1-42 with or without 1 mM EDTA. As before, cells exposed to 9 μM Aβ1-42 without
EDTA for 24h demonstrated increased oxygen consumption by basal respiration (114 ± 4.0
pmol/min, p < 0.0001), maximum respiration (296 ± 8.4 pmol/min, p < 0.0001), and spare
capacity (182 ± 8.0 pmol/min, p < 0.0001). However, treatment with 1mM EDTA completely
ameliorated the Aβ1-42 –induced increase in oxygen consumption. In cells exposed to 9 μM
Aβ1-42 with 1mM EDTA oxygen consumption returned to near vehicle control values for basal
respiration (101 ± 3.3 pmol/min, p < 0.02), maximum respiration (227 ± 8.8 pmol/min, p <
0.0001), and spare capacity (126 ± 7.2 pmol/min, p < 0.0001) (Figure 4.6B-D). Interestingly,
proton leak was the only oxidative phosphorylation parameter that increased further with
EDTA treatment. Cells exposed to Aβ1-42 alone consumed 39 ± 1.2 (p < 0.0001) pmol/min of
oxygen by proton leak while cells exposed to both Aβ1-42 and EDTA consumed 49 ± 1.6 (p <
0.0001) pmol/min of oxygen (Figure 4.6E). In support of our hypothesis, reduction of
mitochondrial Ca2+ ameliorates the increased oxygen consumption mediated by mitochondrial
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Ca2+ accumulation following exposure to Aβ1-42. These data suggest that Aβ1-42 exposure
results in mitochondrial dysfunction by increasing mitochondrial Ca2+ levels.
Mitochondrial Ca2+ content is stimulatory to ATP synthesis by the ATP synthase
respiratory complex. Therefore, we predicted that by blocking Ca2+ from entering
mitochondria, the Aβ1-42 –induced upregulation of ATP production should be prevented. To
determine the interplay between elevated mitochondrial oxygen consumption and matrix Ca2+
accumulation on the production of ATP, we exposed bEnd.3 cells to 9 μM Aβ1-42 with or
without 1 mM EDTA for 24h and then estimated the production of ATP by mitochondria.
Consistently, bEnd.3 cells exposed to 9 μM Aβ1-42 responded by increasing oxygen
consumption for ATP production to 75 ± 3.5 (p < 0.0001) pmol/min. Oxygen consumption in
cells that were exposed to 9 μM Aβ1-42 with 1 mM EDTA restored ATP production to near
vehicle control values, 51 ± 2.6 (p < 0.0001) (Figure 4.6F).
Since mitochondrial Ca2+ accelerates electron transport by increasing the activity of
mitochondrial dehydrogenase enzymes, we hypothesized that blocking Aβ1-42 –induced
mitochondrial Ca2+ accumulation would mitigate the increased production of superoxide by
mitochondria following exposure to Aβ1-42. To determine if mitochondrial Ca2+ accumulation
mediates the Aβ1-42 –induced increase in mitochondrial superoxide production, we exposed
bEnd.3 cells to Aβ1-42 in the presence or absence of EDTA then measured mitochondrial
superoxide levels. Superoxide production by bEnd.3 cells exposed to 9 μM Aβ1-42 / 0 mM
EDTA increased superoxide production 5.5 ± 1.3 (vs. control, p < 0.0001) –fold above control
cells. Whereas, bEnd.3 cells exposed to 9 μM Aβ1-42 / 1 mM EDTA reduced superoxide
production to 1.8 ± 0.2 (vs. Aβ only, p < 0.0001) –fold of control cells (Figure 4.6G).
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Mitochondrial fission-fusion dynamics are a transient process that serves a
physiologically important function, i.e. regulation of mitochondrial quality control and
metabolic homeostasis. Mitochondrial fragmentation often precedes mitophagy of damaged
mitochondria that occurs during states of metabolic and oxidative stress (Quintana et al. 2018).
Mitochondrial fragmentation is well-documented in AD animal models and in human AD
patients (Wang et al. 2008; DuBoff et al. 2013). It is clear that oxidative stress can cause
transient changes to the morphology of mitochondria while prolonged oxidation can result
mitochondrial network fragmentation leading to apoptosis (Qi et al. 2011; Youle and Narendra
2011; Youle and van der Bliek 2012). Since our results demonstrated that chelation of
extracellular Ca2 + was exceptionally effective at ameliorating the Aβ1-42 –induced
dysregulation of mitochondrial activity, we asked whether the chelation of extracellular Ca2+
can rescue mitochondria from aberrant fragmentation. We answered this by labeling
mitochondria in bEnd.3 cells with MitoTracker CMXRos Red and the nuclei with DAPI
counterstain following 24h exposure to 9 μM Aβ1-42 with or without 1 mM EDTA. Indeed, we
observed fragmentation of the mitochondrial network in bEnd.3 cells exposed to Aβ1-42 alone
and found that by chelation of extracellular Ca2+ completely prevented the morphological
changes to the mitochondrial network (Figure 4.6H-K). These observations demonstrate the
role of Aβ1-42 –induced mitochondrial Ca2+ accumulation in the dysregulation of mitochondrial
bioenergetics, resulting in mitochondrial fragmentation following oxidative damage.
Our data describes a mechanism in which mitochondrial Ca2+ accumulation following
cell exposure to Aβ1-42 mediates cell damage by dysregulating mitochondrial function. We next
asked whether preventing the Aβ1-42 –induced mitochondrial dysfunction could rescue
cerebrovascular endothelial cells from Aβ1-42 mediated death. To assess the cytoprotective
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effects of blocking Aβ1-42 –induced mitochondrial Ca2+ accumulation against Aβ1-42 mediated
cell death, we exposed bEnd.3 cells to 9 μM Aβ1-42 with or without 1 mM EDTA for 24h and
then imaged cellular changes in morphology. Exposure to either vehicle control (Figure 4.6L)
or 1 mM EDTA alone (Figure 4.6M) caused no apoptotic cells upon visualization. While,
bEnd.3 cells that were exposed to 9 μM Aβ1-42 / 0 mM EDTA (Figure 4.6N and P)
demonstrated numerous apoptotic cells. However, bEnd.3 cells that were exposed to 9 μM Aβ142

with 1 mM EDTA (Figure 4.6O) completely prevented the apoptotic cells observed in

cultures exposed to Aβ1-42 alone. We observed a reduced number of apoptotic cells in cultures
exposed to Aβ1-42 with 1 mM EDTA. We observed no apoptotic cells in cultures that were not
exposed to Aβ1-42 with and without 1 mM EDTA.

Amyloid-β associated calcium entry into the mitochondria occurs via multiple intracellular
calcium regulation pathways
Since we found that the Aβ1-42-induced elevated mitochondrial calcium could be
attenuated by extracellular calcium chelation, we next assessed intracellular calcium regulation
pathways involved in calcium uptake by mitochondria. To assess the contribution of
intracellular calcium regulation pathways we used pharmacological inhibitors, which prevent
calcium entry into the mitochondria from the endoplasmic reticulum, mitochondrial
permeability transition pore (mPTP), and mitochondrial membrane associated calcium
exchangers. Mitochondrial calcium was measured with Rhod-2AM as previously stated, then
exposed to 9 μM Aβ1-42 or DMEM+ control containing 50 μM 2-APB, 5 μM ER-000444793,
7 μM KB-R7943, or vehicle (DMSO) for 24 hours. We found that bEnd.3 cells exposed to 9
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Figure 4.6. Ca2+ chelation reduces the amyloid-β induced hyper-oxidative state of
mitochondria and superoxide production via reduced mitochondrial Ca2+ uptake. (A)
Bar graph (mean ± SD) demonstrating mitochondrial Ca2+ accumulation as fold-change in
bEnd.3 cells after 24h exposure to vehicle control, 1 mM EDTA, 9 μM Aβ1-42, and 9 μM
Aβ1-42 with 1 mM EDTA (n = 12 per group). Bar graph (mean ± SD) demonstrating
mitochondrial oxygen consumption (pmol/min) by (B) basal respiration, (C) maximum
respiration, (D) spare capacity, (E) proton leak, and (F) ATP production from bEnd.3 cells
after 24h exposure to vehicle control, 1 mM EDTA, 9 μM Aβ1-42, and 9 μM Aβ1-42 with 1
mM EDTA (n = 7 wells per group). (G) Bar graph (mean ± SD) demonstrating
mitochondrial superoxide production as fold-change in bEnd.3 cells after 24h exposure to
vehicle control, 1 mM EDTA, 9 μM Aβ1-42, and 9 μM Aβ1-42 with 1 mM EDTA (n = 10
wells per group). Confocal micrographs at 63x magnification depicting mitochondrial
fragmentation (red) and nuclei (blue) in bEnd.3 cell exposed to (H) vehicle, (I) 1 mM
EDTA, (J) 9 μM Aβ1-42, and (K) 9 μM Aβ1-42 with 1 mM EDTA. Note mitochondria
morphology depicted in panel J, demonstrating numerous fragmented and punctated
mitochondria while panel(s) H-I,K depict(s) complex and elongated mitochondria.
Brightfield micrographs depicting bEnd.3 cell death (blue arrows) following exposure to 9
μM Aβ1-42 after 24h exposure to (L) vehicle control, (M) 1 mM EDTA, (N, P) 9 μM Aβ142,

and (O) 9 μM Aβ1-42 with 1 mM EDTA. One-way ANOVA with Dunnett’s post analysis

was used to determine significance compared to control while a student’s 2-tailed t-test was
used to compare the mean(s) of the 9 μM Aβ1-42 group and the 9 μM Aβ1-42 with 1 mM
EDTA experimental group (*, p < 0.05; **, p < 0.001; ***, p < 0.0001).
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μM Aβ1-42 -vehicle resulted in a 3.2 ± 0.46 (p < 0.0003) -fold increase mitochondrial calcium
above DMEM control 1 ± 0.35 -fold. Whereas, treatment with the IP3 receptor antagonist 2APB (50 μM) attenuated the elevated mitochondrial matrix calcium to 1.2 ± 0.27 (p < 0.00007)
-fold. Inhibition of the mPTP with ER-000444973 (5 μM) also reduced the Aβ1-42-induced
mitochondrial calcium accumulation to 1.8 ± 0.24 (p < 0.002) –fold. Treatment with an
inhibitor of mitochondrial reverse mode Na+/Ca+ exchanger and calcium uniporter, KB-R7943
(7 μM) similarly reduced calcium in the mitochondrial matrix upon exposure to Aβ1-42 to 1.4
± 0.15 (p < 0.0002) (Figure 4.7).

Discussion
Although amyloid-β is heavily studied in AD research, its precise role in the disease
pathogenesis remains unknown. In AD brains, amyloid-β plaques are found clustered around
regions with damaged and degenerating mitochondria (Xie et al. 2013; Gillardon et al. 2007).
In culture, amyloid-β causes ROS production and cell death (Cho et al. 2009; Han et al. 2015).
The mechanism that drives the amyloid-β-induced production of ROS is thought to involve the
Nox subunit of NADPH oxidase that catalyzes the S-nitrosylation of cellular components
(Miller et al. 2005; Drummond et al. 2011). S-nitrosylation of mitochondrial Drp-1 is shown
to cause mitochondrial fission and may contribute to the mitochondrial fragmentation found in
AD both in humans and in animal models (Cho et al. 2009). In addition, amyloid-β has been
shown to cause intracellular Ca2+ dyshomeostasis in culture (LaFerla 2002). However, the
interplay between amyloid-β induced ROS production, mitochondrial effects, and intracellular
Ca2+ levels has not been elucidated previously.
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Figure 4.7. Antagonism of regulatory intracellular calcium pathways attenuates the
Aβ-induced mitochondrial calcium influx. Bar graph (mean ± SD) demonstrating
mitochondrial Ca2+ accumulation as fold-change in bEnd.3 cells after 24h exposure to
vehicle control, 9 μM Aβ1-42, and 9 μM Aβ1-42 with either 50 μM 2-APB, 5 μM ER000444793, or 7 μM KB-R7943 (n = 12 per group). Student’s 2-tailed t-test was used to
compare the mean(s) of each experimental group (***, p < 0.0001).
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We demonstrate in brain vascular endothelial cells that exposure to amyloid-β causes
a rapid change in cellular bioenergetics, characterized by accelerated mitochondrial oxygen
consumption and increased superoxide production. We find that these changes were concurrent
with the accumulation of calcium in mitochondria and could be prevented by blocking calcium
from entering mitochondria by chelation.
In the present study, we investigate the early changes to endothelial cells following
exposure to amyloid-β that contribute to the cellular death observed after prolong exposure to
the peptide. We noticed a rapid change to mitochondrial oxygen consumption after 7 hours of
exposure to amyloid-β, and in both bEnd.3 cells and in primary cerebrovascular endothelial
cells, amyloid-β exposure increased basal respiration, maximum respiration, spare capacity,
and proton leak by 24 hours. Mitochondrial basal respiration is strongly influenced by the
turnover of ATP and partially by the oxidation of substrates and by the leakage of protons from
the intermembrane space (Brown et al. 1990; Ainscow and Brand 1999). Therefore, the rate of
basal respiration reflects the cellular demand for ATP. In the present study, elevated basal
respiration may indicate an increased endothelial demand for ATP in response to the early
cellular injury following exposure to amyloid-β. The spare respiratory capacity of a cell is
defined by the ability to utilize substrate and electron transport to meet cellular energy demand
before reaching its biological limit (Yadava and Nicholls 2007; Choi et al. 2009). We observed
a dose-dependent increase in spare respiratory capacity for both bEnd.3 cells and primary
cerebrovascular endothelial cells. Because we observed both an elevated basal respiration and
spare respiratory capacity in cells exposed to amyloid-β, we interpret this to suggest that both
an enhanced mitochondrial respiratory competency and an elevated respiratory rate participate
in the mechanism of amyloid-β-induced cellular injury.
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Dose-dependent Response to Amyloid-β
Assessment

Subject

Correlation
Coefficient
(R2)

Basal Respiration
Maximum Respiration
Spare Capacity
Proton Leak
Basal Respiration
Maximum Respiration
Spare Capacity
Proton Leak
Mitochondrial Calcium
Cytosolic Calcium
ATP Production
ATP Production
ATP Content, Intracellular
ATP Content, Extracellular
Mitochondrial Superoxide

Linear Trend

Data Depiction

(p-value)

(Figure, Panel)

bEnd.3
0.4554
< 0.0001
Fig. 4.2B
bEnd.3
0.5784
< 0.0001
Fig. 4.2C
bEnd.3
0.4988
< 0.0001
Fig. 4.2D
bEnd.3
0.2811
0.0009
Fig. 4.2E
Primary Endothelial
0.1843
0.0853
Fig. 4.2F
Primary Endothelial
0.3054
0.0193
Fig. 4.2G
Primary Endothelial
0.1327
0.1419
Fig. 4.2H
Primary Endothelial
0.3646
0.0103
Fig. 4.2I
bEnd.3
0.241
0.004
Fig. 4.3A
bEnd.3
0.223
0.0027
Fig. 4.3B
bEnd.3
0.4083
< 0.0001
Fig. 4.4A
Primary Endothelial
0.2028
0.0104
Fig. 4.4B
bEnd.3
0.6478
< 0.0001
Fig. 4.4C
bEnd.3
0.5056
0.0011
Fig. 4.4D
bEnd.3
0.1897
0.0126
Fig. 4.5D
Isolated
Mitochondrial Superoxide
0.9637
< 0.0001
Fig. 4.5E
Mitochondria
Supplemental Table 4.1. Analysis of linear trend (one-way ANOVA) was performed on experimental data to determine if the
measurements are dose-dependent. Assessment: measured parameter, Subject: entity receiving treatment, Correlation Coefficient: R2
value estimates the strength that the linear model describes the data, Linear Trend: p-value indicates whether there is a significant
relationship between the model and the data, Data Depiction: figure number and panel to where the specified data is located. bEnd.3
(cell line), Primary Endothelial (primary cerebrovascular endothelial cells), isolated mitochondria (mitochondria isolated from primary
cerebrovascular endothelial cells).
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It is firmly established that mitochondrial activity is modulated by Ca2+. The influx of
Ca2+ to the mitochondrial matrix can exert both stimulatory and inhibitory effects on
mitochondrial function. Mitochondrial influx of Ca2+ results in upregulated oxidative
phosphorylation by activating mitochondrial dehydrogenase enzymes, glycerophosphate
dehydrogenase, isocitrate dehydrogenase, pyruvate dehydrogenase, and oxoglutarate
dehydrogenase (Hansford and Chappell 1967; Denton et al. 1972; McCormack and Denton
1979). Activation of these enzymes by Ca2+ increases mitochondrial oxidative phosphorylation
and ATP production (McCormack et al. 1990). We found that amyloid-β causes increased
mitochondrial matrix calcium while decreasing cytosolic calcium in bEnd.3 cells. The
stimulatory activity of calcium to resident dehydrogenase enzymes in the mitochondrial matrix
may account for the elevated respiration we observed in both bEnd.3 cells and in primary
cerebrovascular endothelial cells. In addition, increased concentrations of mitochondrial
matrix Ca2+ have been shown to cause the formation of the permeability transition pore (PTP)
on the mitochondrial membrane, allowing the release of apoptotic signaling molecules which
facilitate mitochondrial-mediated apoptosis (Kroemer and Reed 2000; Deniaud et al. 2008;
Orrenius et al. 2003). Thus, the cytotoxicity we observed following prolong exposure to
amyloid-β may be driven by the PTP following amyloid-β-induced accumulation of
mitochondrial matrix calcium.
Exposure to amyloid-β in both bEnd.3 cells and in primary endothelial cells resulted in
increased oxygen consumption for ATP production and intracellular ATP content. This
upregulated ATP synthesis may be an effect of the increased calcium levels in the
mitochondrial matrix and its stimulatory role with mitochondrial dehydrogenase enzymes
(Hansford and Chappell 1967; Denton et al. 1972; McCormack and Denton 1979). The

177

elevated activity of mitochondrial dehydrogenase enzyme enhances the production of NADH.
Catabolism of NADH to NAD+ increases the proton-motive force by serving as a proton donor
substrate, increasing the throughput of hydrogen ions pumped into the mitochondrial
intermembrane space at complex I. The increased hydrogen ions pumped across the
mitochondrial inner membrane drives the accelerated ATP synthesis by mechanically
powering the coupling of ADP to inorganic phosphate by ATP synthase.
Mitochondrial superoxide production is sensitive to the proton-motive force (Brand et
al. 2004). High rates of electron transport can cause its reversal, delivering electrons to
complex I; these electrons are coupled to molecular oxygen and produce superoxide radicals
(Chouchani et al. 2016). Indeed, exposure to amyloid-β resulted in an increased production of
mitochondrial superoxide in intact cells and in isolated mitochondria. These observations
indicate that the aberrant elevated mitochondrial respiration following amyloid-β exposure is
inefficient, resulting in increased production of reactive oxygen species where it can potentially
damage the cell and subsequently lead to cell death.
Since mitochondrial calcium is implicated in many of the cellular changes following
amyloid-β exposure, we hypothesized that blocking the amyloid-β-induced mitochondrial
calcium accumulation would mitigate the elevated mitochondrial respiration, superoxide
production, and cell death following exposure to amyloid-β. Chelation of extracellular calcium
with EDTA was effective at preventing the amyloid-β-induced accumulation of calcium in the
mitochondrial matrix. Thus, we evaluated the role of mitochondrial calcium accumulation as
central to the mechanism underlying amyloid-β mediated endothelial cell injury. We found
that by preventing calcium accumulation in the mitochondria, the elevated respiration
following amyloid-β could be mitigated. In addition, blocking the amyloid-β associated
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ANOVA Summary
Assay

Fvalue

P-value

R2

F(DFn, DFd)

Data
Depiction
(Figure, Panel)

Oxygen Consumption
17.96
< 0.0001
n.a.
57
Fig. 4.2A
Basal Respiration
59.70
< 0.0001
0.8028
3, 44
Fig. 4.2B
Maximum Respiration
91.92
< 0.0001
0.8733
3, 44
Fig. 4.2C
Spare Capacity
46.50
< 0.0001
0.7602
3, 44
Fig. 4.2D
Proton Leak
56.33
< 0.0001
0.8086
3, 44
Fig. 4.2E
Basal Respiration
12.08
< 0.0001
0.6016
3, 24
Fig. 4.2F
Maximum Respiration
24.03
< 0.0001
0.7503
3, 24
Fig. 4.2G
Spare Capacity
9.77
0.0002
0.55
3, 24
Fig. 4.2H
Proton Leak
20.88
< 0.0001
0.723
3, 24
Fig. 4.2I
Mitochondrial Calcium
12.58
< 0.0001
0.4395
3, 40
Fig. 4.3A
Cytosolic Calcium
35.19
< 0.0001
0.7457
3, 36
Fig. 4.3B
ATP Production
46.92
< 0.0001
0.7618
3, 44
Fig. 4.4A
ATP Production
5.71
0.0034
0.3715
3, 29
Fig. 4.4B
ATP Content, Intracellular
60.05
< 0.0001
0.8037
3, 44
Fig. 4.4C
ATP Content, Extracellular
9.13
0.0008
0.6171
3, 29
Fig. 4.4D
Mitochondrial Superoxide
23.68
< 0.0001
0.6764
3, 44
Fig. 4.5D
Mitochondrial Superoxide, Isolated Mitochondria
381.20
< 0.0001
0.9871
3, 17
Fig. 4.5E
Mitochondrial Calcium
15.46
< 0.0001
0.5189
3, 34
Fig. 4.6A
Basal Respiration
51.69
< 0.0001
0.866
4, 20
Fig. 4.6B
Maximum Respiration
56.03
< 0.0001
0.8751
3, 43
Fig. 4.6C
Spare Capacity
216.20
< 0.0001
0.9658
3, 24
Fig. 4.6D
Proton Leak
61.23
< 0.0001
0.8844
3, 24
Fig. 4.6E
ATP Production
126.90
< 0.0001
0.9407
3, 24
Fig. 4.6F
Mitochondrial Superoxide
90.11
< 0.0001
0.8739
3, 39
Fig. 4.6G
Supplemental Table 4.2. Analysis of means by ANOVA. Assay: measured parameter, F-value: group effect, P-value: probability, R2:
coefficient of determination, F (DFn, DFd): degrees of freedom for numerator and denominator, Data Depiction: figure number and panel
to where the specified data is located.
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calcium in the mitochondrial matrix, the elevated ATP production and superoxide generation
could be halted. These data suggest that calcium influx to mitochondria is a central component
to the mechanism mediated by amyloid-β during the early phase of cellular injury in
cerebrovascular endothelial cells.
We further investigated the route by which calcium influx through the plasma
membrane enters mitochondria. Specifically, we assessed the contribution of calcium to the
mitochondria through the endoplasmic reticulum IP3R, reverse mode mNCX, and the PTP.
Each pathway was evaluated by exposing cells to Aβ1-42 in the presence of specific antagonists
then measuring mitochondrial calcium content.
Our data describe a major role for extracellular calcium in the mechanism mediating
the cytotoxicity of Aβ1-42. We found that chelation of extracellular calcium prevented its
accumulation in mitochondria (Figure 4.6) and the increased oxidative phosphorylation and
superoxide production by mitochondria. Recent studies have demonstrated that exposure of
the cell membrane to Aβ results in increased permeability of the bilayer, caused by the insertion
of Aβ into the membrane, forming ion conductive channels (Bode et al. 2017; Demuro et al.
2005). In principal, these channels would allow the influx of calcium into the cell. Furthermore,
we used agents that antagonize mPTP formation, mNCX, and IP3R to evaluate the contribution
of intracellular calcium regulatory pathways in the accumulation of calcium in mitochondria.
In our experiments, inhibition of any of these three calcium pathways resulted in attenuated
calcium influx into mitochondria. Therefore, these data suggest that exposure to Aβ1-42 causes
the cell membrane to become conductive to calcium, the resulting influx of calcium is shunted
into mitochondria via multiple calcium regulatory pathways that cause the hyperoxidative state
of mitochondria observed in endothelial cell mitochondria.
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It is well known that mitochondria possess a sodium / calcium exchanger (mNCX) that
functions in the efflux of calcium from mitochondria (Hoyt et al. 1998; Kiedrowski 1999). It
is possible for mNCX to function in reverse mode during conditions of metabolic and calcium
dysregulation (Griffiths 1999; Smets et al. 2004), transporting calcium into the mitochondria.
To assess this possibility, we used KB-R7943, an inhibitor of reverse mode mNCX at
concentrations previously used in experiments (Brustovetsky et al. 2011), and observed a
profound reduction in Aβ1-42-induced mitochondrial calcium influx (Figure 4.7).
Mitochondrial calcium uptake is a critical cellular function that maintains low cytosolic
calcium concentrations. Calcium influx into the mitochondrial matrix also participates in a
regulatory role facilitating mitochondrial dehydrogenase enzyme activity. However, excessive
accumulation of calcium by mitochondria may lead to mitochondrial damage via the induction
of the mPTP. Calcium-dependent induction of the mPTP is a major mechanism of calciuminduced damage to mitochondria.
Calcium uptake into mitochondria primarily occurs via diffusion across the outer
mitochondrial membrane (OMM) through the voltage-dependent anion channel (VDAC).
Translocation of hydrogen by the respiratory chain forms the mitochondrial membrane
potential that serves as the driving force to transport calcium across the inner mitochondrial
membrane (IMM), down its electrochemical gradient. Calcium influx into the mitochondrial
matrix is mediated by the mitochondrial calcium uniporter (MCU) at the inner mitochondrial
membrane. The MCU channel conducts calcium ions from the outer membrane space into the
mitochondrial matrix. Antagonism of MCU substantially reduced Aβ1-42-induced
mitochondrial calcium influx (Figure 4.7).
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The efflux of calcium from the endoplasmic reticulum via IP3R produce localized
microdomains of elevated calcium concentration that are crucial for calcium uptake by the
mitochondria (Rizzuto et al. 1998). The contact sites that hold mitochondria stationary and
within the calcium-rich microdomain occurs at regions termed mitochondrial associated
membranes (MAMs). MAMs are sites involved in the exchange of biomolecules, such as
lipids, reactive oxygen species, and calcium between the endoplasmic reticulum and
mitochondria. At MAM sites, calcium is conducted into the mitochondrial intermembrane
space via a large protein complex involving VDAC. To determine whether the influx of
calcium into mitochondria following Aβ1-42 exposure involves the IP3R pathway, we used 2APB, an IP3R antagonist. Inhibition of IP3R eliminated Aβ1-42-induced mitochondrial calcium
influx (Figure 4.7).
Together, these data describe a role for calcium in the cytotoxicity exerted by Aβ1-42,
where the cell membrane becomes conductive to extracellular calcium, therefrom the influx of
calcium is shunted into the mitochondria via multiple calcium regulatory pathways, causing
the hyperoxidative state of mitochondria observed following exposure to Aβ1-42.
Consistent with the literature, we observed morphological changes to the mitochondrial
network, characterized by punctated mitochondria via excessive fission (Wang et al. 2008;
Bartolome et al. 2018; Zhang et al. 2016; Almeida and Medina 1998; Cho et al. 2009).
Mitochondrial fission and fusion is a dynamic process modulated by the energy demand of the
cell and participates in the quality control of the mitochondrial network. Damage to
mitochondria, such as from reactive oxygen species can cause mitochondrial fragmentation,
similar to our observation in vascular endothelial cells (Ježek et al. 2018; Wu et al. 2011;
Willems et al. 2015; Hung et al. 2018). Thus, we interpret these data to suggest that the

182

fragmentation of mitochondria in bEnd.3 cells is mediated by the elevated mitochondrial
superoxide production following amyloid-β exposure. Therefore, because we found that the
amyloid-β associated elevation of mitochondrial superoxide production could be mitigated by
preventing mitochondrial matrix calcium. As a result, we expect that the fragmentation of
mitochondria could be abrogated. Indeed, we found that by reducing mitochondrial calcium
via chelation halted the aberrant mitochondrial fission following amyloid-β exposure, lending
evidence to a mechanism involving aberrant mitochondrial fission driven by the oxidative
damage to mitochondria in cerebrovascular endothelial cells exposed to amyloid-β. Lastly,
when we prevented the amyloid-β-induced accumulation of mitochondrial matrix calcium, the
apoptotic morphology of endothelial cells was completely prevented.
Overall, our study provides evidence of early events of cellular injury that involves the
elevation of mitochondrial respiration, calcium accumulation in mitochondria, and the
production of superoxide. We found that calcium influx into the mitochondria is a central
component to the mechanism mediating cell injury. Furthermore, our data indicates that
blocking mitochondrial calcium can completely halt the pathological mechanism mediating
cell death. In addition, these findings provide a mechanism for the mitochondrial dysfunction
and deficits observed in AD and provide evidence for a therapeutic strategy that targets
mitochondrial matrix calcium.
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Abstract
The cerebrovascular system provides crucial functions that maintain metabolic and
homeostatic states of the brain. Despite its integral role of supporting cerebral viability, the
topological organization of these networks remains largely uncharacterized. This void in our
knowledge surmises entirely from current technological limitations that prevent the capturing
of data through the entire depth of the brain. We report high-resolution reconstruction and
analysis of the complete vascular network of the entire brain at the capillary level in adult
female and male mice using a vascular corrosion cast procedure. Vascular network analysis of
the whole brain revealed sex-related differences of vessel hierarchy. In addition, regionspecific network analysis demonstrated different patterns of angioarchitecture between brain
subregions and sex. Furthermore, our group is the first to provide a three-dimensional analysis
of the angioarchitecture and network organization in a single reconstructed tomographic data
set that encompasses all hierarchy of vessels in the brain of the adult mouse.
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Introduction
The cerebral capillary network is the interface between the brain and the periphery and
is therefore decisive for adequate delivery of oxygen and nutrients to the brain. Understanding
capillary network topology and the angioarchitecture of the conduit vessels that move blood
through capillaries is of paramount importance to understand the metabolic activity and
function of the nervous system. Despite its unique positioning as the nexus for advancement
in a number of fields, a complete description of the topological basis of the cerebral
angioarchitecture has not been obtained.
The microvasculature, consisting of the smallest capillaries, has proven hard to image
(Demené et al., 2016; Starosolski et al., 2015). Traditional imaging methods such as ultrasound
and magnetic resonance angiography do not have a resolution that is high enough to detect the
microvasculature (Fukuda, Moon, Wang, & Kim, 2006; Harel, Lin, Moeller, Ugurbil, &
Yacoub, 2006; Uğurbil et al., 2003). Confocal single-photon and two-photon imaging can
provide the resolution needed but have depth limitations (P. S. Tsai et al., 2009). To resolve
the resolution and depth problems, micro-CT imaging, with contrast, can be used. Contrast
agents that fill the vessels have made it possible to capture the vasculature in whole organs in
3-D and the same is true for the brain (Beckmann et al., 2003; Heinzer et al., 2006; Krucker,
Schuler, Meyer, Staufenbiel, & Beckmann, 2004; Meyer, Ulmann-Schuler, Staufenbiel, &
Krucker, 2008).
Light sheet microscopy and laser sheet microscopy (LSM) has become a popular
platform for imaging of large biological specimens. However, because LSM is an optical
imaging method, the quality of the images obtained is dependent on the fluorescence and
transparency of the specimen and similar to other fluorescence based imaging platforms, is
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prone to image aberrations, blurring, scaling by refractive index, autofluorescence, and signal
degradation that progressively get worst with acquisition time and imaging depth. Although
despite the disadvantages to LSM, we must consider the advantages to its use. These
advantages include superior spatiotemporal resolution, excellent optical sectioning, and its low
phototoxicity to live specimens. Furthermore, a well-performed study by Kennel (2018) has
demonstrated the ability to image the microvascular networks of large tissue volumes using
multiview light-sheet fluorescence microscopy (LSFM), enabling highly accurate
reconstruction even when images were acquired at relatively low magnification (Kennel,
Teyssedre, Colombelli, & Plouraboué, 2018).
A growing concern to all fields of research is the ever-growing size of the average data
set. This is especially true for data produced by imaging platforms. Our technological
achievements made on imaging have been focused on developments that increase the ability
to image deeper into specimens and at greater magnification which to produce higher
resolution images. Although undeniably beneficial to research, we now face a bottleneck
obstructing progress. As the ability to image at a greater volume increases along with
progressing resolution, the number of images and size of each image substantially increases,
producing large data sets. Large data sets are difficult to work with. Storage and moving data
become more of a concern as large data begins to accumulate. Post-processing may need to be
performed on computers with computationally powerful capabilities and even more so to
perform three-dimensional quantitation and other complex algorithms for vascular network
mapping and predictive simulations. We provide a method for imaging the entire brain
vasculature, producing a single data set gigabytes in size.
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In the present study, we develop three-dimensional data sets of the cerebrovascular
network of the entire brain from nine mice and evaluate the angioarchitecture at the macroand microscopic level in female and male mice. The present research describes an angiome of
the cerebrovasculature of the entire brain. The overarching goals of the following analyses
were to characterize the geometry, topology, and complexity of the cerebrovasculature of the
entire brain, then to focus on region specific angioarchitecture in the primary somatosensory
cortex, and to compare cerebrovascular topology between sexes. Each of these overarching
goals are divided into three phases: the first phase provides global metrics of the
angioarchitecture, the second phase characterizes the angioarchitecture by mapping network
topology and generating morphometric descriptions of deconstructed network components,
and the final phase focuses on network connectivity and the covariance of morphometry and
frequency within the population of network components.
We provide an analysis of the angioarchitecture and network organization in a single
volumetric data set encompassing all hierarchy of vessels in the brain of the adult female and
male mouse. Our study provides fundamental insight into the cerebral angioarchitecture of
female and male mice and describes sexually dimorphic organization that may be of broad
interest to the scientific community.

Materials and Methods
Animal Usage
Three-month old female (n = 5) and male (n = 4) C57BL/6J mice were used for whole
brain vascular analysis. Power analysis for ANOVA designs indicated a sample size of 4 mice
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per group (power = 0.999) for an effect size of Δ = 1.25. Mice were housed in accordance to
IACUC guidelines of West Virginia University. Animals were maintained under a light/dark
cycle (12 h: 12 h) with food and water available ad libitum. For all procedures performed in
this study that involved the use of laboratory animals were carried out in accordance with the
National Institutes of Health guide for the care and use of laboratory animals (NIH Publication
No. 8023, revised 1978) and in compliance with the ARRIVE guidelines.

Vascular Corrosion Cast Preparation
The procedure described below for the preparation of cerebrovascular corrosion casts
is shown in Supplemental Figure 5.1. Before beginning the cerebrovascular casting procedure,
mice were transported to the surgical suite approximately 4 hours prior to the procedure to
allow an acquisition period to a new environment. The acquisition period reduces the amount
of stress the animal experiences and prevents any stress-induced changes to the
cerebrovasculature. Mice were deeply anesthetized with 4% isoflurane diffused into a 70%
nitrogen and 30% oxygen mixture. After confirming deep anesthetization via tail pinch, mice
received an intraperitoneal injection of 25U of heparin in 250μl saline intravenous solution.
Mice were then transcardially perfused at 160 mmHg with 0.01M PBS containing 25U/ mL of
heparin at physiological pH and warmed to 37° C. Once blood had been completely removed,
mice were perfused at 160 mmHg with 4% paraformaldehyde warmed to 37° C.
Approximately 5 minutes before complete paraformaldehyde perfusion; the vascular corrosion
cast solution was prepared. The PU4ii (VasQtec) corrosion cast solution was prepared by
adding 3g (ℓ) of methyl ethyl ketone with 5-10 mg of blue pigment then mixed thoroughly by
vortex. Once the pigment was completely dispersed into the solution, 5g (ℓ) of polyurethane
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resin was added to the solution followed by thorough mixing. Finally, 0.8g (ℓ) of hardener was
added to the solution and gently mixed by inverting. After mixing, the final solution was placed
into a vacuum chamber for 2 minutes to remove gasses within the solution. The solution was
then perfused into the mice at 160mmHg. Once the casting solution began to harden (3 – 5
minutes) and ceased to perfuse the mouse, mice were allowed to remain at room temperature
for 4 hours to complete the hardening of the cast. After complete hardening of the cast, mice
were decapitated and the skin was removed from the skull with dissecting scissors.

Vascular Corrosion Cast Processing
The isolated skull was decalcified by immersion in 20 mL of 8% formic acid diluted in
Milli-Q water then placed in a water bath warmed to 37° C for 5 hours. From our experience,
it is important to prevent over decalcification of the skull so that the bone tissue becomes
flexible without becoming gelatinous and difficult to remove. Once decalcification was
complete, the skull was rinsed with distilled water and then immersed in 20 mL of 8%
potassium hydroxide diluted in Milli-Q water then placed in a water bath warmed to 37° C for
4 hours. Following the 4-hour incubation in potassium hydroxide, the skull was rinsed in
distilled water and prepared for brain extraction. At this point, the skull was flexible and easy
to tare with small forceps. A small incision at the base of the magnum foramen was gently
made, and with a pair of small forceps, the incision flap was grasped and pulled upward,
breaking the skull up the sagittal suture. With small iris scissors, all major vessels were cut at
the floor of the skull by gently lifting the brain. The brain was then removed and the tissue was
macerated by immersion into 20 mL of 8% potassium hydroxide solution diluted in Milli-Q
water then placed in a water bath at 37 ° C overnight. After the overnight incubation, tissue
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maceration is usually incomplete and requires the potassium hydroxide to be replaced and
incubated at 37° C in a water bath for 24hrs. Once tissue maceration was completed, residual
tissue was removed from the vascular cast by washing 3 times for 1 hour with distilled water
containing 0.25% Triton X-100 then rinsed 3 times for 5 minutes with Milli-Q water to remove
any residual detergent on the cast.
The cleaned casts were placed into a small container and submerged in 20 mL of MilliQ water to be frozen for lyophilization. Lyophilization of the casts was performed on a
benchtop freeze dry system (Labconco) operating at -54 °C and a vacuum pressure of 0.0025
mBar. During the lyophilization process, it is critical that sublimation occurs and that the
melting of ice to a liquid state does not occur. The proper sublimation of ice is critical to
preserve the physiological architecture of the cerebral blood vessels. In our experience,
improper sublimation compromised the structure of the formed vascular casts, often times
producing a relatively flattened appearance. Melting of the ice deformed the small capillary
structures and was irreversible once the cast completely dried. Successful lyophilization
resulted in casts that were rigid and able to maintain moderate pliancy. To allow x-ray detection
of the vascular corrosion casts, 6 mL of a 2% solution of osmium tetroxide diluted in Milli-Q
water was embedded onto the polyurethane casts by immersion and allowed to incubate
overnight at 4° C. Extensive care must be taken when handling solutions or casts containing
osmium tetroxide due to its acute toxicity. Proper personal protective equipment should be
used and the disposal of waste containing osmium tetroxide should be handled as a p-chemical.
Vascular corrosion casts were then removed from the osmium solution with small forceps by
gently grasping the cast by the hindbrain. Casts were allowed to air dry for 1 hour, and then
mounted with cyanoacrylate adhesive on hexagonal pedestals cut from Plexiglas.
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Technical Notes and Quality Control for Cerebrovascular Corrosion Casts
Six mice (2 male and 4 female) at 3-months of age were used to optimize the perfusion
procedure. Optimization of the imaging parameters were performed by selecting one
cerebrovascular cast and imaging it 5 separate times, each with adjusted exposure settings, step
size, and image averaging. Expectedly, perfusion parameters proved to be most influential to
the overall quality of the cast. In our experience, the use of dialysis pumps were most
detrimental to the outcome of the cast that seemed to result in “patchy” perfusion of the resin
that was observable over the cortex. More so, the use of dialysis pumps usually caused vessel
ruptures. We interpret these observations to suggest that the dialysis pump exerts an
incompatible perfusion pressure at relatively low flow rate due to the viscosity of the casting
resin and its characteristic resistance to flow through the vasculature. To overcome this issue,
we found that using a pressurized pump at 160mmHg produced consistent high-quality casts
(Supplemental Figure 5.1B). Noteworthy, we noticed that “good” casts could be predicted and
easily observed by the perfusion of several peripheral tissues. First and most simple to observe
is the dermis over the premaxilla. A good perfusion resulted in an intense coloration of the
dermis to the specific pigment used in the resin composition. A “good” quality cast will often
produce a homogenous hue of the skeletal muscles throughout the entire mouse body.
However, we found that the perfusion of the liver is most accurately representative of the
overall quality of the cerebrovascular cast. This is likely due to the unique physiology of the
hepatic vasculature and its sensitivity to systemic perfusion pressure, where it required venous
perfusion pressure to drive blood through hepatic circulation then communicate it to the
inferior vena cava. Since the hepatic venous system is more extensive than its arterial system,
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the hepatic tissue will not develop a hue specific to the resin pigment if insufficient systemic
perfusion pressure occurs. Additionally, if an excess of perfusion pressure is reached, the liver
noticeably swells and at a certain threshold will cause hepatic vessels to rupture that can be
seen by non-aided observation. Complete perfusion of the cerebrovasculature by the
polyurethane resin was visually apparent in that the casting material entered the venous sinus
system by traversing through the arterial network (Supplemental Figure 5.1C).
Several days are required for the complete hardening of the cast resin. Removal of the
casted brain from the skull is a crucial procedure that requires greater care to prevent damage
to the casted vasculature or compromise of its native angioarchitecture. Decalcification of the
skull with 8% formic acid aids in the opening of the skull followed by 8% potassium hydroxide
to destabilize the tough extracellular matrix of the skull and meninges (Supplemental Figure
5.1D). Adequate decalcification and maceration of the skull and meninges is decisive of the
recovery of the superior sagittal sinus, transverse sinuses, and inferior cerebral veins. These
sinus structures are attached to the meningeal membrane and can easily be broken from the
cerebrovasculature when removing the skull. Incidentally, perfusion of the delicate sinus
structures is indicative of a complete perfusion of the cerebrovasculature. Specifically, resin
that enters the sinus supply must be communicated through the arterial supply indicating transit
through the capillary network. If capillary perfusion pressure is not achieved, the casting resin
will not transit through the capillary network and will not reach sinus supply. Additionally,
evidence of failure to reach capillary perfusion pressure is the observation of casting material
in the circle of Willis and the major arteries of the brain while observing an absence of resin at
the sinuses and homogenous brain pigmentation. Under 40X magnification, penetrating
arterioles and venioles were easily observed confirming complete transit through the vessel
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hierarchy (Supplemental Figure 5.1E). Our experience has taught us that it is imperative that
the perfusion needle not to perforate into the right ventricle during the perfusion procedure.
Perforation of the cardiac septum will allow resin to bypass arterial circulation and compromise
perfusion pressure. Virtually, every instance of this resulted in poor quality of the vascular
corrosion casts.

Micro-Computerized Tomographic Imaging
Tomographic images of the whole brain were acquired using a SkyScan 1272 μ-CT
(Bruker). The μ-CT system was set to operate at 35 kV and 200μA, no filter, and a 4032-by2686 frame size. Before initiating the image routine, flat fields were calibrated and the pixel
size was set to 2 μm. To enhance the quality of acquired images, the voltage and exposure
settings were optimized to a maximum transmission of 35 – 40%, a minimum of 80 – 90%,
and an average of 65 – 75% through the sample. Each vascular cast was imaged over a total of
360° at a step size of 0.05° and averaged by 5 images per 0.05°. Each image routine required
about 15 hours of scan time and produced a file size of 500GB containing 7,200 images and
an additional 400GB and 4,032 images for the final coronal series of the entire cerebrovascular
system. After completing the 15 hours scan, the primary data sets were corrected for
misalignments, beam hardening, and ring artifacts then converted into a coronal image series.
The final data set produced by this imaging routine is a complete coronal series of the entire
cerebrovasculature at a pixel resolution of 2 μm separated in the Z direction by 2 μm for a total
of 43.65 gigavoxels.
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Anatomical Selection of Volume of Interest
The complete set of coronal images was accessed on CTan (Bruker) to isolate a volume
of interest (VOI). To prepare image sets for digital isolation of VOIs, the signal intensity of
the image series was increased so that capillaries were easily observed. Once the intensity was
increased, boundaries of major brain regions were clearly noticeable. Using the Allen Mouse
Brain Atlas (Lein et al., 2007), the VOI was located and selected by tracing. The traced regions
were made in square selections of approximately 1.5 – 2.0 mm and dynamically interpolated
in the Z direction of 1.5 – 2.0 mm. The result was a cube VOI that was saved as an individual
data set. The new data set containing the VOI was filtered in three-dimensions to remove signal
noise by implementing a filter that outputs an image based on the local averaging of the input
image where all the values of the square kernel have the same weight. The data set was
converted into a BMP series of formatted images and saved as a new data series of the isolated
and pre-processed VOI.

Image Processing and Optimization for Volume of Interest
The workflow for the optimization of VOI data sets is depicted in Supplemental Figure
5.2. The binary VOIs were optimized for image analysis and quantification using ImageJ or
Imaris software. Each VOI data set was three-dimensionally cropped to 500 x 500 x 500 µm
cube. The data sets were then rotated so that a selected landmark was co-registered by rigid
transformation similar to the other data sets in the experimental group. Our experience dictates
that the major arteries and their specific branching patterns provided the most convenient and
consistent landmarks for image co-registration. The intensity of the data series was multiplied
by 1.5 so that capillaries were easily seen; however, the signal of the most intense objects
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should not reach a pixel intensity of 255. After signal intensity multiplication, a threedimensional Gaussian blur was applied using a circular mask of 0.65 pixels. Then background
was subtracted from the data by implementing a uniform noise filter that addresses the uniform
noise that often contaminates digital images during acquisition. Please see (Pushpavalli &
Sivarajde, 2013) for a description of uniform noise and digital image processing. Next, the data
set was filtered with an unsharp mask to increase the spatial resolvability of the structures in
the data set. This new optimized data set was duplicated and saved as a series of tiff-formatted
images. One of the duplicated data sets was used to create vessel centerlines that served to
reduce errors during the vessel network-tracing algorithm. Centerlines were created using the
3D/2D skeletonization plugin on ImageJ. With the second duplicated image set, an intensity
threshold was set using the Moments algorithm (W.-H. Tsai, 1985) and a binary image series
was created. The intensity of the binary image set was subtracted by 150 so that the intensity
of the binary image series was uniformly at 105. Finally, the image series containing the
centerlines of the vessels was merged with the processed binary images so that the vessel
structures had an intensity of 105 and the centerlines that passed through them contained an
intensity of 255 (Supplemental Figure 5.3). This optimized data series was then filtered with a
three-dimensional Gaussian blur and saved as a series of tiff-formatted images. For additional
details on the post-processing of the image data and the specific parameters used in each of the
functions, please refer to supplemental table 1. We calculated the signal-to-noise ratio (SNR)
of the optimized images (Kennel et al., 2018) using ROIs by SNR = 20 * log10 (Mean Signal
/ Standard Deviation of Background) to produce an estimate in decibels (dB). In addition, we
calculated the SNR over an entire image using SNR = 20 * log10 (Max Intensity – Minimum
Intensity / Standard Deviation of ROI). Over 32 ROIs from individual images we estimated an
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average SNR of 34.29 dB (St. Dev = 10.52, SEM = 1.86). From 10 separate images, we
estimated an average SNR of 31.08 dB (St. Dev = 3.40, SEM = 1.07).

Volume of Interest Quantification and Analysis of Vascular Networks
The optimized data sets were analyzed with Imaris (Bitplane) software and vascular
networks were identified then quantified using the filament trace function. Filament trace
allows the creation, visualization, editing, and the analysis of filament like structures in twodimensional and three-dimensional images. The settings for the algorithm used for filament
trace were set to automatic filament and path detection. Filament trace will calculate the
diameter of filaments from the image by approximating a circle of the cross section area. We
used the loops algorithm during the tracing process and used the automatic threshold setting.
Filaments that were generated were automatically re-centered to the centerlines of the
volumetric data set. Post filament trace, the vascular networks were visually inspected to
ensure that proper vessel connections were made. Errors encountered following the filament
trace procedure were exclusively to larger vessels with diameters greater than 15 microns. The
type of errors that needed correction was gaps (smaller than vessel diameter) in an otherwise
continuous vessel segment, which required manual connection. The second type of error that
affected large vessels was improper junctions that occurred when two large vessels were in
close proximity to each other. The segments added after manual connections were
automatically recalculated for vessel diameter with Imaris Filament Trace algorithm
(Supplemental Figure 5.4). Once a proper network was created, a number of statistics were
generated and saved as excel sheets. These measurements include vessel diameter, length,
volume, area, tortuosity, branch level, and angle in degrees. Vessels were classified by
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hierarchy that was determined by the mean vessel diameter. Vessels that had a mean diameter
of 2 – 8 μm were classified as capillaries, 9 – 34 μm were arterioles and venioles, and > 34 μm
were classified as arteries and veins. To determine the effects of image noise on our threedimensional vascular network reconstruction and analyses, we created a synthetic data set with
added artificial Gaussian noise at three levels of intensity then compared the measurements
with a ground truth data set that was manually segmented and traced data (Supplemental Figure
5.5) (Corliss, Mathews, Doty, Rohde, & Peirce, 2018; Kennel et al., 2018).

Three-Dimensional Vascular Network Analysis
To evaluate the cerebrovascular network, a network analysis was performed using a
custom MATLAB script. The volumetric data sets were co-registered by rigid transformation.
The pixel intensity of the co-registered data sets was globally multiplied by 1.5 so that the
vascular structures were easily detected; however, the maximum pixel intensity of any data set
was maintained below 255. A three-dimensional Gaussian blur filter with a circular mask of
0.65 pixels was applied to each data set. Then, the background noise is removed from each
data set by subtracting the mean pixel intensity, calculated from a region equal to the diameter
of the largest vessel then repeating this for all regions in a data set. To increase the spatial
resolvability of the structures in the image series, the data sets were filtered with an unsharp
mask. The data sets were then converted to a binary image series by selecting a threshold using
the Moments algorithm. The binary data set was duplicated and converted into a local thickness
map. The second binary data set was used to extract the centerlines of vessels. Our threedimensional network analysis processes the centerline data set and derives nodes as vertices
with degree 3 or greater and edges as vertices with degree 2 and end-points as vertices with
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degree 1. Each edge is stored in a matrix containing all of its component pixel identities and
the nodes that the edge bridges together. Then the local thickness map is used to characterize
the network map for further analysis. The output data for the three-dimensional network
analysis was a vascular map containing the parameters of the angioarchitecture for our
assessment of network connectivity. The results of this analysis were used to assess the
extensity of the vascular network by measuring the connectedness and branch abundance to
the network.

Three-Dimensional Data Rendering
Our imaging device utilizes phase contrast enhancement allowing more information
and detail from a single pixel at the detector. The final voxel size after phase contrast
enhancement is dependent on the number of projections and the rotation step size of the
acquisition routine. Traditional detector systems cannot measure directional information. Our
tomographic detector system can collect information or deflection and scattering by measuring
phase-shift information. This is important when considering that even very small objects can
deflect x-ray beams. This is why imaging x-ray deflection is more sensitive for imaging small
objects, rather than absorption alone. Unlike traditional absorption imaging, imaging
deflection and scattering is not limited by the resolution of the system. Phase-shift information
is stored as intensity for every pixel. During phase stepping, the system creates a sinusoidal
modulation of intensity for every pixel of the camera. The loss of modulation at any specific
pixel of the image reflects the object’s local scatter. The system we used to acquire our image
sets is capable of acquiring isotropic detail down to 0.35um. Because of this principal, the
reconstruction quality of our imaging data exceeded what would be expected at 2um pixel size.
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To view the vascular network of the entire brain in three-dimensions, the data series
was uploaded onto CTvox (Bruker) and the opacity and light intensity was adjusted to provide
the best view of the data set. In order to demonstrate a color-coded three-dimensional structure
of the vascular network, the data sets containing the VOIs were uploaded onto Imaris
(Bitplane), rendered in three-dimensions, and colored based on calculated statistics. Colorcoding of the whole brain vascular network was performed on CTan (Bruker). Additionally,
data sets were color-mapped based on vessel separation to allow the visualization of vessel
density and intervessel distances.

Group Size and Statistical Analysis
All values are presented as mean ± SEM for 5 female and 4 male brains. The specific
statistical analysis used in each experiment was determined based on the intended comparison
that was performed. Statistical tests were either student’s t-test or ANOVA, with Bonferroni
or Dunnett post-hoc tests. Specifically, Bonferroni’s multiple comparison analysis was used to
compare all combinations of the experimental groups, which include sex and brain subregion.
Dunnett’s post-hoc test was used for comparison of the experimental groups with a control
group. Values of p < 0.05 were considered as significant.

Results
Vascular corrosion casts made by transcardial perfusion of a polyurethane resin
(VasQtec, PU4ii) created a structurally precise and highly detailed replica of the
cerebrovascular network of the entire brain in 3-month female and male mice. The creation of
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all vascular corrosion casts were performed within procedural parameters that preserved the
native size and morphology of blood vessels. Female and male mice that were used in this
study were 3.0 - 3.1 months of age, weighed an average of 30 ± 2 grams, and had an average
body temperature of 36 ± 0.2 °C. In addition, mice that were used had systolic (164 ± 0.3),
diastolic (141 ± 0.4), and a mean (149 ± 0.3) arterial pressures that were within the
physiological range (Whitesall, Hoff, Vollmer, & D’Alecy, 2004; Wilde et al., 2017). The
duration for producing a single corrosion cast averaged 10-days. The casting procedure
occurred in three phases: perfusion, cast processing, and tomographic imaging (Supplemental
Figure 5.1A, C and E).

Vascular Network Reconstruction
Completed casts were mounted on Plexiglas pedestals with cyanoacrylate adhesive for
tomographic imaging (Supplemental Figure 5.1F). MicroCT imaging routinely produced 4032
Bitmap images with dimensions of 4032 x 2688 pixels that encompassed the
cerebrovasculature through the entire depth of the brain at a voxel size of 2 x 2 x 2 μm
encompassing 43.65 gigavoxels (Supplemental Figure 5.1G). Each data set was coregistered
by the alignment of a combination of vascular landmarks and major subregions of the brain.
The image quality produced by our reported image acquisition routine was superior; having
essentially no signal-noise, imaging artifacts or intensity variations that are commonly
encountered in fluorescence based imaging paradigms. Additionally, neither the loss or
resolution nor the dissipation of signal intensity occurred to the internal structures of the brain,
indicating that our acquisition routine achieved accurate and complete image collection of the
vasculature through the entire thickness of the brain. With these data sets, we were able to
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reconstruct in three-dimensions the entire cerebrovasculature at one time, allowing for the
rotation, inspection and clipping through the entire volume of the brain (Figure 5.1A). By
general inspection of these reconstructed data sets, major subregions of the brain can clearly
be identified by the changes in vessel density, hierarchy and organization (Figure 5.1A, panel
1-4). Reconstructed data sets in three-dimensions resulted in an anticipated organization of the
cerebrovasculature. Briefly, the superior sagittal sinus and its neighboring pial vessels covering
the surface of the cortex, the circle of Willis and its emanating major cerebral arteries (Figure
5.1B), hippocampal vascular networks in the characteristic hippocampal organization (Figure
5.1A, panel 2), the choroid plexus on the floor of the lateral ventricles (Figure 5.1A, panel 4),
and the caudal rhinal vein (Figure 5.1C) can be identified.
Structure diameter maps were created for each data set allowing us to color code the
hierarchy of vessels based on vessel diameter (Figure 5.2). Color coded images can be used to
aid in navigating through the cerebrovasculature allowing a more intuitive positioning of
volume of interest (VOI) boundaries for region specific analyses. Figure 5.3A depicts a
reconstructed data set of the whole brain cerebrovasculature, color-coded to vessel diameter.
Figure 5.3B depicts a digitally isolated VOI of the prefrontal cortex rotated to an anterior
perspective, posterior perspective, and a toggled inward view. Figure 5.3C depicts a 500 μm
thick coronal slice of a brain hemisphere followed by sequential VOI selection and depiction
of the primary somatosensory cortex, demonstrating the density of the vasculature and
information encompassed by the data set. These data demonstrate the profound
interconnectedness of the vasculature and its resulting emergence.
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Figure 5.1. Three-dimensional reconstruction of the cerebrovascular network of the
entire adult mouse brain. (A) Dorsal perspective of the whole brain vasculature (center)
and selected 1 mm thick coronal slices of the volumetric image set to demonstrate the
acquisition of imaging data through the entire thickness of the brain and to illustrate the
profound density of vessels and the complexity of network connectivity at various brain
subregions (1-4). Insert panel in slice four depicts the choroid plexus on the floor of the
lateral ventricle. Numbered frames indicate the relative anterior-posterior position of each
coronal slice. (B) Ventral perspective of the cerebrovasculature depicting the circle of
Willis and the corresponding vascular network. (C) Lateral perspective of the
cerebrovasculature depicting surface arterial and venous networks. (Panel B; intense
circular structures, panel C; ventral U shaped structure = mount platform for cast).
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Whole Brain Analysis of the Angioarchitecture Demonstrate a Multitude of Vessels that are
Morphometrically Similar between the Sexes
For whole brain vascular analysis (Figure 5.4, table), vessels were automatically
identified and segmented by thresholding using the Ridler-Calvard method (Ridler & Calvard,
1978). ROIs were created using a shrink-wrap routine that stretched over holes with a diameter
of up to 30 pixels. The shrink-wrap routine allows for an automatic generation of ROIs by
wrapping the boundary of the ROI around the periphery of a three-dimensional object
represented in the data set. Selection of a threshold allows the boundary of the ROI to stretch
over pores the size of the threshold in three-dimensional space so that the ROI traces the
boundary of the represented object in the data set without tracing any pores or holes that the
object may contain.
Two exceptions for a completely automated analysis, before automatic thresholding,
the mean gray value of the data sets were manually derived and normalized to a value of 95 by
global multiplication of pixel intensity.
Whole brain vascular analysis demonstrated a broad range of vessel diameters ranging from 2
– 220 μm, with a mean diameter of 36.6 ± 2.4 and 54.3 ± 10.6 μm for female and male mice,
respectively. The data revealed that over the entire brain, the cerebrovascular network is
composed of 1.4x106 ± 2.6x105 and 1.8x106 ± 3.0x105 vessel segments for female and male
mice, respectively. The average intervessel distance in three-dimensions was 20 ± 5 μm in
females and 32 ± 13 μm in males (p = 0.037). Total volume of vessels in the female brain was
2.2x1010 ± 4.0x109 μm3 and in males was 1.3x1010 ± 1.7x109 μm3 (p = 0.053). The total volume
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Figure 5.2. Whole brain vascular network segmentation and color-coding by vessel
hierarchy demonstrates the distribution and frequency of vessels. Whole brain
volumetric data set produced from a female mouse used to create a vessel thickness map to
color-code vessels by hierarchy. Hierarchical classified vessels were migrated to hierarchyspecific volumetric data sets.
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of the brain parenchyma in microns cubed was 1.5x1011 ± 5.1x1010 for females and 4.7x1010 ±
1.7x1010 for males (p = 0.065).
Although whole brain global-averages of the angioarchitecture in female and male mice
appeared somewhat statistically indistinct from one another, specific differences at the level of
vessel hierarchy may exist. We used the vessel thickness maps of the entire brain to classify
vessels and analyzed vascular volume as a function of vessel diameter to provide a distribution
of vessel species relative to the total mass of vessels per brain in female and male mice (Figure
5.4A and B).
We observed sex-related differences in the distribution of vessels of particular sizes
with relatively low intra-group variability. For both female and male mice, vessels ranging
from 2 – 15 um in diameters represented the largest proportion of vessels among all vessel
diameters. In females, this population of vessels represented roughly 50 ± 6 % of all vessels,
whereas in males this population accounted for 40 ± 3 %. Males were found to have a greater
population of vessels with diameters larger than 15 μm (p = 0.01), having 49 ± 3 % of vessels
with diameters falling within 20 – 80 μm in diameter. In females, only 36 ± 3 % of vessels
within this range (Figure 5.4C).
Capillaries form networks varying in density that are acutely tailored to the specific
metabolic requirements of the surrounding tissue. The plasticity of capillary formation and
regression is crucial for dynamically active cells, such as neurons, where during periods of
elevated activity they require capillaries to be closer and more numerous. Capillaries and other
small vessels were more numerous in female than in male mice (Figure 5.4C). Because the
density of capillary networks is influenced by localized neuronal activity, and the need to meet
metabolic demand, we next asked whether there are sex-related differences in the distance
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Figure 5.3. Large-scale volumetric data collection of intact cerebrovascular network
at exceptional quality and resolution for microvascular network analysis. (A)
Reconstructed whole-brain data set of the cerebrovasculature color-coded to vessel
diameter. (B) Rotated sub-block of the right frontal pole to demonstrate the absence of
morphological distortions that can be caused by aberrations of signal intensity. (C)
Sequential magnification of the primary somatosensory cortex from a whole brain data set
demonstrating the throughput and resolution of the collected data and depict microvascular
networks that do not contain gaps or “missing” segment components that are often produced
by confocal microscopy. Color-coded vessels from red (small) to blue (large).
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between vessels and by extension the distance between cells of the parenchyma and the nearest
vessel. To examine this possibility, we analyzed the distance between vessels in threedimensions by measuring the radius of the largest sphere that fits between vessels (Figure 5.4D,
insert). The radius of the sphere represents the maximum distance of any given cell in a
particular parenchymal space is to the nearest vessel. A map of the distribution of parenchymal
spaces as a function of maximum distance to the nearest vessel revealed a larger number of
parenchymal spaces with shorter distances in male rather than female mice (Figure 5.4D).
Capillary networks form the interface for the exchange of molecules to and from the
brain parenchyma and peripheral circulation. The total surface area of these capillaries is
influential to the extent to which exchange can occur at the blood-brain barrier interface. To
gauge the magnitude of this interface, we calculated the parenchymal volume to surface area
ratio of capillaries. We found that the capillary surface area to tissue volume ratio of the whole
brain to be 17.8 ± 3.2 mm2 of capillary surface to every mm3 of brain tissue. Our estimate was
in agreement with previous literature reporting the surface area of the blood-brain barrier in
mice (Hartung et al., 2018) and in humans (Abbott, Patabendige, Dolman, Yusof, & Begley,
2010; Pardridge, 2007) to be in range of 9-17 mm2 of capillary surface per mm3 of brain tissue.

Whole Brain Analysis of the Vascular Network Topology Reveal an Array of Profoundly
Interconnected Vessels
We then examined the network properties of the whole brain vasculature. Consistent
with the literature (Gross, 2006; Sheth & Liebeskind, 2014), we observed a large prevalence
of redundant pathways that formed a highly interconnected network. To measure the geometric
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Figure 5.4. Topological analysis of the cerebrovasculature of the entire brain describes
a sex-specific distribution of vessel frequency that is associated with vessel diameter
and

the

frequency

of

parenchymal

regions

with

intervessel

distance.

Cerebrovasculature reconstructed, parameterized (table), and color-coded by vessel
diameter from (A) female and (B) male mice. (C) Line plot (mean ± SEM) as a function of
vessel diameter and the percentage of total vessel volume from female (red, n = 5) and male
(blue, n = 4) mice. The grouped bar graph inset depicts expanded data denoted by the box
and arrow insert. (D) Line plot (mean ± SEM) as a function of intervessel distance and
normalized frequency of parenchymal regions from female (red, n = 5) and male (blue, n =
4) mice. The inset is a three-dimensional reconstructed coronal slab of the parenchyma that
is color-coded from small (red) to large (blue) intervessel distance. To compare means, 2way ANOVA with Bonferroni multiple comparison analysis was used (**, p < 0.01; ***, p
< 0.001).
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connectedness of the network, we used an algorithm to calculate the Euler number and
connectivity value of the network in three-dimensions. The Euler number takes into account
three classes of events to estimate the total number of connections: islands, bridges, and holes.
The connectivity number in a multiply connected network such as capillaries is topologically
defined as the maximum number of cuts in the network that could be made without separating
the network into two isolated networks (Nyengaard, 1999). Geometric analysis of the whole
brain network revealed an Euler number of 1.1x106 ± 3.7x105 connections in females and
1.7x106 ± 2.4x105 connections in males. The connectivity value revealed 5.2x105 ± 2.2x105
and 1.2x105 ± 6.2x104 number of cuts to the network before splitting into two isolated networks
in female and male mice, respectively.
Fractal dimension is a mathematical concept used to describe the complexity of selfsimilar structures. The prototypical idea of self-similar repeating functions originated as early
as the 1600’s but was only formalized in 1975 by Benoit Mandelbrot who coined the term
fractal dimension. Briefly, fractal dimension analysis is used to parameterize structures with
undefined functions. We measured network complexity using Kolmogorov box counting
method for fractal dimensions and revealed a fractal dimension of 2.6 ± 0.05 and 2.5 ± 0.06
for female and male mice, respectively.

Region of Interest Acquisition and Preprocessing
To perform subregion specific vascular analyses, VOIs were digitally dissected from
the whole brain data set. Positioning of VOIs was guided by the Allen Mouse Brain Atlas (Lein
et al., 2007) and co-registered to landmarks comprised of arterial branching and positioning.
Briefly, the medial orbital prefrontal cortex, cingulate gyrus, somatosensory cortex, corpus
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callosum, perirhinal cortex, and entorhinal cortex were isolated from the whole brain data sets
(Figure 5.5). To increase the accuracy of the tracing process of the vessel network, the data
sets containing the VOIs were optimized by inserting the centerlines of the vessels onto each
z-plane of the same data set (Supplemental Figure 5.2). Imaris Filament Trace function
computes pathways of the vascular network based on local pixel intensity of the vessels
structure within the volumetric data set. The insertion of centerlines at the maximum pixel
intensity of 255, aids in this process by serving as the only local intensity at the highest pixel
value of each vessel segment. Therefore, filament tracing by Imaris compute filament
pathways based on the precise intersection of a vessel junction, negating errors caused by
vessel segments in close proximity (close to touching) and spurious hair-like filament caused
by improper setting of pathways due to irregular local intensity profiles.

Region Specific Analysis of the Angioarchitecture Demonstrate a Highly Organized and
Emergent Pattern
Previous literature has demonstrated that in mice the primary somatosensory cortex
receives the greatest vascular density compared to other brain regions (P. S. Tsai et al., 2009).
In addition, there is a growing interest in understanding the neurovascular coupling involved
in nuclear imaging and its relationship with blood-oxygen-dependent (BOLD) signal and
neuronal activation (Magistretti & Pellerin, 1999; Zhao, Wang, Hendrich, Ugurbil, & Kim,
2006). Literature focused on the structural relationship of vascular networks in the
somatosensory cortex (vS1) barrel field suggests that angioarchitecture of these networks are
innately adapted to the topology of tissue (P. S. Tsai et al., 2009) and functional modules of
the cortical columns in the vS1 barrel field (Blinder et al., 2013). We first assessed the
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Figure 5.5. Identification and localization of brain subregions for morphometric
analysis of the angioarchitecture. Three-dimensional reconstructed coronal slice of a
single hemisphere with overlay box-and-stem insert demarcating the relative location of
isolated perirhinal cortex, entorhinal cortex, CA3, somatosensory cortex, CA1, cingulate
gyrus, corpus callosum, and dentate gyrus subregion. Subregion-specific vascular data sets
were collected in 500 x 500 x 500 um selections.
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angioarchitecture of the primary somatosensory cortex by global morphometric analysis in
female (n = 5) and male mice (n = 4, data set = 500 μm3). Vessel density varied as a function
of depth through the layers of the primary somatosensory cortex (Figure 5.6A). The greatest
vascular density was found in cortical layer 2/3 and the lowest density in layer 6b (Figure
5.6B). The largest average vessel diameter was observed on the cortical surface and then
remained constant throughout the depth of the cortex (Figure 5.6B). Morphometric and
geometric analysis of the vascular network revealed modest sex-related differences in 3-month
old mice (Figure 5.6C-K). Vascular analysis was performed on 660 ± 54 and 468 ± 107 vessel
segments in female and male mice, respectively (Figure 5.6C). The calculated average over all
vessel segments in the vS1 identified the average vessel diameter to be 14.76 ± 0.22 μm in
females and 14.37 ± 0.31 μm in males (Figure 5.6D). Total vascular surface area was 5.3x106
± 5.5x105 and 4.5x106 ± 3.3x105 μm2 for female and male mice, respectively (Figure 5.6E).
Vessels occupied a total volume of 1.7x107 ± 2.1x106 and 1.4x107 ± 1.4x106 μm3 in female
and male mice, respectively (Figure 5.6F). Whereas, parenchymal volume was observed at
1.0x108 ± 2.1x106 and 1.1x108 ± 1.4x106 μm3 in female and male mice, respectively (Figure
5.6G). Comparable to the literature (Meyer et al., 2008; P. S. Tsai et al., 2009; Zhao et al.,
2006), we observed an average distance between vessels in the somatosensory cortex to be
38.6 ± 2.4 μm in females and 43.1 ± 1.5 μm in males (p = 0.10) (Figure 5.6H). Similar to the
average intervessel distance of the whole brain, female rather than in male, demonstrated
smaller distance between vessels.
We next extrapolated on the global calculations of total vascular volume and
parenchymal volume by mapping the distribution of vessel and parenchymal space diameter
as a function of total volume (Figure 5.6I). We found that female relative to male mice had a
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greater volume of vessels with a diameter of 15 μm, occupying a volume of 6.5x106 ± 1.2x106
and 3.8x106 ± 7.7x105 μm3 (p < 0.01) in female and male mice, respectively (Figure 5.6J).
However, when these values were normalized to the percentage of total vascular volume,
female mice have greater proportional volume of vessels with diameters that range 5 - 10 μm
than male mice (p < 0.001). We then examined parenchymal separation volume to estimate
vascularization of the primary somatosensory cortex. To assess somatosensory cortex
vascularization, we mapped the distribution of parenchymal separation in three-dimensions as
the maximum diameter of an inscribed sphere per parenchymal area as a function of total
volume (Figure 5.6I). Our parenchymal separation analysis revealed a slightly larger total
volume of parenchymal spaces with diameters that ranged from 10 – 30 μm in females
compared to males (Figure 5.6K). In contrast, males demonstrated a larger total volume of
parenchymal separation with diameters ranging 40 – 55 μm. Although the distribution of areal
parenchymal diameter as a function of cumulative volume provides an adequate description of
the topological composition of the parenchyma that touches on the variation of parenchymal
compartmentalization, a more direct assessment of the variation of minimum-distances of
parenchymal cells to neighboring vessels is needed. We resolved this by examining the average
minimum distance within a parenchymal volume and repeated this for all parenchymal zones.
Our analysis revealed a heterotypic distribution of shortest distances between female and male
mice. Female mice were found to have a greater number of parenchymal zones with smaller
average minimum distances than male mice. Specifically, female mice demonstrated 3.2x104
± 6.5x103 parenchymal zones with an average minimum distance below 15 μm, whereas male
mice contained 2.4x104 ± 2.7x103 parenchymal zones with distances below 15 μm.
Furthermore, parenchymal zones with an average minimum distances of 15 μm showed the
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Figure 5.6. The primary somatosensory cortex demonstrates a topological distinct
vascular network. (A) Reconstructed vascular network through the entire depth of the
somatosensory cortex (500 x 500 x 1450 um) from a female mouse. Line insert demarcates
the boundaries of the cortical layers. (B) Line graph (mean ± SEM) as a function of cortical
depth and normalized vascular density (black, n = 3) or average vessel diameter (green, n =
3). Bar graph(s) (mean ± SEM) illustrating the (C) number of vessel segments, (D) average
vessel diameter, (E) vessel surface area, (F) total vessel volume, (G) parenchymal volume,
and (H) vessel separation from female (n = 5) and male (n = 4) mice. (I) Reconstructed
volumetric data set containing the vasculature from the primary somatosensory cortex
merged with the parenchymal image series color-coded to the distance between vessels.
Line graph(s) (mean ± SEM) as a function of (J) vessel diameter with total vessel volume
and (K) maximum distance from vessel with the number of parenchymal spaces. Statistical
comparison was performed by 2-way ANOVA and Bonferroni post hoc test to compare the
means (**, p < 0.01).
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largest discrepancy (p = 0.04) between female (3.6x105 ± 3.0x104) and male (2.5x105 ±
3.6x104) mice and accounted for the majority of all parenchymal zones in both male and female
mice (Figure 5.6K). Our estimates are in agreement with the predictions reported in the
literature (P. S. Tsai et al., 2009).

Region Specific Analysis of the Vascular Network Topology Reveal a Conserved Network
Organization and Connectivity that Covaried with Vessel Hierarchy
The vascular network is highly interconnected and may asymmetrically form
connections based on vessel hierarchy and diameter (Figure 5.7A). We would expect the
vascular network to have asymmetric connectivity with a greater number of junction points at
the capillary level due to their physiological relevance of distributing the flow of blood. As
such, a penetrating arteriole can have a number of branch points along its length whereas
capillaries branch at their distal segment (Figure 5.7B). In contrast, a network with symmetric
connectivity should demonstrate a constant value of junctions across varying segment
diameters (symmetric distribution). To determine whether the vascular network has
asymmetric connectivity, we calculated the number of branch points as a function of parent
vessel diameter (26,435 branch points across 9 mice) (Figure 5.7C). We then compared this to
the estimated symmetric distribution of branch points and found that all vessels statistically
differed from a symmetric distribution (p < 0.001) except for vessels with diameters of 3 and
7 μm (Figure 5.7D). We next compared the total number of branch points per average vessel
diameter across all other average diameters to determine whether a hierarchy or characteristic
vessel diameter forms proportionally greater number of interconnections. We found that
vessels with diameters of 4 and 6 μm represented 57 ± 1.5 % of the total population of vessel-
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vessel connections. Specifically, 21.5 ± 2.2 % (p < 0.0002) and 35.5 ± 1.9 % (p < 0.001) of all
vessel junction points were found on vessels with diameters of 4 and 6 μm, respectively. This
observation agrees with our prediction that the vascular network of the primary somatosensory
cortex has asymmetric connectivity where capillaries are the primary vessel hierarchy that
bridge together to form networks. Additionally, our data imply that among capillaries there is
an asymmetric distribution of connections that interacts with specific capillary caliber
preferential to diameters of 4 and 6 μm (p = 0.000005). We next compared the distribution of
branch points by parent vessel diameter across sexes to uncover any sex specific differences
in network connectivity. We first compared the total number of branch points over all vessel
diameters in the primary somatosensory cortex and found no statistical difference across sex
(Figure 5.7E). If we average both female and male mice together, we obtain approximately
2937 branch points which is 7% less than reported in the literature (Blinder et al., 2013). Thus,
we then hypothesized that between male and female mice there would be no difference in
network connectivity in relation to vessel diameter and number of branch points. Our null
hypothesis is that there are sex-dependent differences in network connectivity that are related
to network component diameter. To assess this we used an equivalence test to determine if the
overall distribution of branch points across vessel diameters were similar between the female
and male mice and found statistically significant similarity with 95% confidence that the
distributions were equivalent (Pearson R = 0.95; p < 0.0001; R2 = 0.91). Although we found
the overall distribution to be equivalent between female and male mice, we next asked whether
the magnitude of network connectivity preferential to 4 and 6 μm vessels were similar. This
was determined via multiple comparison analysis using a 2-way ANOVA and a Bonferroni
post hoc test for level of significance and found that females (1835 ± 490) over males (1082 ±
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102) demonstrated a greater number of branch points for vessels with an average diameter of
6 μm (p < 0.01; Figure 5.7F). These data indicate that in mice regardless of sex, the
composition of the vascular network follows a conserved organization of connectivity in
respect to capillary diameter. Furthermore, our finding that female mice have a greater number
of branch points from vessels with 6 μm diameters suggests that the differences in whole brain
angioarchitecture between the sexes were influenced primarily by an elevated number of
capillaries with 6 μm diameters.
Penetrating arterioles deliver blood to subsurface microvascular networks, which drain
into the penetrating venioles. There are no pathways to transit blood out of the brain that bypass
the capillary network. Arteriovenous anastomoses that form in the brain that are pathological
in nature confound the perfusion of blood into capillary beds by rerouting blood flow through
a malformed arteriole that feeds blood directly into the corresponding veniole. In a healthy
brain, there are a profound number of pathways for blood flow to reach the nearest veniole
(Figure 5.7G). Blood flow can be regulated by modulating the resistance of these pathways
individually to redistribute blood by shunting blood flow away or toward specific areas. The
capillary angioarchitecture provides redundant pathways for the delivery of blood from any
arteriole (Figure 5.7H). This network redundancy provides multiple direct pathways for blood
to transit into and out of a given region (Figure 5.7I).
To quantify the number of connections within the local vascular network of the primary
somatosensory cortex, we used an algorithm to calculate the Euler number and connectivity
value of the three-dimensional vascular network and found an average of 310 ± 66 connections
in female and male mice together. A comparison of the number of connections in the primary
somatosensory cortex in female and male mice revealed 361 ± 67 and 226 ± 142 connections
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(p = 0.18) in females and males, respectively (Figure 5.7J). We next measured the redundancy
of the vascular network by using an algorithm that randomly cuts the network repeatedly until
the network splits into two isolated components. We found that the vascular network of the
primary somatosensory cortex could receive 504 ± 95 cuts before breaking apart, regardless of
sex. Specifically, our analysis revealed as many as 587 ± 134 and 366 ± 95 cuts to the vascular
network of the primary somatosensory cortex before splitting into two isolated networks in
female and male mice (p = 0.14), respectively (Figure 5.7K). These findings demonstrate that
the vascular network of the primary somatosensory cortex are profoundly interconnected
forming as many as 310 connections able to withstand the removal of 503 segments before
network breakdown. Moreover, these observations imply that there is no difference in the
interconnectedness of the vasculature between female and male mice.

Sex Differences in Intragroup Interregional Angioarchitecture
Within the brain, there exist subregion-dependent differences in vascular network
organization and density. The specific architecture of the vascular network is closely tied to
the local metabolic demand. As such, in gray matter regions, the energy requirement is
relatively greater than in regions of white matter (Attwell & Laughlin, 2001; Magistretti &
Pellerin, 1999), therefore vascular network density is increased in these zones. Brain structure
and organization of neurons differ between subregions. For example, the cortex and
hippocampus form layers and these layers demarcate zones in which specific cells can be
found. In addition, differences in neuronal activity between brain subregions require specific
angioarchitecture. This implies that within the cortex both anatomical organization of cells and
local cellular activity within a cortical layer or between cortical layers can influence the local
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Figure 5.7. Vascular network connectivity analysis in the primary somatosensory
cortex indicates a preference for interconnections to specific vessel hierarchy. Vascular
network through the depth of the somatosensory cortex (A, C) and single penetrating
arteriole (B), color-coded to cortical depth (A), vessel diameter (B), and demarcated branch
points (C, orange spheres). Bar graph(s) (mean ± SEM) depicting parent vessel diameter as
a function to number of branch points (D), total number of branch points (E), and parent
vessel diameter as a function to number of branching vessels (F) in female (n = 5) and male
(n = 4) mice. Dorsal perspective of a vascular network depicting the shortest pathways of
each vessel to all other vessels (yellow) (G). Non-connected vessels segments are colored
green and blue. Representative image of the extracted shortest pathways between vessels
predicts the network at its most rudimentary form (H). Depiction of the shortest pathways
of each arteriole (green, cyan, blue, magenta, yellow, brown) to a veniole (beige),
demonstrating the most effective pathway for blood to transit through penetrating arterioles
and feed into venioles (I). Bar graph(s) (mean ± SEM) demonstrating the number of vesselto-vessel connections (J) and network redundancy (K) from female and male mice. To
compare means, 2-way ANOVA with Bonferroni multiple comparison analysis was used
(**, p < 0.01).
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organization and density of the vascular network. This suggests that the topology of the
vascular network throughout the brain is highly heterogeneous yet somewhat predictable by
its acute responsiveness to local demand of blood perfusion. The goal of this analysis was to
describe the magnitude of inter-subregion differences of the cerebrovascular topology. This
analysis was achieved by means of geometric assessment of the vasculature then by pairwise
comparing these metrics across subregions (Figure 5.8). We then assessed the magnitude of
inter-subregion differences between sexes. The analysis uses intra-group differences in the
angioarchitecture then compares the degree of heterogeneity across sex, to provide a metric of
the diversity of vascular network parameters in female and male mice.
Subregion-specific vascular network differences can occur through hierarchy specific
angiogenesis. Therefore, we categorized vessels by binning into two groups, vessels with
diameters of 2-8 and 9-20 μm for capillaries and arterioles/venioles, respectively. For each data
set, the total length of vessels that fell into either bin was summated (Figure 5.8A-B) and
compared by 1-way ANOVA across subregions (medial orbital prefrontal cortex,
somatosensory cortex, cingulate gyrus, and the dentate gyrus) or students t-test for comparing
across the overall average of the subregions. The degree of difference was represented as the
p-values per pairwise comparison (Figure 5.8C-F). We observed the highest density of
capillaries in the primary somatosensory cortex versus other brain regions (female, p = 0.0005;
male, p = 0.0001). The second highest capillary density was found in the medial orbital
prefrontal cortex (female, p = 0.0005; male, p = 0.0001). Whereas, lower densities were found
in the cingulate gyrus (female, p = 0.003; male, p = 0.002) and dentate gyrus (female, p =
0.003; male, p = 0.02). Relative to all other regions, the lowest vascular density was found in
the dentate gyrus for both female and male mice. A comparison of the total capillary length in
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the cingulate gyrus between female and male mice indicated a greater total length of capillaries
in male mice (Figure 5.8A; p = 0.02). Our finding is consistent with the literature in that the
highest capillary density is found in the primary somatosensory cortex in rodents (Harrison,
Harel, Panesar, & Mount, 2002).
In contrast we found the highest arteriole/venioles density in the cingulate gyrus
(female, p = 0.02; male, p = 0.001) and dentate gyrus (female, p = 0.2; male, p = 0.005) and
the lowest in the medial orbital prefrontal cortex (female, p = 0.02; male, p = 0.0004) and
primary somatosensory cortex (female, p = 0.2; male, p = 0.001) in both sexes. Comparison of
the sum length of arterioles in the medial orbital frontal cortex indicated that females have a
greater value than males (Figure 5.8B; p = 0.01).
Our data indicate clear network differences between the subregions. However, our
comparison of subregional differences to the global average is useful to identify a region that
contains relatively elevated or reduced densities, but fails to demonstrate differences or
similarities in a region-by-region manner. Therefore, we compared the total capillary length of
all subregions to all other subregions to assess region similarities and differences (Figure 5.8C
and E). We then performed the same comparison for arteriole/veniole densities across regions
(Figure 5.8D and F). We found that the capillary density in the medial orbital prefrontal cortex
and in the somatosensory cortex significantly differed compared to all other regions and most
strongly differed from the cingulate gyrus and dentate gyrus in both female (Figure 5.8C) and
male (Figure 5.8E) mice. In contrast, we found that the capillary density in the cingulate gyrus
and in the dentate gyrus contained similar density profiles (p = 0.820) while being significantly
different from the medial orbital prefrontal cortex (p = 0.01) and primary somatosensory cortex
(p = 0.001).
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Figure 5.8. Inter-subregional differences in the vascular architecture vary in
magnitude between the sexes. Grouped bar graph (mean ± SEM) depicting (A) total length
of capillaries (2 – 8 μm) and (B) total length of non-capillaries (9 – 21 μm) in micrometers
for each of the brain subregions. Inter-subregional analyses of the differences in total (C
and E) capillary and (D and F) non-capillary length in (C and D) female and (E and F) male
mice represented as mean p – values color by hue intensity to the level of significance.
Brain subregions (500 x 500 x 500 um): medial orbital prefrontal cortex (MO F CTX),
primary somatosensory cortex (SS CTX), cingulate gyrus (CG), dentate gyrus (DG). To
compare means, 2-way ANOVA with Bonferroni multiple comparison analysis was used
(**, p < 0.01; ***, p < 0.001).
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The comparison of arteriole/venioles profiles between subregions revealed group wise
differences between the medial orbital prefrontal cortex and primary somatosensory cortex
compared to the cingulate gyrus and dentate gyrus. In female mice the greatest disparity was
found between the medial orbital prefrontal cortex and the cingulate gyrus (p = 0.002) or the
dentate gyrus (p = 0.01). In males, the medial orbital prefrontal cortex showed a greater
dissimilarity compared to the cingulate gyrus (p = 0.0002) and dentate gyrus (p = 0.0002).
Similarly, in males, there was also strong dissimilarity between the primary somatosensory
cortex and the cingulate gyrus (p = 0.0002) or the dentate gyrus (p = 0.0003). Interestingly,
both female and male mice demonstrated similar arteriole/venioles profiles between the medial
orbital prefrontal cortex and primary somatosensory cortex (female, p = 0.3; male, p = 0.3) and
between the cingulate gyrus and the dentate gyrus (female, p = 0.1; male, p = 0.1).

Discussion
We demonstrate a procedure for the acquisition and analysis of the entire brain
cerebrovascular system at a microvessel-relevant resolution and provide a detailed
characterization of the geometrical and topological properties of the vessels and their networks
in the adult female and male mouse brain.
We used a vascular corrosion cast method to replicate the complex structures of the
cerebrovasculature (Figure 5.1). We describe a procedure that yields with high fidelity, a
structurally precise and extensively detailed replica of the network of cerebral vessels through
complete depth of the adult mouse brain (Supplemental Figure 5.1). Our imaging paradigm
yields a single volumetric data set that encompasses the entire brain at a resolution required to
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investigate microvasculature (Figure 5.3). The produced data sets were of high quality,
essentially devoid of non-specific signal (background) or imaging aberrations. Reconstruction
of the cerebrovasculature from the volumetric tomographic data sets demonstrated the capture
of the geometry of microvascular networks that were seemingly absent of segment breakage
and disconnected components. We report in detail the analytical models employed to
investigate the structural and connective complexity of the brain vasculature from nine mice.
When performed under idealistic conditions, we would expect the procedure to produce
a vascular cast that contains all vessels of the entire adult mouse brain. However, some
limitations should be noted. First, although polyurethane is one of the most thermally,
mechanically, and chemically resilient polymers in production we have to consider potential
damage to the cast during processing. Particularly, small structures such as microvessels can
break and potentially tangle if the cast is improperly handled or if the cast is disturbed before
complete curing of the resin. Once the resin has cured, the elasticity and durability of
polyurethane makes the manipulation of the cast simple (Krucker, Lang, & Meyer, 2006).
Earlier methods to produce corrosion casts used methyl methacrylate resins, which are
exceptionally brittle, and rigid (Hodde & Nowell, 1980). Handling of the polyurethane cast
prior to and after maceration is less critical than with methyl methacrylate resin. Second,
imaging on a desktop MicroCT system requires the cast to be mounted in such a way to prevent
movement artifacts caused by vibration or shifting of the specimen. This can prove to be
difficult because mounting in any form requires contact with the cast. This contact, if not
maintained as minimal as physically possible can have an impact on analysis and
measurements of vessels at the location of the cast-mount interface. Third, the time required
from the creation of a cast to final analysis is large. Alone, image acquisition at the resolution
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described in this study requires over 15 hours of continuous scan time, in addition, analysis of
a single data set of the whole brain requires over 18 hours of computer processing. While there
are several limitations to consider when applying a corrosion cast to research, if performed
correctly and carefully, the advantages clearly outweigh its limitations.
The convoluted nature of the cerebrovascular system requires the use of appropriate
mathematical models to represent accurately its geometry, organization, and functional
properties. Geometric descriptions of the brain’s vascular system have proven useful in the
literature (Cassot et al., 2010; Cassot, Lauwers, Lorthois, Puwanarajah, & Duvernoy, 2009).
Indeed, geometric analysis of the vascular system provides valuable insight to fundamental
physiological features such as, branch characteristics and cumulative length (Lauwers, Cassot,
Lauwers-Cances, Puwanarajah, & Duvernoy, 2008). However, commensurately important is a
description of the vessel network organization using non-integrated parameters. In
mathematics, the concept of topology is used when describing an object beyond its geometrical
features, rather focusing on its structural connectivity. Topological analysis of the vasculature
has only recently emerged in the literature. The reason for this delay is the unavailability of
large data sets at the resolution required for robust statistical analyses of the cerebrovasculature
(Hirsch, Reichold, Schneider, Székely, & Weber, 2012). Knowledge of the topology of the
cerebrovasculature is critical for understanding the principals of neurovascular coupling and
for functional predictions such as, the differential impact of a vessel occlusion at different
locations and vessels in the brain. Progress made on describing the interplay between vascular
network topology and layer-specific differences in blood flow, resistance, and pressure
gradients has provided an essential perspective of the contribution of vascular network
topology to the local regulation of blood flow in the brain (Blinder et al., 2013; Gould, Tsai,
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Kleinfeld, & Linninger, 2017; Guibert, Fonta, & Plouraboué, 2010; Lyons, Parpaleix, Roche,
& Charpak, 2016; Schmid, Tsai, Kleinfeld, Jenny, & Weber, 2017). Such studies have revealed
that the relationship between the topology of a vascular network and its distribution of blood
and pressure is so fundamentally linked that it is argued to be one entity (Schmid et al., 2017).
In this study, we use both geometrical and topological analysis to describe the
morphology and connectivity of the angioarchitecture that represents its structural properties
in a physiologically meaningful manner (Supplemental Table 5.2).
There are sex-related differences in cerebral blood flow and metabolism. It is well
accepted that females have greater cerebral blood flow than do males (Aanerud, Borghammer,
Rodell, Jónsdottir, & Gjedde, 2017; Amen et al., 2017). However, extensive research also
supports the notion that males have a thicker cortex and higher synaptic density than do females
(Alonso-Nanclares, Gonzalez-Soriano, Rodriguez, & DeFelipe, 2008). Both notions are well
accepted in the field yet seem counterintuitive. Having a thicker cortex with a greater number
of synapses would intuitively suggest a greater metabolic demand and a corresponding increase
of cerebral blood flow. Our data could resolve this conflict by providing insight into the sex
differences of the cerebrovascular system; we report our findings that the entire brain vascular
network in female mice contains proportionally greater capillary networks than do males
(Figure 5.4C). This discrepancy is likely caused by an elevated number of branching vessels
that are 6 μm in diameter in female mice (Figure 5.7F). However, in contrast to our integrated
parameterization of the whole brain, when we consider subregion-specific differences between
the sexes we encounter the opposite effect to variable degrees. This is best illustrated in our
analysis of the vasculature in the cingulate cortex, in which we observed males to have a greater
total length of capillaries than do females (Figure 5.8A). The increased capillary content in the
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cingulate cortex of male mice is likely sexually dimorphic and is the result of an underlying
difference in subregion activity (Lawal, Kern, Sanjeevi, Hofmann, & Shaker, 2005; Liu,
Zubieta, & Heitzeg, 2012). Furthermore, we find that within the sex, subregional
vascularization can be similar to other subregions. We interpret these observations to suggest
that brain subregions with similar vascular profiles may demonstrate commensurate activation.
Furthermore, similarities and dissimilarities of the vascular profile between subregions were
conserved in both female and male mice. Importantly, observing no differences in integrated
vascular parameters between the sexes does not indicate that the networks are homotopic. For
instance, in the primary somatosensory cortex, our analysis revealed a lack of differences in
total length of capillaries between the sexes (Figure 5.8A) indicating commensurate capillary
vascularization that intuitively suggests homotopic networks. However, when we analyzed the
branching properties of these networks we found a dissimilarity of vessel connectivity that
specifically propagated from capillaries with a diameter of 6 μm (Figure 5.7F) which indicates
incongruence of the deconstructed network and heterotopy of the capillary network.
Importantly, we observed cerebrovascular parameters that were similar regardless of
sex. These similarities provide us with information of a conserved network at the species level.
Analysis of vascular network organization and hierarchical involvement in the formation of
network connections demonstrated a precise relationship between parent vessel diameter and
number of branching vessels that were similar in both sexes (Figure 5.7F). This informs us that
network formation follows specific rules where its population of vessel components exist and
interact differently, and is governed by its hierarchical vessel diameter. Interestingly, we
observed two peaks in the distribution of number of branches by parent vessel diameter (Figure
5.7D). These peaks represented branches emanating from parent vessels with 4 and 6 microns
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diameters. Although, female mice were found to have a greater number of 6 microns vessel
branching, the distribution proportional to other parent vessel diameters was the same between
female and male mice. Parent vessels with diameters of 7 microns tended to be greater in
females. All other parent vessel diameters were nearly identical between female and male mice.
These observations are interpreted to imply that network formation has specific organization
where it follows a conserved set of rules that pertain to vessel diameter and connectivity.
Specific branching patters that follow a diameter-related organization may be physiologically
important for healthy hemodynamic function. It would be interesting to determine if changes
in these branching properties of vascular networks occurs during pathology.
The cerebrovascular system is a complex network of highly interconnected pathways
that maintain physiological hemodynamic states of blood delivery to support the perpetual
activity of neuronal transmission. The consistency and precision of the forces and amount of
blood delivery to the various brain regions is critical for normal information processing of
neurons (Douglas & Martin, 2004). Our analysis of whole brain network complexity supports
the notion that females more so than males demonstrate complex vascular organization. Fractal
dimension is a mathematical concept used to describe the complexity of self-similar structures.
In contrast to topological analysis, measuring fractal dimension provides an index that
quantitatively and qualitatively describes the difference of a structure’s space filling behavior
compared to an orthodox geometric structure. In vascular biology, analysis of fractal
dimension is used to measure network complexity (Cassot, Lauwers, Fouard, Prohaska, &
Lauwers-Cances, 2006; Lorthois & Cassot, 2010). The quasi-fractal structure of vascular
networks is produced by its hierarchical branching patterns (i.e. Figure 5.7B) that scale many
iterations to give rise to progressively smaller vessels (Lorthois & Cassot, 2010; Peyrounette,
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Davit, Quintard, & Lorthois, 2018). In this case, the term quasi-fractal is used to denote the
combination of fractal and non-fractal characteristics of vessel networks. For a greater
description of quasi-fractal geometry of vascular networks, see (Cassot et al., 2006; Lorthois
& Cassot, 2010; Smith et al., 2019). Our fractal analysis of the whole brain vasculature
indicated a fractal dimension of 2.6 ± 0.05 and 2.5 ± 0.06 in female and male mice,
respectively. Our observation is in agreement with the literature, reporting a fractal dimension
of 1.82 and 2.17 of the vasculature in subcortical and cortical areas, respectively (Cassot et al.,
2006). It is important to note, the relationship between space-filling properties of a structure’s
organization with its derived fractal dimension is a measure of the structure’s complexity in
terms of its self-similar repetitive nature and the degree of regularity to which its repeated
structure propagates through multiple scales. It is incorrect to assume that an object’s fractal
dimension and the relationship to space filling properties is a measurement of its density.
Qualitatively, the fractal dimension of a vascular structure gauges its branch patterns by
assessing the uniformity between its branches of like hierarchical order and the number of
branch levels the network produces (i.e. how extensive are the branches in the network and do
these branches resemble parent vessel morphology through multiple subsequent branch
levels?). Our data suggest that the branching properties in the female brain are more organized
and thorough, and are therefore more complex than in male mice.
Vascular network complexity can influence the outcome severity following an
ischemic event. Premenopausal women and intact female rodents sustain smaller infarctions
than males (Alkayed et al., 1998; Faber, Moore, Lucitti, Aghajanian, & Zhang, 2017). Some
studies argue that sex differences of ischemic stroke sensitivity are caused by gonadal
hormones (Manwani et al., 2015). During normal aging in females, sexually dimorphic
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capillary density and network organization may decline with gonadal hormones resulting in
increased sensitivity to ischemic injury. In menopausal women, collateral rarefaction ensues,
resulting in increased severity of ischemic injury (Li & Chi, 2011; Moore, Zhang, Maeda,
Doerschuk, & Faber, 2015). One study, comparing the number of collateral vessels in female
and male mice with the outcome of ischemic injury found no statistical difference in the
number of collateral vessels between the sexes while observing smaller infarct volumes in
female mice (Faber et al., 2017). Our data demonstrates a greater total number of capillaries,
more extensive capillary-capillary network, and smaller intervessel distances in female mice
than in male mice. In consideration of these findings, we argue that female mice have more
complex and robust vascular infrastructure that reduces ischemic sensitivity compared to male
mice. Moreover, microvascular density rather than number of collateral vessels may cause the
sex differences in sensitivity to ischemic injury.
We find the average parenchymal volume of the whole brain to differ between the
sexes, albeit non-significantly (p = 0.065). This comparison revealed females to have on
average a considerably greater volume of parenchyma than do males (Figure 5.3). In a study
by Hammelrath (2016), reported ongoing brain development in mice at three months of age,
including cortical flattening and increased myelination (Hammelrath et al., 2016). The study
demonstrated that the largest rate of myelination occurred by three months of age.
Unfortunately, the sexes of the mice used in the study were not reported. In others published
work, have demonstrated a wide discrepancy in the timing of brain development between
female and male rodents (Mengler et al., 2014). It is for these reasons, that we predict that the
differences we observed in the average parenchymal volume between female and male mice is
likely caused by temporal differences in brain development between the sexes. Specifically,
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female brain development may be temporally ahead of the development in males and since
brain volume continues to increase until around 2 months of age and myelination at around 3
months of age. Our measured parenchymal volume in mice of both sexes may have captured
two different stages of brain development.
The majority of the literature reporting the cerebral angioarchitecture employs
paradigms that utilize fluorescent dyes (Blinder et al., 2013; Lugo-Hernandez et al., 2017;
Zhang et al., 2018), chromatic dyes (Hasan, Herz, Hermann, & Doeppner, 2013; Xiong et al.,
2017; Xue et al., 2014), radio opaque solutions (Walker, Shen, Young, & Su, 2011), and
antibodies targeted against vascular epitopes (Park et al., 2014). The unifying limitations of
these methods are inadequate imaging depth and the tradeoff between resolution and field of
view. Light sheet microscopy (LSM) has become a popular platform for imaging large
samples. However, because LSM is an optical imaging method, the quality of the images
obtained is dependent on the fluorescence and transparency of the specimen. Mounting of
specimens for LSM is also problematic, to prevent shrinkage caused by drying, the specimen
must be either embedded or submerged without compromising the transparency of the
specimen or increasing signal-noise (Santi, 2011; Watkins & St Croix, 2018). Similar to other
fluorescence based imaging platforms, LSM is prone to image aberrations, blurring, scaling by
refractive index, autofluorescence, and signal degradation that progressively get worst with
acquisition time and imaging depth (Santi, 2011; Watkins & St Croix, 2018). To date, the
aforementioned

techniques

have

demonstrated

difficulty

imaging

the

complete

angioarchitecture of the entire brain. Reported in the literature indicate that investigators are
encountering complications of achieving perfusion of capillaries (Ghanavati, Yu, Lerch, &
Sled, 2014; Lugo-Hernandez et al., 2017; Pathak, Kim, Zhang, & Jones, 2011; Walker et al.,
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2011), observing broken vessel segments (Amato, Pan, Schwartz, & Ragan, 2016; LugoHernandez et al., 2017; Pathak et al., 2011; Walker et al., 2011), and incomplete vascular
networks (Amato et al., 2016; Ghanavati et al., 2014; Lugo-Hernandez et al., 2017).
A growing concern to all fields of research is our current technological limitations.
Large data sets are difficult to post-process and even more so to perform three-dimensional
quantitation and other complex algorithms for vascular network mapping and predictive
simulations. We describe a procedure for imaging the entire brain vasculature, producing a
single data set gigabytes in size.
We report a procedure to acquire volumetric data of the cerebrovasculature for threedimensional reconstruction and analysis of the whole brain in adult mice. Our analysis of the
whole brain reveled sex-related differences in vascular topology. These differences were
observed over the whole brain and varied by brain subregion. Overall, our study describes for
the first time, a whole brain analysis of the cerebrovascular network and provides fundamental
information for the advancement of vascular research.
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Supplemental Figure 5.1. Workflow of the procedure used to produce the
cerebrovascular corrosion casts. (A) Perfusion of the adult mouse brain. (B) Transcardial
perfusion via cannulated ascending aorta of the eluate, fixative, and casting resin at 160
mmHg. (C) Preprocessing of the vascular corrosion cast. (D) Decalcification, maceration,
washing, and osmium embedding of the vascular corrosion casts. (E) Processing of the
vascular corrosion cast for tomographic imaging. (F) Mounting and positioning of vascular
cast on pedestals. (G) Setup of Image acquisition routine for μ computerized tomographic
imaging of vascular corrosion cast.
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Supplemental Figure 5.2. Process flow diagram for brain vascular subregion
optimization by segmentation and centerline insertion. Specific brain subregions were
isolated into separate VOI image sets by 3-dimensional cropping of the primary data set.
The intensity of each VOI data set was normalized to the average intensity of all VOIs by
arithmetic adjustment. Standard deviation intensity projection of the image series was
created to aid in the co-registration of the data set to a specified orientation. The final coregistered image series produced a 500 x 500 x 500 um VOI readjusted to a pixel size of
1um. The VOI data set was duplicated to produce three identical sub-blocks. The first subblock was converted into a binary image series then used to extract the centerlines of
vessels. The second sub-block served as a mask to subtract the intensity of all regions above
165 in the third sub-block. Finally, the centerlines of the first sub-block is merged with the
third sub-block producing an image series with centerlines having a pixel intensity of 255
and vascular structures with a pixel intensity < 165.
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Supplemental Figure 5.3. The post-processing of image data sets causes no artifactual
alterations to vessel diameter or destruction of the native network architecture. The
maximum intensity projection of a data set depicting cortical vessels after post-processing
of an image by multiplication, unsharp mask, 3D Gaussian filter, maximum pixel intensity
cutoff, binarization, centerline extraction and final image composition. Line graph
demonstrating the linear pixel intensity profile (y-axis) across the entire diameter (x-axis)
of a vessel before (black circles) and after the post-processing (gray triangle) of image data.
The final version of the data set contains centerlines at a maximum pixel intensity of 255
while non-centerline pixel intensities are cut off at a maximum of 160.
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Supplemental Figure 5.4. Manual error corrections following an automated filament
trace function. Depiction of an erroneous gap (first panel, yellow) after automated filament
tracing resolved by manually joining (second panel) the segment together followed by
recalculating the diameter of the new portion of segment (third panel, yellow) from the
image data set. Final version of a vessel filament that was manually corrected for a gaperror (fourth panel) that appeared following the automated filament trace function.
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Supplemental Figure 5.5. Effect of image noise on the three-dimensional vascular
network reconstruction and analysis. Gaussian noise (top row) at a standard deviation of
35, 45, or 55, was artificially introduced into a 250 x 250 x 250 μm3 data set. The quality
of the generated filament structures (middle row) from each of the data sets was inspected.
The specific positioning of the reconstructed filaments for each data set can be seen by
overlay (bottom row). (A) Scatter plot of the measured filament diameters from each data
set containing elevated Gaussian noise as a function to the filament diameters of the
manually segmented and manually traced data set. Linear trend indicates agreement
between the measured filament diameters. R2 value indicates the strength of fit to the linear
model.
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2.1x106
2.4

1.1x108
43.1

1.4x106
1.5

μm3
μm

6.5x106

1.2x106

3.8x106

7.7x105

0.164
0.1
0.01

Parencymal Zones < 15 μm

3.2x104

6.5x103

2.4x104

2.7x103

n.r.

μm3
Count

5

4

5

4

0.04
0.01
0.18
0.14

Count
Segments
Connections
Cuts

Parencymal Zones > 15 μm
Network Composition, Vessels 6 μm
Euler Number
Connectivity Volue (Redundancy)

3.6x10
1835
361
587

3.0x10
490
67
134

2.5x10
1082
226
366

3.6x10
102
142
95

Supplemental Table 2. Analysis of the whole brain cerebrovasculature and in the somatosensory cortex in female and male
mice. Not reported = n.r..
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Abstract
Cardiovascular disease and its corresponding risk factors are positively correlated with
the incidence of AD. Cerebrovascular hypoperfusion and microvascular dysfunction are
common comorbidities in patients with Alzheimer’s disease (AD). Although there is ostensible
involvement of dysfunctional cerebrovasculature in AD pathophysiology, the characterization
of the specific changes, and the time-course of the development of vascular injury during AD
remains unclear. In the present study, we establish a time-course for the structural changes and
degeneration of the angioarchitecture with the age-related progression of AD. We used
cerebrovascular corrosion cast and μCT imaging to evaluate the geometry, topology, and
complexity of the angioarchitecture in the brain of wild type and triple transgenic AD mice.
We hypothesized that changes to the microvasculature could be identified during the early
stages of the disease progression. We predicted that these early identifiable changes to the
microvasculature would be more prominent in particular subregions of the brain that are
implicated in the cognitive decline of AD. We found age- and disease-related deficits of
cerebral blood flow in 3xTg AD mice. The whole-brain analysis of the angioarchitecture
indicated early structural abnormalities and degeneration of microvascular networks in 3xTg
AD. Our analysis of hippocampal and cortical subregions revealed microvascular degeneration
with onset and progression that was subregion dependent.
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Significance Statement
Cerebrovascular

hypoperfusion

and

hypometabolism

are

fundamental

neuropathological features of Alzheimer’s disease. This study demonstrates in a mouse model
of AD, age-related changes to the angioarchitecture over the whole-brain that occurred early,
before the onset of Aβ-plaque deposition and neurofibrillary tangles. Changes to the
cerebrovasculature dramatically affected the microvasculature over the whole-brain and in key
brain regions that are implicated in behavioral and cognitive deficits in AD. These results
revealed a critical period of cerebrovascular dysfunction and degeneration during early
presymptomatic stages of AD development. These findings provide a basis for development
of novel therapeutic strategies targeting early cerebrovascular changes and may provide a
prophylactic strategy for AD and indicate novel early biomarkers of the vasculature for
diagnosis of the disease.
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Introduction
Alzheimer’s disease (AD) is the most common form of dementia and is characterized
by progressive neurodegeneration and cognitive decline. Histopathological examination of the
postmortem brain from AD patients demonstrates parenchymal deposition of amyloid-β (Aβ)plaques and neurofibrillary tangles formed by hyper-phosphorylated tau, both of which are
neuropathological hallmarks of AD (Querfurth and LaFerla 2010; Castellani et al. 2010). The
contribution of Aβ deposition to the development and progression of AD has been a central
focus of AD research. Unfortunately, though many novel drugs targeting Aβ have entered
clinical trials, none have been successful at altering the trajectory of the disease.
Comorbidities of the cerebrovasculature are frequently reported in AD, as many as 92%
of patients diagnosed with AD also demonstrate ischemic lesions of the white matter that
resemble arteriosclerosis of small vessels (Rosenberg et al. 2016). It is well established that
regional hypoperfusion, hypometabolism, and blood-brain barrier disruption are common
pathological manifestations in patients with AD (de la Torre 2004; Brundel et al. 2012a;
Brundel et al. 2012b). Aβ is a potent vasoconstrictor (Thomas et al. 1996) and its production
has been associated with impaired endothelium-dependent regulation of cortical
microcirculation and aberrant functional hyperemia (Iadecola et al. 1999; Niwa et al. 2000).
In rodents, transient exposure to brain ischemia results in increased neuronal tau, APP
expression, and deposition of Aβ in the hippocampus and cortex (Iadecola 2004; Bailey et al.
2004). In addition, patients diagnosed with AD are at an increased risk for developing
hemorrhagic

stroke,

cerebral

microinfarctions,

spontaneous

cerebral

emboli,

and

microhemorrhages (Brundel et al. 2012a; Chi et al. 2013; Purandare and Burns 2009;
Tolppanen et al. 2013). Evidence from both clinical and animal studies has demonstrated that
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cerebrovascular impairment precedes the onset of neurodegeneration and progresses with agerelated cognitive decline and with dementia (de la Torre 2010; Jellinger 2010; Kalaria 2010;
Fischer et al. 1990; Kalaria and Hedera 1995), suggesting that vascular dysfunction to
participate in a causative manner in the emergence of AD.
Remarkably, 90% of patients with AD demonstrate cerebral amyloid angiopathy
(CAA), a neuropathological disease characterized by the deposition of amyloid-β on the walls
of cerebral vasculature (Janson 2015; DeSimone et al. 2017; Vinters 1987; Han et al. 2015).
Aβ deposition on the basement membrane of blood vessels promotes local inflammation, and
the activation of vascular endothelial cells, perivascular microglia, pericytes, and astrocytes
(Bailey et al. 2004; Vinters and Farag 2003; Farkas et al. 2001), which contribute to the
degradation of the vascular wall. In addition, Aβ accumulation at blood vessels causes vascular
smooth muscle cell (vSMC) degeneration (Van Nostrand et al. 2001), which together with the
weakened blood vessel wall can increase the risk for hemorrhagic stroke that is common in
patients with AD (Vinters and Farag 2003).
Despite demonstrations of strong evidence linking various pathology of the
cerebrovasculature with AD etiology, the precise timeline and extent of cerebrovascular
changes remain unclear, representing a critical barrier to research progress in the field. Data
collected using an innovative whole-brain cerebrovascular casting approach demonstrated for
the first time that 3xTg AD mice display functionally significant disruptions in the
cerebrovasculature that occur early in the disease time course and preceded the accumulation
of AD neuropathological hallmarks such as Aβ.
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Materials and Methods
Animal Usage
Procedures performed in this study that involved the use of laboratory animals were
carried out in accordance with the National Institutes of Health guide for the care and use of
laboratory animals (NIH Publication No. 8023, revised 1978) and in compliance with the
ARRIVE guidelines. For the purposes of this study, we used the male B6; 129-Tg (APPSwe,
tauP301L) 1Lfa Psen1tm1Mpm/Mmjax [RRID:MMRRC_034830-JAX] (3xTg AD) mouse
model of Alzheimer’s disease and the B6129SF2/J (wild type, WT) mouse strains from the
Mutant Mouse Resource and Research Center (MMRRC) at The Jackson Laboratory. To study
the effects of aging, experiments were performed on these mice at 3-months (WT n = 4, 3xTg
AD n = 5), 6-months (WT n = 7, 3xTg AD n = 5), 12-months (WT n = 5, 3xTg AD n = 4), and
24-months (WT n = 5, 3xTg AD n = 4) of age. Power analysis for ANOVA designs indicated
a sample size of 4 mice per group (power = 0.999) for an effect size of Δ = 1.25. Mice were
maintained under a light/dark cycle (12 h : 12 h) with food and water available ad libitum at
West Virginia University vivarium.

Measurement of Cerebral Blood Flow
Mice were deeply anesthetized with 4% isoflurane and maintained with 2% isoflurane
diffused into a 30% oxygen and 70% nitrogen mixture. Mice were placed on a feedback
controlled heating pad to maintain the body temperature at 37 °C. Ophthalmic ointment was
placed on each eye; then the surgical area was prepared by removing the fur and sanitizing the
skin at the surgical site with isopropanol and betadine. A 1.0 cm incision was made on the
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scalp of each mouse. The skin was retracted to expose the skull and cleaned with a cotton swab.
Ten consecutive measurements of cerebral blood flow (CBF) were acquired with a MoorFLPI
laser speckle flowmeter (Moor Instruments, England) over the course of 5 minutes with an
exposure of 200 ms. After CBF measurements were acquired, the incision was closed by
suturing (Quintana et al. 2018).

Vascular Corrosion Casts
For a detail description of the procedure used to prepare cerebrovascular corrosion
casts, please refer to our previous report (Quintana et al. 2019). Briefly, mice were deeply
anesthetized with 4% isoflurane diffused into a 30% oxygen and 70% nitrogen mixture. After
confirming anesthetization via tail pinch, mice received an intraperitoneal injection of 25U
heparin in 250 μl saline intravenous solution. Mice were then transcardially perfused at 160
mmHg with 0.01M phosphate buffered saline (PBS) containing 25U/mL of heparin followed
by 4% paraformaldehyde (PFA) in 0.01M PBS at physiological pH. The polyurethane (PU4ii,
VasQtec) cast solution was prepared by adding 5 g (ℓ) of polyurethane resin with 3 g (ℓ) of
methyl ethyl ketone containing

approximately 10 mg of blue pigment. Shortly before

perfusion of the cast resin, 0.8 g (ℓ) of polyurethane hardener was added to the solution then
immediately perfused into mice at 160 mmHg. Resin perfused mice were kept at room
temperature for 4 hours to facilitate the hardening of the polyurethane resin.

272

Vascular Corrosion Cast Processing
Perfused mice were decapitated and the skin was removed from the skull with
dissecting scissors. The isolated skull was decalcified by immersion in 20 mL of 8% formic
acid diluted in Milli-Q water for 5 h at 37 °C. After decalcification, the skull was rinsed with
distilled water then immersed in 20 mL of potassium hydroxide solution diluted in Milli-Q
water for 4 h at 37 °C. The skull was rinsed with distilled water and the brain carefully extracted
with a pair of iris scissors and forceps. The extracted brain was macerated by immersion into
20 mL of 8% potassium hydroxide diluted in Milli-Q water at 37 °C overnight. Macerated
tissue was removed from the cerebrovascular cast by several washes with Milli-Q water, until
only the casted vessels remained. At this point, the clean cerebrovascular cast was lyophilized
with a benchtop freeze dryer system (Labconco) operating at -54 °C and a vacuum pressure of
0.0025 mBar. To enhance the radio opacity of the cerebrovascular casts, 6 mL solution of 2%
osmium tetroxide diluted in Milli-Q water was embedded onto the polyurethane cast by
immersion overnight at 4 °C. Osmium embedded casts were mounted with cyanoacrylate
adhesive on custom-made hexagonal pedestals cut from Plexiglas.

Micro-computerized Tomographic Imaging
Tomographic images of the vascular network of the whole brain were acquired using a
SkyScan 1272 μCT (Bruker) operating at 35 kV and 200 μA with no filter and a frame size of
4032-by-2686. Acquisition parameters were as follows, a pixel size of 2 μm, and exposure
settings that produce a maximum transmission of 35-40%, minimum of 80-90%, and an
average of 65-75% through the sample. Tomographic images of each vascular cast were
acquired over the total 360° of the sample at a step size of 0.05°, and averaged by 5 images per
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rotation step. Before further processing, each dataset was corrected for misalignments, beam
hardening, and ring artifacts then converted into a coronal image series. Each acquisition
routine produced 7200 projection images and 4032 images in coronal series.

Anatomical Selection of Volume of Interest
Datasets containing the whole brain vasculature in coronal series were accessed on
CTan (Bruker) to isolate the volume of interest (VOI). Guided by the Allen Mouse Brain Atlas
(Lein et al. 2007), VOIs over the medial orbital prefrontal cortex (MO PFC), somatosensory
cortex (SS CTX), cingulate cortex (CC), entorhinal cortex (ENT CTX), dentate gyrus (DG)
and hippocampal CA1 and CA3 were located and selected by tracing. The traced regions were
made in square selections of approximately 1.5 mm and dynamically interpolated in the Z
direction for 1.5 mm. These selected VOIs were converted into a BMP formatted series and
saved as pre-processed VOIs.

Image Processing and Optimization for Volume of Interest
For a detailed description of VOI dataset optimization please refer to our previous
report (Quintana et al. 2019). Briefly, VOI datasets were optimized for further image analysis
using ImageJ (NIH). Each VOI was cropped in three-dimensions to 500 x 500 x 500 (MO PFC,
SS CTX, ENT CTX, CA1, and CA3) or 400 x 400 x 400 (CC and DG) then rotated so that a
preselected landmark was co-registered by rigid transformation across all datasets. For each
dataset, the image series was duplicated and saved as TIFF formatted images. With the 3D/2D
skeletonization plugin on ImageJ, the first duplicated dataset was used to produce centerlines
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of the vascular structures. The second duplicated dataset was filtered by maximum pixel
intensity of 160 to produce a dataset with pixel intensities 160 and below. Finally, both image
series containing the vessel centerlines and capped pixel intensity were merged so that the final
dataset contains vessel structures composed of pixel intensities 160 and below and centerlines
of vessels at an intensity of 255.

Vascular Network Analysis
Datasets were analyzed with Imaris (Bitplane) software. Vascular networks were
identified and quantified with the Imaris Filament Trace function using the automatic filament
and path detection algorithm. Filament trace approximates the diameter of blood vessels in a
volumetric data set by calculating the diameter of the largest sphere that fits within the cross
sectional area of a vessel segment. We used the Loops algorithm and automatic threshold
during the tracing procedure for an accurate identification of circular pathways between vessel
segments. Traced networks were automatically re-centered to the centerlines of the vascular
structures that were inserted into the volumetric dataset in each VOI. The identified vascular
networks were manually inspected for errors that occurred during the tracing process before
measurements were generated from the mapped vessel network(s). These measurements
included vessel diameter, length, volume, area, tortuosity, branch level, and angle in degrees.

Experimental Design and Statistical Analysis
Power analysis for ANOVA designs indicated a sample size of 4 mice per group (power
= 0.999) for an effect size of Δ = 1.25. To study the effects of aging and disease on the
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cerebrovasculature over the whole-brain, analyses were performed on mice at 3-months (WT,
n = 4; 3xTg AD, n = 4), 6-months (WT, n = 3; 3xTg AD, n = 4), 12-months (WT, n = 4; 3xTg
AD, n = 3), and 24-months (WT, n = 4; 3xTg AD, n = 4) of age. Analyses of the
cerebrovasculature in specific brain regions were performed on mice at 3-months (WT, n = 4;
3xTg AD, n = 5), 6-months (WT, n = 7; 3xTg AD, n = 5), 12-months (WT, n = 5; 3xTg AD, n
= 4), and 24-months (WT, n = 5; 3xTg AD, n = 4). All values are presented as mean ± SEM
for all data provided. All statistical analyses were performed on GraphPad Prism 8.4.2. The
planned comparison for all data were the effects of genotype at each age. Before performing
planned comparisons, 2-way ANOVA analyses of Genotype by Age were used to qualify the
data from each of the experimental measurements. Details of each 2-way ANOVA, including
degrees of freedom, F-values, and p-values are reported in the Results section of the text. To
compare means, significant 2-way ANOVAs were probed for effects of Genotype with planned
student’s t-test at each age. All student’s t-tests are two-tailed unless specified. Analysis of
trend was performed with linear regression analysis. Details of each linear regression analysis,
including R2-values and p-values are reported in the Results section of the text. Values of p <
0.05 were considered as significant.

Results
We have reported previously a procedure for the acquisition and analysis of the entire
brain cerebrovascular system at a microvessel-relevant resolution, to provide a detailed
characterization of the morphological and topological properties of vessels and their networks
(Quintana et al. 2019). In the present study, we use vascular corrosion casts to acquire data
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from complete networks of cerebral blood vessels in a state that preserves native connectivity.
We performed an in-depth analysis of the cerebrovasculature in WT (n = 20) and 3xTg AD (n
= 20) mice by assessing the function, morphology, topology, and complexity of vascular
networks over the entire brain then focused on prominent brain regions critically affected
during the progression of AD (Figure 6.1). Indeed, geometric characterization of the
vasculature has provided valuable insight for identifying fundamental, yet broad changes to
the cerebrovasculature during age and AD. However, these broad changes may only be
detectable when the pathology of the cerebrovascular system is severe. It is likely that early
changes to the organization of the vascular network cause dysregulated functional connectivity
before the onset of detectable changes to broad parametric properties such as volume density
of cumulative length. It is firmly accepted that with the progression of AD, the development
of vascular dysfunction is at increased risk (Santos et al. 2017). It is unknown whether the
3xTg AD mouse line manifests functional deficits and degeneration of the vasculature that is
similar to human patients with the disease. Therefore, our first goal was to determine if the
3xTg AD mouse line developed functional deficits in cerebral blood flow during aging and
disease progression.
The mice used in this study were 3.0 ± 0.5, 6.0 ± 0.3, 12 ± 0.6, and 24 ± 0.6 months of
age and had an average body temperature of 35.9 ± 0.8 °C. Systolic (F(3,49) = 5.969, p =
0.0015, 2-way ANOVA) and diastolic (F(3,49) = 36.71, p < 0.0001, 2-way ANOVA) blood
pressure fell within physiological range (Whitesall et al. 2004; Wilde et al. 2017). There were
no group differences in blood pressure between WT and 3xTg AD mice at either 3- nor 6months of age. However, at later ages, both systolic (12-months, t(12) = 2.41, p = 0.01, t-test;
24-months, t(16) = 5.99, p < 0.0001, t-test) and diastolic (12-months, t(12) = 3.31, p = 0.001,
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Figure 6.1. The cerebrovasculature in 3xTg AD mice develops pathology.
Reconstructed cerebrovascular corrosion cast in three-dimensions, color-coded by vessel
diameter of (A) whole brain, (B-E) cortex, and (F) hippocampus. Color-coded penetrating
arteriole demonstrating (B) normal morphology compared to a (C and D) tortuous vessel
from a 3xTg AD mouse. Color-coded vasculature demonstrating (D) arteriolar aneurysm
and (E and F) capillary aneurysm from 3xTg AD mice.
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t-test; 24-months, t(16) = 13.58, p < 0.0001, t-test) blood pressure were lower in 3xTg AD
mice compared to age-matched WT mice (Figure 6.2A and B). The mean arterial pressure
(MAP) is the perfusion pressure that facilitates the delivery of blood to the brain. Inadequate
MAP can result in ischemia to the brain and other organs (Wehrwein and Joyner 2013). Mean
arterial pressure is determined by cardiac output during systole and the net driving force of
blood back to the heart during diastole. MAP (F(3,49) = 5.711, p = 0.002, 2-way ANOVA) was
lower in 3xTg AD mice at 12-months (t(12) = 2.0, p = 0.05, t-test) and 24-months (t(16) =
5.77, p < 0.0001, t-test) of age compared to age-matched WT mice (Figure 6.2C). Although,
we observed only a small reduction in heart rate (F(3,49) = 1.935, p = 0.13, 2-way ANOVA) at
3-months in 3xTg AD (t(14) = 2.27, p = 0.02, t-test) compared to WT mice, we found no
change at 6-, 12- and 24-months of age (Figure 6.2D).

Cerebrovascular hypoperfusion occurs early and progresses with age in 3xTg AD mice
It is well documented that deficits in CBF occur in patients with AD (Thomas et al.
2015; Love and Miners 2016; Dong et al. 2018; Shi et al. 2019; Daulatzai 2017; Göttler et al.
2019; Zhai et al. 2016; Marrif and Juurlink 1999; Verclytte et al. 2016). However, it is yet
unknown whether these deficits occur in 3xTg AD mice and if so, when these deficits take
place during the disease. We measured global CBF (F(3,45) = 4.095, p = 0.01, 2-way ANOVA)
in 3-, 6-, 12-, and 24-month male WT and 3xTg AD mice using laser speckle flowmetry (Figure
6.2E). We found that deficits in CBF began early and progressed with age in 3xTg AD mice.
At 3-months of age, 3xTg AD mice demonstrated similar CBF (t(12) = 1.45, p = 0.15, t-test)
to age-matched WT mice. However, at 6-months of age, 3xTg AD mice demonstrated a deficit
of CBF (t(11) = 3.54, p = 0.0009, t-test) relative to age-matched WT mice (Figure 6.2F). We
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found that the CBF deficit in 3xTg AD mice persisted at 12-months (t(15) = 3.70, p = 0.002,
t-test) and also at 24-months (t(12) = 5.99, p < 0.0001, t-test) of age (Figure 6.2F).

Whole-brain analysis revealed early structural changes to the angioarchitecture occur
before the onset of vascular degeneration in 3xTg AD mice
Our first goal was to characterize the extent of vascular disruption over the whole brain
with age and the progression of AD. To evaluate the evolution of the structural changes to the
angioarchitecture, we calculated the overall means of the geometric properties over all vessels
of the brain. Morphometric analysis of the vasculature over the entire brain indicated that the
average vessel diameter at 3-months (t(7) = 1.897, p = 0.05, t-test) and 6-months (t(6) = 2.310,
p = 0.03, t-test), but not at 12- (t(6) = 0.135, p = 0.4, t-test) and 24- (t(7) = 1.234, p = 0.13, ttest) months were statistically different between the two genotypes (Figure 6.3A). A change to
the average vessel diameter may indicate a compensatory adaptation of the vascular network,
likely caused by either chronic injury to vessels or via disrupted angiogenesis.
Arborization of the vasculature is achieved by the growth of new vessel segments. With
the growth of new segments, vascular density increases, enhancing the exchange of waste and
nutrients with the surrounding tissue. Therefore, we quantified the total number of vessel
segments (F(3,22) = 17.53, p < 0.0001, 2-way ANOVA) of the whole brain and found early
changes to the number of segments in 3xTg AD mice that began at 6-months of age. At 6months of age, the cerebrovascular network in 3xTg AD mice was composed of a greater
number of vessel segments (t(6) = 2.476, p = 0.02, t-test) than in age-matched WT mice (Figure
6.3B). The total number of vessel segments in 3xTg AD mice remained increased (t(6) = 2.222,
p = 0.04, t-test) at 12-months of age. Interestingly, at 24-months of age, the total number of
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Figure 6.2. Progressive decline in cerebral blood flow in 3xTg AD mice. Bar graph(s)
(mean ± SEM) with individual data points depicting (A) systolic, (B) diastolic, (C) mean
arterial blood pressure, and (D) heart rate in 3- (WT, n = 5; 3xTg AD, n = 10), 6- (WT, n =
5; 3xTg AD, n = 7), 12- (WT, n = 5; 3xTg AD, n = 8), and 24- (WT, n = 8; 3xTg AD, n =
5) month mice. Cerebral blood flow (E) color coded by mean flux value in WT and 3xTg
AD mice. Bar graph (mean ± SEM) depicting cerebral blood flow as percentage of agematched control from 3- (WT, n = 5; 3xTg AD, n = 8), 6- (WT, n = 5; 3xTg AD, n = 6), 12(WT, n = 5; 3xTg AD, n = 9), and 24- (WT, n = 5; 3xTg AD, n = 8) month mice. To compare
means, significant 2-way ANOVAs were probed for effect of Genotype with planned
student’s t-test at each age (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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vessel segments in 3xTg AD mice was substantially lower (t(7) = 6.806, p = 0.0005, t-test)
than the number of segments recorded in age-matched WT mice (Figure 6.3B).
These data support the notion that early changes to the cerebrovasculature are driven
by compensatory adaptations to the network composition in response to chronic vascular injury
associated with the disease. An essential physical property of blood vessels is the surface area
they possess. The total surface area a vascular network possesses is directly proportional to the
efficacy of solute exchange between the parenchyma and peripheral circulation. Regression
analysis of the total surface area (F(3,22) = 4.882, p = 0.009, 2-way ANOVA) of all vessels
revealed a linear trend that decreased with age in 3xTg AD mice (R2 = 0.55, p = 0.0013),
whereas the linear trend in WT mice increases with age (R2 = 0.29, p = 0.036). The total surface
area of vessels was most affected at 24-months in 3xTg AD mice. At this age, the complete
cerebrovascular network provided a total surface area that was substantially less (t(7) = 3.867,
p = 0.0008, t-test) in 3xTg AD mice than in age-matched WT mice (Figure 6.3C).
Given these findings, since the majority of the surface area is provided by the
microvasculature (Gould et al. 2017), we interpret these data to suggest that the age-dependent
changes to the cerebrovasculature of 3xTg AD mice are largely driven by microvascular
degeneration. In order to determine the extent of vascular degeneration in 3xTg AD mice, we
measured the total vascular volume of the entire brain with age. We found no early differences
in the total volume occupied by vessels between the genotypes (Figure 6.3D). However, a
regression analysis of these changes revealed an age-dependent reduction of volume in 3xTg
AD mice (Figure 6.3D). In contrast, WT mice demonstrated a pattern of vessel volume that
increased with age. When we compared means between genotypes, the total volume of vessels
(F(3,22) = 4.621, p = 0.01, 2-way ANOVA) was concordant at 3- (t(7) = 0.84, p = 0.35, t-test),
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6- (t(6) = 0.59, p = 0.14, t-test), and 12- (t(6) = 0.29, p = 0.15, t-test) months of age in 3xTg
AD and age-matched WT mice. At 24-months of age, 3xTg AD mice demonstrated a marked
reduction of the total volume occupied by vessels (t(7) = 3.84, p = 0.0009, t-test) compared to
age-matched WT mice (Figure 6.3D). These data support the notion that early structural
changes to the organization of the cerebrovasculature occur before the onset of large-scale
changes, which may result in vascular degeneration.
We measured the average intervessel distance in three-dimensions as a proxy to assess
the adequacy of vascularization. We found intervessel distance (F(3,22) = 28.34, p = 0.0001,
2-way ANOVA) to be a profoundly compromised property of the angioarchitecture in all ages
of 3xTg AD mice (Figure 6.3E). At 3-months of age, the average distance between vessels was
larger (t(7) = 6.40, p < 0.0001, t-test) in 3xTg AD mice than in WT mice. Increased intervessel
distance in 3xTg AD mice was also evident at 6-months (t(6) = 7.13, p < 0.0001, t-test) and to
12-months (t(6) = 4.01, p = 0.0006, t-test) of age compared to age-matched WT mice.
Interestingly, we found that by 24-months, intervessel distance (t(7) = 4.86, p < 0.0001, t-test)
was reduced in 3xTg AD mice than WT mice (Figure 6.3E). Regression analysis revealed that
intervessel distance is inversely associated with age in 3xTg AD mice (R2 = 0.64, p = 0.003)
while positively associated with age in WT mice (R2 = 0.82, p < 0.0001). These data indicate
an early deficit of vessel density that persists to later stages of progression in 3xTg AD mice.

Topological analysis of the vascular network over the whole brain revealed disrupted
network organization in 3xTg AD mice that progresses with age
Since morphometric analyses of the angioarchitecture provided evidence of early
structural changes to the vasculature that preceded loss of vessels, we assessed the topology of
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the vascular network over the entire brain. We used a topological analysis to evaluate the
organization and complexity of the vascular network with age. We first examined the
connectedness of the vascular network. Consistent with the literature (Gross 2006; Sheth and
Liebeskind 2014), we observed a dense network of vessels with elevated pathway redundancy
in both WT and 3xTg AD mice at all ages.
We used an algorithm to calculate the Euler number and pathway redundancy of the
vascular network in three-dimensions. The Euler number is calculated based on the
classification of several morphological events: islands, bridges, and holes. We first quantified
the number of connections in the vascular network by counting vessel-to-vessel junctions
(F(3,22) = 10.96, p = 0.0002, 2-way ANOVA) within the entire brain. At 6-months of age, the
number of vessel junctions in 3xTg AD mice were greater (t(6) = 2.72, p = 0.05, t-test) than
the number of junctions in WT mice. While we observed no difference in the number of
connections at 12-months (t(6) = 0.74, p = 0.46, t-test) between genotypes, by 24-months of
age, the total number of connections in 3xTg AD mice were lower (t(7) = 5.61, p < 0.0001, ttest) than those in WT mice (Figure 6.3F).
The cerebrovascular network provides a profound number of redundant pathways for
the delivery of blood to any given region. These redundant pathways maintain perfusion by
providing an alternate route to communicate shunted blood to a particular region. These
collateral pathways for blood flow lend to the resilience of the network to maintain adequate
blood delivery during an event of a pathway communicating blood becomes compromised. We
next evaluated the redundancy of pathways (F(3,22) = 3.694, p = 0.02, 2-way ANOVA) within
the vascular network by calculating the connectivity value and compared this across genotype.
The connectivity value is topologically defined as the maximum number of cuts that can be
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performed on a network before splitting into two isolated subnetworks (Nyengaard 1999).
Regression analysis of pathway redundancy indicated an inverse correlation (R2 = 0.32, p =
0.02) with age in 3xTg AD mice. In contrast, pathway redundancy in WT mice correlated
positively (R2 = 0.17, p = 0.15) with age. Connectivity analysis indicated an elevated (t(7) =
2.37, p = 0.03, t-test) number of redundant pathways in 3xTg AD mice at 3-months of age.
These pathways remained elevated (t(6) = 2.25, p = 0.05, t-test) in 3xTg AD mice relative to
WT mice at 6-months of age. Interestingly, these differences were absent at 12-months (t(6) =
1.37, p = 0.18, t-test) and 24-months (t(7) = 1.27, p = 0.21, t-test) of age (Figure 6.3G).
We next evaluated the complexity of the vascular network with age and progression of
AD. We used Kolmogorov box counting method for fractal dimensions (Quintana et al. 2019)
and found that the complexity of the vascular network progressively declines with the
progression of age in 3xTg AD mice whereas in WT mice partially increases with age. The
fractal dimension of a vascular structure quantitatively evaluates its branching patterns and
their space-filling ability by assessing the relationship between its branches of like hierarchical
order and the number of levels the network branches. Analysis of fractal dimension value
(F(3,22) = 10.53, p = 0.0002, 2-way ANOVA) indicated no difference between the two
genotypes at 3-months of age. However, at 6-months of age, the complexity of the vascular
network of 3xTg AD mice was greater (t(6) = 2.96, p = 0.007, t-test) than of age-matched WT
mice. Following 6-months, the vascular network complexity of 3xTg AD mice begins to trend
downward with age (R2 = 0.79, p = 0.0002) whereas in WT mice, network complexity trends
upward with age (R2 = 0.39, p = 0.05) (Figure 6.3H). By 24-months of age, network complexity
in 3xTg AD mice was severely compromised (t(7) = 4.42, p = 0.0002, t-test) when compared
to age-matched WT mice (Figure 6.3H).
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Age and disease related changes to vessel hierarchy over the whole brain occur in 3xTg
AD and WT mice
Specific differences at the level of vessel hierarchy may exist between age and
genotype. We generated thickness maps of all vessels of the brain to classify and analyze
vascular volume as a function of vessel diameter. Such that, the sum volume is calculated for
all vessels of each successive diameter. We found that the distribution of vessel volume in
3xTg AD mice demonstrated large changes that occurred with age and the progression of the
disease (Figure 6.3I – L). The distribution of vessels as a function of diameter depicted that the
largest changes between genotypes per age was accounted for by vessels with an average
diameter between 2 – 40𝜇𝑚 (Figure 6.3I-L). When we compared the mean volume per vessel
diameter between the two genotypes at each age we found that vessels with an average
diameter between 2 – 20𝜇𝑚 appeared to decrease with age in 3xTg AD mice whereas in WT
mice, these vessels increased with age (Figure 6.3M-P). Interestingly, 3xTg AD mice
demonstrated an early increase (F(7,40) = 6.0, p < 0.0001, 2-way ANOVA) of vessels with an
average diameter between 2 – 20μm at 3-months of age. This observation was also seen at 6months of age (F(7,40) = 10.97, p < 0.0001, 2-way ANOVA), relative to age matched WT mice
(Figure 6.3M and N). However, by 12-months of age, vessels with an average diameter
between 2 – 20μm was not significantly different (F(7,40) = 1.99, p = 0.08, 2-way ANOVA)
between the two genotypes and remained indifferent (F(7,40) = 1.49, p = 0.19, 2-way ANOVA)
by 24-months of age (Figure 6.3O and P). Furthermore, larger vessels with an average diameter
between 20 – 40μm were reduced at later ages in 3xTg AD mice. Although we found no
difference in the population of larger vessels at 3- and 6-months of age, we observed reduced
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Figure 6.3. Brain-wide vascular degeneration in 3xTg AD mice that progresses with
age. Bar graph(s) (mean ± SEM) depicting (A) average vessel distance, (B) number of
vessel segments, (C) total surface area, (D) total vascular volume, (E) intervessel distance,
(F) number of junctions, (G) network redundancy, and (H) fractal dimension from 3- (WT,
n = 4; 3xTg AD, n = 4), 6- (WT, n = 3; 3xTg AD, n = 4), 12- (WT, n = 4; 3xTg AD, n = 3),
and 24- (WT, n = 4; 3xTg AD, n = 4) month old mice. Line graph(s) (mean ± SEM)
depicting total vascular volume as a function of average vessel diameter from (I) 3- (WT, n
= 3; 3xTg AD, n = 4), (J) 6- (WT, n = 3; 3xTg AD, n = 4), (K) 12- (WT, n = 4; 3xTg AD,
n = 3), and (L) 24- (WT, n = 4; 3xTg AD, n = 4) month old mice. Bar graph(s) (mean ±
SEM) depicting expanded data denoted by the box inserts (M-P). To compare means,
significant 2-way ANOVAs were probed for effects of Genotype with planned student’s ttest at each age or vessel diameter (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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vessels with an average diameter with 20 – 40μm by 24-months of age in 3xTg AD mice
relative to WT mice.
These data indicate that the cerebrovascular network in 3xTg AD mice undergo an
early vascularization by 3-months of age then begin to progressively decline by 12-months of
age (Figure 6.4). To better demonstrate these changes with age, we measured the total volume
of capillaries and non-capillaries for both genotypes at each age. Regression analysis revealed
an age-associated decline (R2 = 0.53, p = 0.002) of the total capillary volume in the brain of
3xTg AD mice, whereas in WT mice, the total capillary volume increased with age (R2 = 0.47,
p = 0.006). When we compared means across genotype per age group (F(3,21) = 6.41, p =
0.003, 2-way ANOVA), we found that by 3-months the total volume of capillaries was increased
(t(6) = 3.84, p = 0.01, t-test) in 3xTg AD mice compared to age-matched WT mice (Figure
6.4A). The total capillary volume remained elevated (t(6) = 3.70, p = 0.01, t-test) by 6-months
in 3xTg AD mice, relative to age-matched WT mice (Figure 6.4A). By 12-months of age, the
total volume of capillaries in 3xTg AD mice did not differ (t(6) = 1.70, p = 0.14, t-test) from
that in age-matched WT mice. At 24-months of age the total volume of capillaries was lower
(t(7) = 2.37, p = 0.05, t-test) in 3xTg AD mice compared to age-matched WT mice (Figure
6.4A).
Similarly, regression analysis of the total volume of non-capillaries revealed an ageassociated decline (R2 = 0.76, p < 0.0001) in 3xTg AD mice, whereas in WT mice, the total
volume of non-capillaries increased with age (R2 = 0.15, p = 0.15). When we compared means
across genotype at each age group (F(3,21) = 6.29, p = 0.003, 2-way ANOVA), we found no
significant difference at 3- (t(6) = 1.79, p = 0.06, t-test) and 6-months (t(6) = 0.17, p = 0.43, ttest) months of age (Figure 6.4B). However, at 12-months of age, the total volume of non-
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capillaries was reduced (t(6) = 1.98, p = 0.05, t-test) compared to WT mice and continued to
decline (t(7) = 3.14, p = 0.009, t-test) by 24-months of age (Figure 6.4B).

Cerebrovasculature of the hippocampal formation during ageing and the progression of
AD
We next evaluated the angioarchitecture of the hippocampal formation by measuring
the composition and topology of the vascular network in order to characterize regional
pathology to the vasculature network of the hippocampus and to establish a time-course for the
onset and progression of vascular disruption in 3xTg AD mice.
The hippocampus develops age-dependent neuropathy in 3xTg AD mice (Billings et
al. 2005; Oddo et al. 2003b; Oddo et al. 2003a; Giménez-Llort et al. 2007; España et al. 2010)
and is the first region of the brain to develop Aβ-plaque (Oddo et al. 2003b; Oddo et al. 2003a).
Furthermore, the hippocampus is a major region of the brain for the deposition of Aβ in hAPPJ20, APP/PS1, and 3xTg AD mice (Oddo et al. 2003a; Oddo et al. 2003b; Whitesall et al.
2004). To characterize the region-specific and age-associated, disease-related pathology to the
vascular network of the hippocampus, we analyzed the angioarchitecture in subfield(s) CA1,
CA3 and DG of the hippocampus proper and the ENT CTX of the hippocampal formation in
3xTg AD and WT mice.
Our initial assessment consisted of morphometric analyses of all vessels to evaluate the
breadth of vessel branching (vessel segment count and number of vessel-to-vessel junctions),
regional vascularization (total vessel volume and vessel surface area), and network efficacy
(intervessel distance). We found that changes to the angioarchitecture in the hippocampus
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Figure 6.4. Topological analysis of the cerebrovasculature of the entire brain describes
changes that progress with age in 3xTg AD mice. Reconstructed cerebrovascular
corrosion cast, color-coded by vessel diameter from a 3-month and 12-month WT and 3xTg
AD mouse. (A) The total volume of capillaries and (B) non-capillaries in WT and 3xTg AD
mice at 3- (WT, n = 3; 3xTg AD, n = 4), 6- (WT, n = 3; 3xTg AD, n = 4), 12- (WT, n = 4;
3xTg AD, n = 3), and 24- (WT, n = 4; 3xTg AD, n = 4) months of age. To compare means,
significant 2-way ANOVAs were probed for effects of Genotype with planned student’s ttest at each age (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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occurs early, at 3-months of age (Figure 6.5), prior to the development of Aβ-plaques in 3xTg
AD mice (Oddo et al. 2003a; Oddo et al. 2003b; Whitesall et al. 2004). Morphometry of the
vasculature at the age of 3-months indicated that the earliest changes to the angioarchitecture
consisted of a significantly reduced number of vessel segments in the CA1 (t(8) = 2.65, p =
0.01, t-test) and CA3 (t(8) = 2.05, p = 0.005, t-test) hippocampal subfield(s) and a significantly
reduced number of vessel-to-vessel junctions in the CA1 (t(8) = 2.77, p = 0.01, t-test), CA3
(t(8) = 2.32, p = 0.02, t-test), and DG (t(8) = 2.25, p = 0.05, t-test) subfield(s) (Figure 6.5AH). However, these differences diminished by 6-months and throughout age, whereas the total
volume occupied by all vessels (Figure 6.5I-L) and the total surface area of all vessels (Figure
6.5M-P) significantly reduced, while the intervessel distance (Figure 6.5Q-T) significantly
increased by 6-months and progressed with age. Furthermore, we found that the
angioarchitecture of the ENT CTX to be weakly affected with age in 3xTg AD mice. Thus, we
interpret these measurements to suggest that early deficits in vessel branching occur before the
onset of age-associated progression of vessel loss at 6-months of age.

Age and disease-related changes specific to vessel hierarchy occur in the hippocampus of
3xTg AD mice
We next sought to extrapolate on the differences obtained by morphometric and
geometric analysis of the vasculature to determine if these genotypic differences were a result
of changes to vessels of a specific hierarchy. Therefore, by mapping the total length of vessels
as a function of average vessel diameter, we searched for genotypic differences in the
summated length of vessels per vessel diameter. We observed in 3xTg AD mice at 3-months,
a major deficit of microvessels in the CA1 (Figure 6.6C), CA3 (Figure 6.6D), and DG
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Figure 6.5. Vascular network analysis of the hippocampus indicates early and agedependent changes to the vasculature in 3xTg AD mice. Bar graph(s) (mean ± SEM)
depicting (A-D) number of vessel segments, (E-H) number of vessel junctions, (I-L) total
vascular volume, (M-P) total vascular surface area, and (Q-T) intervessel distance from 3(WT, n = 4; 3xTg AD, n = 5), 6- (WT, n = 7; 3xTg AD, n = 5), 12- (WT, n = 5; 3xTg AD,
n = 5), and 24- (WT, n = 6; 3xTg AD, n = 3) month WT and 3xTg AD mice. To compare
means, significant 2-way ANOVAs within each brain region were probed for effects of
Genotype with planned student’s t-test at each age (*, p < 0.05; **, p < 0.01; ***, p <
0.001).
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(Figure 6.6G) subfield(s) but not in the ENT CTX (Figure 6.6H). By 6-months, microvascular
deficits worsened in the CA1 (Figure 6.6C) and persisted in the CA3 (Figure 6.6D)
subregion(s) in 3xTg AD mice. In contrast, vessels with diameters larger than capillary caliber
were considerably elevated in the CA1 (Figure 6.6C), CA3 (Figure 6.6D), and DG (Figure
6.6G) in AD mice at 3-months, then became concordant between genotypes in the CA1 and
CA3 but not DG subfield(s) by 6-months of age. By this time, microvessels begin to decline
and larger vessels increase in the ENT CTX in 3xTg AD mice (Figure 6.6H).
Although, capillary deficits in the CA1, CA3, and DG seem to be most severe at 3- and
6 -months of age, the deficits persist throughout age in 3xTg AD mice. Peculiar to us, is our
observation of increased length of larger vessels that were seemingly transitorily affected with
age in all of the measured hippocampal subregions. Nonetheless, since the data revealed
profound changes to microvessels and only minor transitory changes to larger vessels we
conclude that in the hippocampus of 3xTg AD mice, microvessels are the major population of
vessels affected at both early and late stages of the disease progression and that these vessels
account for many of the genotypic differences of the vascular network we observed via
morphometric and geometric analyses.

Changes to the cortical vasculature in 3xTg AD mice is age-associated and regiondependent
We next examined the cortical vasculature via morphometric and geometric analyses
to determine the time-course of the onset and progression of vascular disruption. In order to
make these assessments, we measured the intensity of vessel branching, regional
vascularization, and network efficacy in the MO PFC, SS CTX, and CC in 3xTg AD and WT
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Figure 6.6. Microvascular degeneration in the hippocampus occurs early and
progresses with age in a hippocampal subregion specific manner. Reconstructed
vascular network, color-coded by vessel diameter from hippocampal subregions (A) CA1,
(B) CA3, (C) DG, (D) and entorhinal cortex from WT and 3xTg AD mice. Grouped bar
graph(s) (mean ± SEM) depicting the total length of vessels as a function of average vessel
diameter in hippocampal subregion(s) (E-H) CA1, (I-L) CA3, (M-P) DG, and (Q-T)
entorhinal cortex from 3- (WT, n = 4; 3xTg AD, n = 5), 6- (WT, n = 7; 3xTg AD, n = 5),
12- (WT, n = 5; 3xTg AD, n = 5), and 24- (WT, n = 5; 3xTg AD, n = 3) month old WT and
3xTg AD mice. To compare means, significant 2-way ANOVAs within each age group and
in each region were probed for effects of Genotype with planned student’s t-test at each
vessel diameter (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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mice. Deposits of extracellular Aβ in the MO PFC begin to appear at 6-months of age in layers
4 and 5 and becomes severe by 12-months (Oddo et al. 2003b; Oddo et al. 2003a). Similar to
the neuropathological progression in 3xTg AD mice, deposition of Aβ in human patients with
AD usually begin in the cortex and later in the hippocampus while tangles begin to develop in
the limbic regions and progress to the cortex (Mesulam 1999). Our analyses revealed that the
vascular network of the CC was the only cortical region to be affected at 3-months of age in
3xTg AD mice. Similar to that observed in the hippocampus, the number of vessel segments
(Figure 6.7C) and number of vessel junctions (Figure 6.7F) were significantly reduced in 3xTg
AD mice compared to age-matched WT mice. However, these genotypic differences
diminished by 6-months and throughout age in the CC. We found no differences to the number
of vessel segments and the number of junctions in the MO PFC (Figure 6.7A) and SS CTX
(Figure 6.7B) at 3-months, however by 6-months there were significantly fewer vessel
segments and junctions in the MO PFC but not in the SS CTX of 3xTg AD mice. Compromised
vascular volume was initially observed at 6-months in the MO PFC (Figure 6.7G) and CC
(Figure 6.7I) and again at 12-months of age but only in the CC. In fact, at 6-months of age, the
total surface area of all vessels and the intervessel distance was significantly reduced in all
cortical regions evaluated. At 12-months of age, the surface area of all vessels in the MO PFC
(Figure 6.7J) and CC (Figure 6.7L) was significantly reduced in 3xTg AD mice. Similarly, the
intervessel distance at the MO PFC (Figure 6.7M), SS CTX (Figure 6.7N), and CC (Figure
6.7O) of 3xTg AD mice was significantly higher at 6-months, an effect that largely persisted
at later ages.
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Figure 6.7. Vascular network analysis of the cortex indicates early and age-dependent
changes to the vasculature in 3xTg AD mice. Bar graph(s) (mean ± SEM) depicting (AC) number of vessel segments, (D-F) number of vessel junctions, (G-I) total vascular
volume, (J-L) total vascular surface area, and (M-O) intervessel distance from 3- (WT, n =
4; 3xTg AD, n = 5), 6- (WT, n = 7; 3xTg AD, n = 5), 12- (WT, n = 5; 3xTg AD, n = 5), and
24- (WT, n = 5; 3xTg AD, n = 4) month WT and 3xTg AD mice. To compare means,
significant 2-way ANOVAs within each brain region were probed for effects of Genotype
with planned student’s t-test at each age (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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Early deficits of cortical microvessels progress with age in 3xTg AD mice
We next extrapolated on these differences by evaluating the changes that occur to
vessels of specific hierarchy. Using local thickness maps of vessels, we calculated the total
length of vessels as a function of average vessel diameter. We found that the earliest changes
to the vasculature occur in the SS CTX and CC at the age of 3-months. In both of these regions,
3xTg AD mice demonstrated a deficit of microvessels that had an average diameter less than
5 μm and a significant increase of vessels with a diameter greater than 7 μm (Figure 6.8). At
6-months, microvessels with an average diameter of 3 and 4 μm were significantly reduced in
all three cortical regions (Figure 6.8A-C). However, at this age, larger vessels in the MO PFC
and CC were reduced in 3xTg AD compared to WT mice (Figure 6.8). At 12-months of age,
microvessel deficits were observed only in the SS CTX and MO PFC (Figure 6.8).
Interestingly, larger vessels were increased in the MO PFC while reduced in the SS CTX and
CC in 3xTg AD mice. By 24-months of age, microvessel deficits were observed only in the
MO PFC of 3xTg AD mice. Whereas, deficits of larger vessels were observed in the MO PFC
and CC of 3xTg AD mice at 24-months of age (Figure 6.8).

Discussion
Although numerous neuroimaging studies in patients with AD confirm a reduction in
CBF during early and late stages of AD, it remains unclear whether cerebrovascular
hypoperfusion is a cause or consequence of AD. Pathological changes to the structure of the
microvasculature have been shown to be more prominent in demented than in non-demented
individuals (Brown et al. 2009). Further evaluation of the pathological changes that occur to
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Figure 6.8. Microvascular degeneration in the cortex occurs early and progresses with
age in a subregion specific manner. Reconstructed vascular network color-coded by
vessel diameter from hippocampal subregions (A) somatosensory cortex (SS CTX), (B)
medial orbital prefrontal cortex (MO PFC), and (C) cingulate cortex from WT and 3xTg
AD mice. Grouped bar graph(s) (mean ± SEM) depicting the total length of vessels as a
function of average vessel diameter in cortical subregion(s) (D-G) SS CTX, (H-K) MO
PFC, and (L-O) cingulate cortex from 3- (WT, n = 4; 3xTg AD, n = 5), 6- (WT, n = 7; 3xTg
AD, n = 5), 12- (WT, n = 5; 3xTg AD, n = 5), and 24- (WT, n = 5; 3xTg AD, n = 4) month
old WT and 3xTg AD mice. To compare means, significant 2-way ANOVAs within each
age group and in each region were probed for effects of Genotype with planned student’s ttest at each vessel diameter (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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the cerebrovasculature during AD offers a promising approach to identify useful biomarkers
for the detection of AD at early stages.
In the present study, our goal was to characterize the changes to the cerebrovasculature
in 3xTg AD mice by establishing the time-course for vascular degeneration with age and the
progression of AD. We hypothesized that the degeneration of the microvasculature is a major
component of the pathophysiology of AD. We addressed this hypothesis by evaluating the
microvasculature of the whole brain and in key brain regions with age and the progression of
AD in 3xTg AD mice.
Vascular risk factors for hypoperfusion can cause hemodynamic changes to the brain
microvasculature that can result in cognitive impairment by preventing optimal delivery of
oxygen and glucose to the brain (Duron and Hanon 2008). Furthermore, previous studies
conducted with AD patients suggest that hypoxia increases the levels of Aβ in the vasculature
of the brain (Peers et al. 2009). It is believed that Aβ exerts its toxicity to the vasculature by
dysregulating intracellular calcium homeostasis, which can lead to the dysfunction of many
cellular processes (Quintana et al. 2020).
Reconstruction of cerebrovascular corrosion casts in three-dimension demonstrated
visual evidence of chronic cerebrovascular injury in 3xTg AD mice including, tortuous vessels
in the cortex (Figure 6.1B and C) and aneurysms of capillaries and arterioles (Figure 6.1D-F).
Progressive weakening of the structural elements of the vascular wall is responsible for both
the formation of aneurysms and tortuosity vessels (Dobrin et al. 1988). Elastin is an important
extracellular matrix protein of the vessel wall and its degradation can compromise the
structural integrity of the vascular wall (Dobrin and Canfield 1984). Elastin deficiency has
been implicated in the formation of tortuous vessels in patients with arterial tortuosity
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syndrome and in transgenic mice (Taarnhøj et al. 2008; Nakamura et al. 2002; Coucke et al.
2006; Yanagisawa et al. 2002; Carta et al. 2009). Elastolytic enzymes have been noted to be
elevated in the aneurysmal wall, including neutrophil elastase and members of the matrix
metalloprotease (MMP) class. It is likely that the deposition of Aβ on the wall of cerebral blood
vessels causes damage to the extracellular matrix and degeneration of the vessel wall.
Noteworthy, vessel stress can cause the activation of vascular smooth muscle cells (vSMC)
resulting in a phenotype shift from a contractile state into a biosynthetic state. Activated vSMC
directly participate in the destabilization of the vascular wall via the production of matrixdegrading proteases such as MMPs. Activation of vSMC may provide a potential mechanism
for the Aβ-induced damage to cerebral blood vessels and to the formation of aneurysms and
tortuous vessels.
Cerebrovascular hypoperfusion causes metabolic stress and degeneration of the brain
parenchyma (Quintana et al. 2018). We found that at 6-months, CBF begins to decline
progressively with age in 3xTg AD mice (Figure 6.2). As cerebrovascular hypoperfusion
progresses, reactive oxygen species (ROS) are produced and accumulate within mitochondria
(Halestrap and Pasdois 2009; Clanton 2007). Concomitantly, hypoperfusion results in ATP
depletion, causing high intracellular Na+ concentration, which compromises the Na+/Ca+
antiporter resulting in the accumulation of intracellular Ca+ (Halestrap and Pasdois 2009).
Increased intracellular Ca+ concentration together with elevated levels of mitochondrial ROS
induce the formation of the mitochondrial membrane permeability transition pore (mPTP),
facilitating the pathway for necrotic cell death (Halestrap 2010; Loor et al. 2011).
Geometric analysis of the angioarchitecture revealed early changes to the
cerebrovasculature that indicated morphological response to chronic injury. Interestingly,
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these early changes occurred at 3-months of age, and included alterations to the average vessel
diameter, intervessel distance, and pathway redundancy of the vascular network, suggesting
an alteration to the network composition. This was in contrast to the changes to the
angioarchitecture that occurred following 6-months of age. In 3xTg AD mice at later ages,
whole brain analyses of the angioarchitecture demonstrated changes that indicated
degeneration of the cerebrovasculature. These changes included a decline in number of vessel
segments that occurred with reduced vascular volume, vessel surface area and a greater
distance between vessels. Along with these degenerative changes to the angioarchitecture, late
age was also associated with reduced number of vessel-to-vessel junctions and compromised
network complexity in 3xTg AD mice.
Consistent with the literature, whole brain analyses of vessel volume as a function of
average vessel diameter revealed smaller vessels to be most affected by age in 3xTg AD mice,
indicating that the majority of the changes to the angioarchitecture are accounted for by
changes to the microvasculature.
When we assessed the region specific changes to the hippocampal and cortical
vasculature with age, we found early differences to the number of vessel segments and vesselto-vessel junctions at 3-months of age. The most severely affected region of the hippocampus
was the CA1, DG, CA3, and then ENT CTX, in that order. Similar to our whole brain analyses,
changes to the hippocampal vasculature in 3xTg AD mice indicated network adaptations to
chronic injury that occurs early and progresses with age. Hippocampal vasculature began to
demonstrate evidence of vascular degeneration at 6-month that progressed with age in 3xTg
AD mice. The hippocampus is among the first region of the brain to accumulate Aβ plaque in
patients and mice with Alzheimer’s disease. In 3xTg AD mice, the hippocampus develops
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sparse Aβ plaques by 6-months of age and by 12-months plaque deposition is dense (Oddo et
al. 2003a). We found that the major contribution to these changes were via alterations to the
microvasculature. Our analysis of the distribution of vessels by hierarchy as a function of
average vessel diameter indicated that changes to the microvascular network occurred with age
and differed between genotype. These data indicate that vascular damage in the hippocampus
occurs before the onset of plaque deposition in 3xTg AD mice.
Hypoperfusion of the frontal cortex is implicated in causing the unawareness of
cognitive deficits in patients with AD (Amanzio et al. 2011). Likewise, hypoperfusion of the
cingulate cortex is associated with the impaired orientation for time in AD patients (Yamashita
et al. 2019). Region specific analyses of the cortical vasculature indicated it to be less affected
than regions of the hippocampus. The deposition of Aβ plaques in cortical regions is first
detected at 12-months of age in 3xTg AD mice (Belfiore et al. 2019). We found the
angioarchitecture of the MO PFC to be the most severely affected cortical region. At 3-months,
the vasculature of the CC and not the MO PFC and SS CTX, demonstrated a reduced number
of vessel segments and a lower count of vessel-to-vessel junctions. At 6-months of age, the
MO PFC contained a reduced number of segments, vessel junctions, total vessel volume,
surface area, and intervessel distance. Whereas, the angioarchitecture of the SS CTX and CC
provided a reduced surface area of vessels and a greater distance between vessels relative to
age-matched WT mice. Interestingly, at 12- and 24-months of age, an increased intervessel
distance was the only measured parameter to be affected and in all cortical regions assessed.
Overall, our data demonstrate that the cerebrovasculature of 3xTg AD mice is affected
early during aging, and is characterized by morphological and structural adaptations that are
likely caused by chronic injury to vessels. These data indicated that alteration to the
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angioarchitecture occurs before the onset of plaque development. Once plaque deposition
occurs, changes to the angioarchitecture begin to indicate structural changes that occur via
vascular degeneration. These data suggest that changes to the vasculature that occur early
during AD may progress, resulting in cerebrovascular degeneration, initiating the onset of
clinically detectable AD in patients.
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Cerebral Amyloid Angiopathy and Cerebrovascular Hypoperfusion
The decline of cerebral blood flow is known to occur during normal aging (Chen et al.
2011). However, the age-related mechanisms that account for, or are a result of, reduced
cerebral blood flow during age is unknown. Observational studies in healthy adults have
demonstrated that reduced cerebral blood flow during aging is independent of region-specific
atrophy of the gray matter (Chen et al. 2011). Similarly, capillary density decreases with age
in humans, non-human primates, and rodents (Amano et al. 1982; Bell and Ball 1990; Goldman
et al. 1987; Jucker et al. 1990; Melamed et al. 1980) which may indicate an age-associated
decline in density of the capillary network. It is possible that a threshold exists, separating the
age-associated decline in capillary density and cerebral blood flow during normal aging from
disease.
Cerebrovascular hypoperfusion is frequently observed in patients with AD (Johnson et
al. 2005; Chen et al. 2011). The onset of cerebral hypoperfusion in the etiology of AD occurs
early, before the development of Aβ plaques, NFT tangles, and cerebral hypometabolism
(Thomas et al. 2015; Zhang et al. 2018). The manifestation of hypoperfusion during the early
stages of AD development supports its use as a clinical biomarker for the disease (Alsop et al.
2010; Chao et al. 2010). As in healthy aging, the mechanisms that underlie the deficits in
cerebrovascular perfusion in AD remain unclear. Studies on transgenic mice that overexpress
the APP gene have demonstrated a reduction in cerebral blood flow as part of the pathological
events of AD progression (Weidensteiner et al. 2009; Faure et al. 2011; Poisnel et al. 2012;
Hébert et al. 2013; Massaad et al. 2010). A critical question to the field that remains
unanswered is why these transgenic mice that overexpress APP, demonstrate reduced
cerebrovascular perfusion. The APP protein is a precursor to Aβ1-42 and Aβ1-40 production, both
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of which are found deposited in the parenchyma and on the walls of vessels in these transgenic
mice. Although histopathological analysis of the brain in mice have demonstrated a reduced
density of capillaries in regions around Aβ plaques (Kouznetsova et al. 2006), the deficits of
cerebrovascular perfusion in these mice did not correlate to the density of the plaques
(Weidensteiner et al. 2009).

Cerebral Hypometabolism in Alzheimer’s Disease
Reduced cerebral metabolic demand may be another potential cause of the
cerebrovascular hypoperfusion in APP mice. However, when cerebral glucose uptake is
measured with [18F]-fluoro-2-deoxy-D-glucose PET, no correlation was found between
metabolic deficit and the perfusion of cerebral tissue (Poisnel et al. 2012). In APP/PS1
transgenic mice at 3-months of age, cerebral glucose uptake is decreased in the hippocampus,
cortex, and striatum; however, by 12-months of age, glucose uptake was increased in brain
regions with persistent deficits in cerebrovascular perfusion. Impaired vascular function
including vascular signaling (Niwa et al. 2001; Niwa et al. 2000), renin-angiotensin
mechanism (Takeda et al. 2009), vascular tone, and blood perfusion, occur in APP mice prior
to the onset of Aβ plaque deposition (Han et al. 2008; Park et al. 2013; Faure et al. 2011;
Hébert et al. 2013).
It is currently unknown whether CAA aggravates the functional deficits, or is a
prerequisite to the dysfunction, of the vasculature. However, it is known that Aβ can act
directly on cerebral blood vessels resulting in dysfunction. This suggests that low levels of Aβ,
before its accumulation on vessel walls and the development of CAA can induce vascular
dysfunction and contribute to the development of cerebrovascular hypoperfusion in humans
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and rodents with AD. The age at onset and the rate of Aβ deposition on the cerebral vasculature
in mice is dependent on the specific mutation harbored by the APP gene. An earlier onset of
CAA is observed in mice that harbor more than one autosomal dominant mutation as do Thy1APP751, TgCRND8, and Tg-SwDI transgenic mice. The development of CAA at later ages is
seen in mice carrying a single familial mutation of the APP gene such as in Tg2576, APPDutch,
APP23, APP/ London, PDAPP, and TgAPPArc transgenic mice. The age at onset of CAA can
be shifted earlier if the mice carry a mutated presenilin gene in addition to an APP mutation as
seen in APPswe/PS1dE9 and Thy1-APP751SLxHMG-PS1M146L transgenic mice. Empirical
evidence has indicated that the ratio between Aβ1-40 and Aβ1-42 production is influential to the
severity of AD and the age at onset of CAA (Herzig et al. 2004; Herzig et al. 2006; Herzig et
al. 2007). In Tg-SwDI transgenic mice that carry the Swedish, Dutch, and Iowa APP mutation
develop severe CAA with an onset at 6-months of age (Davis et al. 2004; Miao et al. 2005; Xu
et al. 2007). Similarly, in Thy1-APP751SLxHMG-PS1M146L mice that carry the Swedish
and London APP mutation develop severe CAA with an onset at 3-months of age (Blanchard
et al. 2003; Schmitz et al. 2004; El Tayara et al. 2007; El Tannir El Tayara et al. 2010). In the
3xTg AD mouse line, which carry the PS1 M146V presenilin mutation, the Swedish hAPP695
APP mutation, in addition to K679M, N671L + htau (P301L) mutated tau develop Aβ plaques
at 6-months of age, however the onset of CAA remains to be determined (Oddo et al. 2003b;
Oddo et al. 2003a; Billings et al. 2005; Fuhrmann et al. 2010). Hence, our first goal was to
establish the severity and age at onset of cerebrovascular Aβ accumulation in the 3xTg AD
mouse model of AD. To label Aβ in the brain of 3xTg AD mice we used anti-Aβ1-42 antibodies,
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Figure 7.1. Image demonstrating the distribution and pattern of Aβ deposition in the
hippocampus and cortex. Confocal micrographs depicting the maximum intensity
projection of a z-stack containing immunofluorescent labeling of collagen IV (red) and
amyloid-β 1-42 (green) in tissue sections of the brain from 24-month old 3xTg AD mice.
Micrographs acquired at high magnification depict dense Aβ-plaque deposition in
hippocampal subregions and vascular deposition in the cortex.
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methoxy-X04, and Congo red histological procedures for both the in vivo and ex vivo detection
of Aβ deposits in the parenchyma and cerebrovascular walls.
We found that the brain of 3xTg AD mice were severely affected by amyloidosis,
having substantial deposition of Aβ in both the parenchyma and around cerebral blood vessels
at many of the critical brain regions that are implicated in the disease (Figure 7.1). These
affected regions demonstrated much of the deposition of Aβ on cerebral blood vessels occurs
between the endothelium and the lamina densa of the basal lamina (Figure 7.2). This unique
pattern of deposition indicates a compromised trans-endothelial cell transport system, a process
that is essential for the clearance of Aβ through the BBB and out of the brain.
It seems that during the early stages of AD, prior to the deposition of Aβ-plaque,
tangles, hypometabolism, and hypoperfusion, the increased production of Aβ exerts a state of
chronic stress to the vascular endothelium. As age progresses and stress persists, the vascular
endothelium cannot sustain their physiological functions within normal parameters, which
initiates a cascade of pathological events including, reduced Aβ clearance, which exacerbates
endothelial dysfunction, ultimately resulting in vascular dysfunction and the degeneration of
cerebral tissue of affected regions and the major pathological features of AD.

Cerebrovascular Hypoperfusion, Mitochondrial Deficits, and Inflammation
Astrocytes and microglia are central players involved in the development of
inflammation of the central nervous system and both cells have been demonstrated to be
associated with the localized inflammation of vascular Aβ deposits in AD (Grabowski et al.
2001; Eng et al. 2004; Zabel et al. 2013). Therefore, an aim of this project was to explore the
metabolic changes in astrocytes that are associated with hypoxia as a model of hypoperfusion
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Figure 7.2. Image demonstrating the accumulation of amyloid-β on the wall of cerebral
blood vessels. Confocal micrographs at 63x magnification depicting immunofluorescence
labeling of collagen IV (red) and amyloid-β 1-42 (green) in the dentate gyrus and CA1
regions of the hippocampus in tissue sections of the brain from 24-month old 3xTg AD
mice. Boxed region depicts a magnified area of a blood vessel with cerebral amyloid
angiopathy.
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in vitro. The results obtained from this study suggest that hypoxia induces metabolic stressrelated changes to the mitochondrial network. In astrocytes exposed to 3-hours of hypoxia, the
size distribution of the mitochondrial network shifted in favor of smaller mitochondria.
Hypoxia resulted in the excessive fission of astrocytic mitochondria producing a numerous
population of small mitochondria that resembled punctate. Mitochondrial fission was caused
by the dephosphorylation of serine at residue 637 of the Drp-1 mitochondrial membrane
protein. When astrocytes were reoxygenated for 10-hours, we observed a modest recovery to
the original size distribution of mitochondria and the complete re-phosphorylation of the Drp1 protein. During hypoxia and following reoxygenation caused mitophagy of the hypoxiainduced population of small mitochondria, which resulted in a deficit of the total number of
mitochondria and to the total mitochondrial area within astrocytes. These observations suggest
that hypoperfusion in AD can cause mitochondrial deficits via upregulated mitophagy in
astrocytes but also in cerebrovascular endothelial cells. Perhaps, the mitochondrial deficit we
observed in astrocytes in response to hypoxia may occur from the hypoperfusion of tissue, and
provide a reason for the development of hypometabolism in AD patients and in animal models.
In astrocytes, we observed as many as 40% of all mitochondria being targeted for mitophagy
following post-hypoxia reoxygenation. Indeed, previous studies have demonstrated
mitochondrial number and functional deficits in human and animal models of AD with
evidence of cerebrovascular hypoperfusion (Aliev et al. 2004; Moreira et al. 2010; Aliev et al.
2003a; Aliev et al. 2003b). We found that the intracellular ATP content after exposing primary
astrocyte cultures to hypoxia for 3-hours caused a 64% decline in available ATP, suggesting
that cellular ATP levels are likely depleted in hypoperfused mice in AD. During a metabolic
crisis such as in AD, reduced intracellular ATP content may be insufficient to maintain normal
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cellular functions including Aβ clearance by vascular endothelial cells. As stated above, we
observed vascular deposition of Aβ between the endothelium and lamina densa from
fluorescently labeled tissue of 3xTg AD mice (Figure 7.2), which provides evidence of a faulty
transendothelial clearance mechanism for Aβ potentially explained by the acute sensitivity of
mitochondria to hypoxic conditions, such as during cerebrovascular hypoperfusion.

Cerebrovascular Hypoperfusion and Ischemic Injury in Alzheimer’s
Disease
The hallmark pathology of AD is the appearance of Aβ plaques and NFT in the
brain, which leads to neuronal degeneration and cortical thinning (Walsh and Selkoe 2007).
Additionally, it is well known that AD patients display white matter changes that are associated
with the pathophysiology of AD (Barber et al. 1999; Englund 1998; Kim et al. 2015). The
study presented in chapter 3 was aimed to determine if cerebrovascular hypoperfusion alone
can produce parenchymal damage that is similar to the histopathology seen in AD. To address
this aim, we developed a model to gradually induce cerebral hypoperfusion by bilateral carotid
artery stenosis in mice using microcoils and ameroid constrictor rings. This procedure resulted
in a gradual hypoperfusion that reduced cerebral blood flow to 43% of baseline over the course
of 34 days. Histopathological analyses of the brain revealed neuronal and axonal damage
throughout the brain, where the hippocampus was the most severely affected structure. We
found evidence of gray matter injury that included; pyramidal cell loss in the CA1, CA2, and
CA3 of the hippocampus; granular cell loss in the dentate gyrus; and parenchymal lesions in
the globus pallidus internus and globus pallidus externus. In addition, we found white matter
injury that was characterized by axonal disorganization and degeneration that most extensively
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affected the hippocampus and corpus callosum. The gradual development of hypoperfusion in
these mice produced degenerative parenchymal injury that is similar to the neuronal
degeneration in AD. The progression of neuropathological changes in AD begin in the
entorhinal cortex and the hippocampal formation, then spread to the temporal, parietal, and
finally to the frontal association cortices (Braak and Braak 1996; Braak and Braak 1991;
Hyman et al. 1984). Neuronal degeneration in AD is most severe in regions involved in
memory function, including the entorhinal cortex and hippocampus and in cortical regions
involved in language and executive function (Verma and Howard 2012; Lehmann et al. 2013).
Cortical and hippocampal atrophy is seen in patients with AD (Sabuncu et al. 2011).
Hippocampal atrophy is a marker of AD and the rate to which it occurs correlates with the
change in clinical status of AD (Jack et al. 2000; Sabuncu et al. 2011). During healthy aging,
0.2 – 0.4% of the brain volume is lost per year, in aging patients with AD, up to 10% of the
brain volume is lost per year, particularly in regions that are vulnerable, such as the
hippocampus (Fox et al. 1996; Fox et al. 2000; Andrews et al. 2013). Indeed, we found
hippocampal and cortical atrophy in the brain of hypoperfused mice. The atrophic changes to
the hippocampus included, pyramidal cell loss in the CA1, CA2, and CA3; granular cell loss
in the DG; and diffuse axonal degeneration throughout the hippocampus. Similarly, loss of
pyramidal cells in the neocortex and hippocampus is seen in AD and is a fundamental
neuropathology of the disease (Mann 1996). The loss of hippocampal pyramidal cells in AD
seems to predominantly occur in regions of the hippocampal formation (Davies et al. 1992).
In a study the quantified the density of pyramidal cells in the postmortem brain of
histopathologically confirmed AD patients found that the density of these cells decreased 44%
in the subiculum, 28% in the prosubiculum, and 41% in the CA1 region of the hippocampus
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(Davies et al. 1992). Additionally, plaque deposition and NFT are more densely populated in
regions affected with pyramidal cell loss (Davies et al. 1988). Hippocampal pyramidal cells
are essential for the normal function of the hippocampus. Expectedly, the extent of pyramidal
cell loss correlates with the clinical severity of dementia (Jack et al. 2000). A study of 144
patients that met the diagnostic criteria for AD that underwent magnetic resonance imaging
(MRI) demonstrated that reduced hippocampal volume in patients with AD was more severe
in patients with one or more vascular risk factors (Dhikav and Anand 2011), linking the
vascular factors to the development of hippocampal atrophy in AD (Dhikav and Anand 2012).
We found white matter damage in hypoperfused mice that consisted of diffused axonal
injury, axonal disorganization, axonal degeneration, and vacuolation. Additionally, we
observed corpus callosal thinning and degeneration to the fornix in the brain of hypoperfused
mice. Parenchymal vacuolation, also called spongiform degeneration, typically occurs in white
matter regions of the brain where dendrites and myelinated axons degenerate. Cerebrovascular
injury and microcirculation dysfunction can result in oligodendrocyte apoptosis and the
vacuolation of the parenchyma in heroin addicts (Yin et al. 2013). Vacuolation in AD is found
in the medial temporal lobe, amygdala, and upper layers of the isocortex and less common in
the limbic lobe (Smith et al. 1987; Mancardi et al. 1982). In a study using spin-echo magnetic
resonance imaging and proton magnetic spectroscopic imaging revealed axonal injury and
membrane alterations in AD patients (Meyerhoff et al. 1994). Axonal transport may fail during
the progression of AD (Cash et al. 2003). Senile plaques are linked to alterations of the axonal
compartment (Terry 1996), as they are composed of dystrophic neurites that correspond to
axonal swellings containing aberrant accumulations of axonal cargo and tau (Masliah et al.
1993). These observations indicate that the prominent white matter injury in AD patients, that
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is characterized by axonal injury, vacuolation, axonal transport failure, and dystrophic neurites
can be caused by vascular dysfunction alone. This is further supported by a study of AD
patients with cerebrovascular disease, which demonstrated extensive swelling and vacuolation
of white matter astrocytes that contained beaded and/or disintegrated processes (Tomimoto et
al. 1997). These astrocytes were immunoreactive for serum proteins, which are known to
induce astrocyte activation (Tomimoto et al. 1997). This suggests that vascular dysfunction
and impaired BBB is sufficient to induce the activation of astrocytes and white matter damage.
This is in agreement with our study reported in chapter 2, demonstrating that the exposure of
primary astrocytes to hypoxia can cause metabolic changes and retraction of astrocytic
extensions, indicative of cellular reactivity and the activation of astrocytes.
Astrocytes perform functions that are essential to the homeostasis and ongoing function
of the central nervous system. One of these important functions is the regulation of immune
response by modulating inflammation via inflammatory signaling. In AD, astrocytes express
apolipoprotein E and participate in the degradation and removal of Aβ (González-Reyes et al.
2017). Excessive cerebral inflammation and/or reactive oxygen species can affect astrocytic
process that involve calcium signaling regulation, NADPH oxidase, glutamate uptake, and
mitochondrial function (González-Reyes et al. 2017). These cellular changes can induce
damage to the parenchyma including, oxidation of proteins and lipids, calcium dysregulation,
and excitotoxicity (González-Reyes et al. 2017). We found polynuclear lesions in white matter
regions of hypoperfused mice. These lesions are likely a result of activated astrocytes that
result from the hypoxic environment, serum proteins, and damage associated molecular
patterns that were caused by hypoperfusion-related injury. In AD, astrocytes are a major area
of research, as they are commonly associated with the neuronal damage seen in AD. It is likely
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that early cerebrovascular dysfunction results in astrocyte activation leading to the initial
neuronal damage in AD. Furthermore, activation of astrocytes by Aβ can be potentiated by
oxidants (García-Matas et al. 2010), such as hypoxia during hypoperfusion. Since nonactivated astrocytic function is reduced when activation occurs, astrocytic degradation of Aβ
and its removal should also be reduced. These changes to the cellular environment would
exacerbate parenchymal damage, including enhanced vascular injury. In addition to the
increased oxidative stress and inflammatory signaling, vascular endothelial cells would be
required to clear parenchymal Aβ without astrocytic degradation of the polymers, a potential
initiating factor leading to the development of CAA.

Amyloid-β-mediates Mitochondrial Dysfunction and Cell Death in Vascular
Endothelial Cells
The mitochondrial cascade hypothesis attempts to explain late-onset AD, where the
dysfunction of mitochondria initiates the deposition of Aβ, NFT formation, and synaptic
degeneration (Swerdlow et al. 2014; Swerdlow and Khan 2009). Mitochondrial dysfunction
and oxidative stress are important factors in the early pathogenesis of AD (Moreira et al. 2006;
Moreira et al. 2009; Su et al. 2008; Nunomura et al. 2001). Aβ plaques are found clustered
around regions with damaged and degenerated mitochondria (Xie et al. 2013). Dysfunctional
mitochondrial

enzymes

including,

cytochrome

c

oxidase

(COX),

α-ketoglutarate

dehydrogenase complex, and pyruvate dehydrogenase complex also contribute to the
pathogenesis of AD (Silva et al. 2012; Maurer et al. 2000; Parker et al. 1990). Reduced COX
activity has been documented in hippocampal neurons (Cottrell et al. 2002; Maurer et al. 2000)
and in cortical neurons (Mutisya et al. 1994; Maurer et al. 2000) of AD patients.
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Previously, the specific intracellular events induced by Aβ that mediate the changes to
mitochondria in AD is largely unknown. The goal of the study described in chapter 4 aimed to
determine the mechanism in which Aβ mediates the dysfunction of mitochondria in AD. To
address this aim, we studied the effects of Aβ on the bEnd.3 cell line and primary
cerebrovascular endothelial cell cultures. We found that the exposure of cerebrovascular
endothelial cells to Aβ accelerated mitochondrial oxygen consumption and increased
superoxide production. We found that these changes occurred via accumulated calcium in the
mitochondrial matrix and could be prevented by chelating extracellular calcium. Although
dysregulated calcium homeostasis is well documented in AD research (Jadiya et al. 2019;
LaFerla 2002), its roll in cerebrovascular dysfunction in AD is limited. Calcium signaling
mediates vascular endothelial cell sensing of shear stress via P2X4 receptor (Yamamoto et al.
2000; Kwan et al. 2003), an important mechanism that allows the vascular endothelium to
adapt to dynamic changes of blood flow. Disrupted endothelial cell calcium signaling is likely
a factor involved in the pathological events leading to the development of tortuous vessels.
Additional calcium entering the cell by mitochondria-produced superoxide anions via redoxsensitive NSCC can increase mitochondrial calcium accumulation, progressing the respiratory
dysfunction. Although, metabolic function is reduced in patients at late stages of AD, studies
have documented a hypermetabolic phenotype in rodent models at earlier stages (Knight et al.
2012; Snellman et al. 2019; Bouter and Bouter 2019; Luo et al. 2012). This early elevation of
mitochondrial respiration may mediate the initial mitochondrial damage and endothelial cell
stress that results in dysfunction of critical cellular process and contribute to Aβ accumulation
as the disease progresses.
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Deficits in function and the transport of mitochondria have been reported in primary
cultures exposed to Aβ (Calkins and Reddy 2011; Rui and Zheng 2016; Rui et al. 2006) and
from 3xTg AD cultured neurons overexpressing mutated APP (Cavendish et al. 2019).
Additionally, mitochondrial morphology is altered AD (Hirai et al. 2001b; Moreira et al.
2007). When we exposed vascular endothelial cells to Aβ we found that mitochondrial size
reduced via a process that was consistent with stress-induced fission. This is consistent with
the literature that documents excessive mitochondrial fission in the brain of both patients and
animal models of AD (Manczak et al. 2011; Kandimalla and Reddy 2016; Hirai et al. 2001a;
Lu et al. 2018). This provides a potential mechanism for the observation of increased
mitochondrial fission in AD, where Aβ-induced stress causes mitochondrial fission in vascular
endothelial cells and likely in other cell types. Additionally, the Aβ-induced mitochondrial
fission could be prevented when we chelated extracellular calcium, indicating a prominent role
in the stress-related signaling that results from Aβ exposure.
Ultimately, endothelial cell exposure to Aβ resulted in cell death, possibly via a
mitochondrial mediated mechanism.

Cerebrovascular Corrosion Casting and MicroCT Imaging for the
Assessment of the Cerebrovasculature
Imaging of the mammalian brain and its systems has long been a goal of neuroscience
research. However, acquiring images of structures deep within the brain has proven difficult
to obtain without the need to slice the tissue into thin sections. This difficulty is caused by
interference from the tissue, which results in reduced efficiency and resolution of the collected
images. This is a serious limitation; poor-quality images produce inaccurate interpretation of
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the data and potentially mislead the scientific community. The development of more advanced
imaging methods for deep-brain structures is crucial for continuing progress of the field. This
is especially true for highly complex systems such as the cerebrovascular network. The unique
nature of the blood vessel geometry and the complex network(s) that they comprise are highly
dimensional, as such, image data collection of vascular networks from sections of sliced tissue
is impractical for analyses of vascular network composition and organization.
Therefore, the study described in chapter 5 aimed to develop the methodology required
to study the complete cerebrovascular network from the entire brain. A secondary goal of this
study was to develop an array of analyses that could be used to evaluate the angioarchitecture
in a biologically meaningful manner. We focused on developing a procedure that enables the
collection of volumetric imaging data at micron-level resolution of the complete
cerebrovascular network of the whole brain of adult female and male mice. This is a crucial
advance, as many contemporary imaging studies of the cerebrovasculature have been limited
to cubic millimeters of brain. Additionally, literature on sex differences of the
cerebrovasculature beyond vessel counting is limited. In complex systems such as vascular
networks, major differences can be found beyond the absolute number of vessels, such as the
particular topology of vascular networks, which can influence the efficiency, stability, or
redundancy of blood flow to the brain and its subregions.
We reported for the first time, three-dimensional data sets of the cerebrovascular
network over the entire brain from nine mice and evaluate the angioarchitecture at the macroand microscopic level in female and male mice. We provided a characterization of the
cerebrovasculature by measuring the geometry of the angioarchitecture. We then mapped the
topology of the vascular network to generate morphometric descriptions of deconstructed
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network components, assessed the connectivity, and provided global metrics of the network
angioarchitecture. These analyses revealed sexual dimorphic traits of the organization of the
vascular network, where female mice demonstrated more complex and thorough network
structures. Additionally, female mice contained on average a greater density of microvessels
demonstrating smaller intervessel distances than did male mice. Overall, we performed over
30 separate analyses to characterize the cerebrovasculature in female and male mice and
revealed a number of parameters that qualified as sexually dimorphic. This work may prove
crucial to the field by providing a new perspective to explain the reasons why sensitivity to
some diseases are different in females and males.
A thorough assessment of the cerebrovasculature in AD has not been previously
reported. This shortcoming is broadly due to the difficulty of acquiring volumetric datasets of
cerebrovascular networks that are sufficiently robust for accurate interpretations of the
dimensional properties of network structures. This is important for AD research, in that, due
to the dynamic nature of the cerebrovasculature, chronic neurodegenerative diseases that
progress with age are likely to cause structural changes to the vascular network, which may
participate in the pathophysiology of disease. For example, cerebrovascular malformations that
can develop in response to hemodynamic stress over long periods of time. Vascular tortuosity
is a prominent cerebrovascular malformation found in the brain of patients and rodents with
AD (Dorr, J. Brain). Elevated blood flow can injure the wall of blood vessels, causing the
aberrant deposition of basement membrane components, the degradation of elastin, and the
elongation of blood vessels. These pathogenic changes to the vessel wall can cause the blood
vessel to become dysmorphic and often results in a vessel becoming tortuous (Dobrin et al.
1988; Carta et al. 2009; Taarnhøj et al. 2008; Coucke et al. 2006).
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In AD, a major source of damage to the cerebrovasculature is caused by Aβ (Selkoe
and Hardy 2016). Particularly, cerebral capillaries are responsible for 85% of the clearance of
Aβ from the brain (Deane et al. 2008; Deane et al. 2004; Shibata et al. 2000; Zlokovic 2008).
It is conceivable that age-associated capillary dysfunction compromises the efficiency of Aβ
clearance through capillary endothelial cells, initiating the onset of CAA and subsequently, the
pathogenic cascade responsible for the manifestation of AD. The particular vascular risk
factor(s) or combination, harbored by an individual may be decisive to whether capillary
function is compromised during aging. Cerebrovascular dysfunction that weakens
transendothelial transport and/or lysosomal degradation would result in the progressive
accumulation of Aβ, enhancing endothelial cell stress and promoting apoptosis. Early
endothelial cell death can cause vessel regression and the thinning of capillary network density.
Early loss of capillary network density and concomitant dysfunction of transendothelial cell
transport may mark the onset of Aβ-plaque development and CAA. A goal for the study
described in chapter 5 was to develop analytical solutions to characterize the magnitude,
complexity, and organization of the angioarchitecture in the brain. These assessments would
allow us to determine if early changes to the cerebrovasculature occur in AD and to
characterize the progression of these changes with age.

Changes to the Cerebrovasculature in AD Occurs Early and Progresses with
Age
In his seminal work, Alzheimer documented observations of vascular pathologies and
their comorbidities in his original report (Alzheimer 1907). Since then, a growing body of
research has established an association with the occurrence of AD and vascular factors
(Montagne et al. 2016; Dickstein et al. 2010; Murray et al. 2011; Shin et al. 2007; Grammas
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et al. 2002). Although, reports documenting changes to the cerebrovasculature in AD have
overwhelmingly indicated that vascular network density decreases with AD (Sagare et al.
2013; Vinters et al. 1994; Kalaria and Hedera 1995; Miyakawa et al. 1988; Hashimura et al.
1991), several studies have demonstrated the opposite observation, where vascular density is
increased (Desai et al. 2009; Durrant et al. 2020; Ek Olofsson and Englund 2019). This is
further confounded by conflicting studies that demonstrate both hypermetabolism and
hypometabolism in mouse models of AD (Knight et al. 2012; Snellman et al. 2019; Bouter and
Bouter 2019; Luo et al. 2012). However, past studies of the cerebrovasculature in humans and
in rodents with AD have largely been limited to tissue sections and small volumetric datasets
restricted to selected brain regions. Although these past studies have provided important
information, there exists a need to describe the vascular changes over the entire brain while
also providing information regarding the connective organization of the cerebrovasculature,
which is more closely tied to its function. Therefore, the study described in chapter 6 was aimed
to characterize the changes to the cerebrovasculature at early stages of AD and how these
changes progress with age. Reconstruction of the cerebrovasculature in three-dimensions
revealed evidence of chronic vascular injury in 3xTg AD mice including, tortuous vessels in
the cortex and aneurysms of capillaries and arterioles. Morphometric analysis of the
angioarchitecture revealed early changes to the cerebrovasculature that indicated a structural
response to chronic injury. Interestingly, these early changes were observed at 3-months of
age, and included alterations to the average vessel diameter, intervessel distance, and the
redundancy of pathways, suggesting altered network composition. Consistent with the
literature, analysis of the whole-brain that measured the volume of vessels as a function of
average vessel diameter indicated that the majority of these early changes were accounted for
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by changes to the microvasculature. Although, reports documenting changes to the
cerebrovasculature in AD have overwhelmingly indicated that vascular network density
decreases with AD, several studies have demonstrated the opposite observation, where
vascular density is increased. Indeed, at 3-months, 3xTg AD mice demonstrated an increased
amount of microvessels compared to age-matched WT mice. This elevated microvascular
content in 3xTg AD mice persisted to 6-months of age. Increased microvascular volume in
3xTg AD mice may be associated with the proangiogenic properties of Aβ (Biron et al. 2011;
Zand et al. 2005; Fioravanzo et al. 2010). Additionally, endothelial cell stress can stimulate
cell proliferation and the growth of new vessels. Early chronic damage to the microvasculature
can cause reoccurring regression and growth of microvessels that may drastically change the
connectivity of the network and affect the pathways and efficiency of blood flow through the
vascular network.
The changes at 3- and 6-months were in contrast to the changes to the angioarchitecture
at later ages. Whole brain analysis indicated a decline in the number of vessel segments that
occurred along with reduced vascular volume, vessel surface area, and a greater intervessel
distance in 3xTg AD mice at late ages. Late age in 3xTg AD mice was also associated with
reduced number of vessel-to-vessel junctions and compromised network complexity in 3xTg
AD mice. These late changes are consistent with the majority of the literature that suggest a
reduced capillary density in AD.
Declarative memory is the first cognitive domain affected during the progression of
AD. The hippocampus and the medial temporal lobe are critical regions for declarative
memory function (Stoub et al. 2006; Zola-Morgan et al. 1986). When we evaluated the
cerebrovasculature of the hippocampal formation, we found early differences to the number of
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vessel segments and vessel-to-vessel junctions at 3-months of age. These early changes most
severely affected the CA1, DG, CA3, and then ENT CTX, in that order. Similar to our wholebrain analysis, the hippocampus demonstrated microvascular degeneration that began at 6months and progressed with age.
Sensory input form the primary somatosensory cortex and association cortex project
information to the hippocampus through the perforant path; the loss of layer II neurons in the
entorhinal cortex can cause a disconnection of information transmitted to the hippocampus
(Hyman et al. 1984; Amaral et al. 1987; Van Hoesen et al. 1975). We found the
angioarchitecture of the MO PFC to be the most severely affected cortical region. At 3-months,
the vasculature of the CC and not the MO PFC and SS CTX, demonstrated a reduced number
of vessel segments and a lower count of vessel-to-vessel junctions. At 6-months of age, the
MO PFC contained a reduced number of segments, vessel junctions, total vessel volume,
surface area, and intervessel distance. Whereas, the angioarchitecture of the SS CTX and CC
provided a reduced surface area of vessels and a greater distance between vessels relative to
age-matched WT mice. Interestingly, at 12- and 24-months of age, an increased intervessel
distance was the only measured parameter to be affected and in all cortical regions assessed.
Overall, our data demonstrate that the cerebrovasculature of 3xTg AD mice is affected
early during aging and is characterized by morphological and structural adaptations that are
likely caused by chronic injury to vessels. These data indicated that alteration to the
angioarchitecture occurs before the onset of plaque development. Once plaque deposition
occurs, changes to the angioarchitecture begin to indicate structural changes that occur via
vascular degeneration. These data suggest that changes to the vasculature that occur early
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during AD may progress, resulting in cerebrovascular degeneration, initiating the onset of
clinically detectable AD in patients.

Summary of Dissertation Research
We have demonstrated that pathological changes to the cerebrovasculature is a
prominent event during AD. We have demonstrated age-related changes to the
angioarchitecture over the whole-brain in 3xTg AD mice that occurred early, before the onset
of Aβ-plaque deposition and NFT development in 3xTg AD mice. We have provided evidence
indicating that the microvasculature is dramatically affected over the entire brain and in key
brain regions that are implicated in the behavioral and cognitive deficits in AD. Additionally,
we have demonstrated that Aβ is cytotoxic to vascular endothelial cell, causing dysregulated
oxidative phosphorylation that resulted in aberrant ATP synthesis and enhanced superoxide
production. We found that mitochondrial calcium is critically involved in the Aβ-induced
changes to mitochondrial function and endothelial cell death. We have provided visual
evidence depicting Aβ deposition on cerebrovascular walls, including microvessels. The
proximity of Aβ to the endothelium of these vessels suggests nascent endothelial injury and
apoptosis via the mechanisms described above. Vascular degeneration, especially
microvascular degeneration can result in an insufficient perfusion of blood to the parenchyma.
We have demonstrated in astrocytes, a major participant of CNS inflammatory regulation that
reduced oxygen delivery can cause metabolic stress, characterized by excessive mitochondrial
fission, mitophagy, and potentially astrocytic activation. These changes to astrocytes may
prime the CNS for an inflammatory state. Furthermore, we have demonstrated that
hypoperfusion alone, results in parenchymal injury that presents itself similarly to the neuronal
degeneration in AD. Hypoperfusion caused both gray matter and white matter injury that

335

primarily affected the hippocampus and cortex of mice. The damage to white matter included
axonal dystrophy, disarrangement, and degeneration that is similar to the histological
observations from AD tissue. Additionally, we observed vacuolation of the parenchyma in
hypoperfused mice, which is known to form after the degeneration of dendrites and axons.
Overall, these findings provide a basis for the development of novel therapeutic
strategies that target the changes to the cerebrovasculature for the treatment of AD. Our data
revealed a critical period of cerebrovascular dysfunction and degeneration during the early
presymptomatic stages of AD. This observation may pave the way for the development of a
prophylactic strategy for the treatment of AD by preventing the initial factors that lead to
compromised cerebrovasculature.
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